<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants - Doyle, LW - 2021 | Cochrane Library</title> <meta content="Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants - Doyle, LW - 2021 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001145.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants - Doyle, LW - 2021 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001145.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001145.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants" name="citation_title"/> <meta content="Lex W Doyle" name="citation_author"/> <meta content="lwd@unimelb.edu.au" name="citation_author_email"/> <meta content="Jeanie L Cheong" name="citation_author"/> <meta content="Susanne Hay" name="citation_author"/> <meta content="Beth Israel Deaconess Medical Center, Harvard Medical School" name="citation_author_institution"/> <meta content="Brett J Manley" name="citation_author"/> <meta content="Henry L Halliday" name="citation_author"/> <meta content="Retired Honorary Professor of Child Health, Queen's University Belfast" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD001145.pub5" name="citation_doi"/> <meta content="2021" name="citation_date"/> <meta content="2021/11/11" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001145.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001145.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001145.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Adrenal Cortex Hormones [adverse effects]; Anti-Inflammatory Agents [adverse effects]; *Bronchopulmonary Dysplasia [prevention &amp; control]; Dexamethasone [therapeutic use]; Drug Administration Schedule; Glucocorticoids [adverse effects]; Infant, Premature" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001145.pub5&amp;doi=10.1002/14651858.CD001145.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="dLyXbLct";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001145\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001145\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","th","ms","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001145.pub5",title:"Late (\\u2265 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants",firstPublishedDate:"Nov 11, 2021 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Neonatal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001145.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001145.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001145.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001145.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001145.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001145.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001145.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001145.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001145.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001145.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6845 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001145.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/appendices#CD001145-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/table_n/CD001145StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/table_n/CD001145StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2021 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#CD001145-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Lex W Doyle</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#CD001145-cr-0005">Jeanie L Cheong</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#CD001145-cr-0006">Susanne Hay</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#CD001145-cr-0007">Brett J Manley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information#CD001145-cr-0008">Henry L Halliday</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information/en#CD001145-sec-0093">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 11 November 2021 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001145.pub5">https://doi.org/10.1002/14651858.CD001145.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001145-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001145-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001145-abs-0016">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001145-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001145-abs-0014">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD001145-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001145-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001145-abs-0001" lang="en"> <section id="CD001145-sec-0001"> <h3 class="title" id="CD001145-sec-0001">Background</h3> <p>Many infants born preterm develop bronchopulmonary dysplasia (BPD), with lung inflammation playing a role. Corticosteroids have powerful anti‐inflammatory effects and have been used to treat individuals with established BPD. However, it is unclear whether any beneficial effects outweigh the adverse effects of these drugs. </p> </section> <section id="CD001145-sec-0002"> <h3 class="title" id="CD001145-sec-0002">Objectives</h3> <p>To examine the relative benefits and adverse effects of late (starting at seven or more days after birth) systemic postnatal corticosteroid treatment for preterm infants with evolving or established BPD. </p> </section> <section id="CD001145-sec-0003"> <h3 class="title" id="CD001145-sec-0003">Search methods</h3> <p>We ran an updated search on 25 September 2020 of the following databases: CENTRAL via CRS Web and MEDLINE via OVID. We also searched clinical trials databases and reference lists of retrieved articles for randomised controlled trials (RCTs). We did not include quasi‐RCTs. </p> </section> <section id="CD001145-sec-0004"> <h3 class="title" id="CD001145-sec-0004">Selection criteria</h3> <p>We selected for inclusion in this review RCTs comparing systemic (intravenous or oral) postnatal corticosteroid treatment versus placebo or no treatment started at seven or more days after birth for preterm infants with evolving or established BPD. We did not include trials of inhaled corticosteroids. </p> </section> <section id="CD001145-sec-0005"> <h3 class="title" id="CD001145-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. We extracted and analysed data regarding clinical outcomes that included mortality, BPD, and cerebral palsy. We used the GRADE approach to assess the certainty of evidence. </p> </section> <section id="CD001145-sec-0006"> <h3 class="title" id="CD001145-sec-0006">Main results</h3> <p>Use of the GRADE approach revealed that the certainty of evidence was high for most of the major outcomes considered, except for BPD at 36 weeks for all studies combined and for the dexamethasone subgroup, which were downgraded one level to moderate because of evidence of publication bias, and for the combined outcome of mortality or BPD at 36 weeks for all studies combined and for the dexamethasone subgroup, which were downgraded one level to moderate because of evidence of substantial heterogeneity. </p> <p>We included 23 RCTs (1817 infants); 21 RCTS (1382 infants) involved dexamethasone (one also included hydrocortisone) and two RCTs (435 infants) involved hydrocortisone only. The overall risk of bias of included studies was low; all were RCTs and most trials used rigorous methods. </p> <p>Late systemic corticosteroids overall reduce mortality to the latest reported age (risk ratio (RR) 0.81, 95% confidence interval (CI) 0.66 to 0.99; 21 studies, 1428 infants; high‐certainty evidence). Within the subgroups by drug, neither dexamethasone (RR 0.85, 95% CI 0.66 to 1.11; 19 studies, 993 infants; high‐certainty evidence) nor hydrocortisone (RR 0.74, 95% CI 0.54 to 1.02; 2 studies, 435 infants; high‐certainty evidence) alone clearly reduce mortality to the latest reported age. We found little evidence for statistical heterogeneity between the dexamethasone and hydrocortisone subgroups (P = 0.51 for subgroup interaction). </p> <p>Late systemic corticosteroids overall probably reduce BPD at 36 weeks' postmenstrual age (PMA) (RR 0.89, 95% CI 0.80 to 0.99; 14 studies, 988 infants; moderate‐certainty evidence). Dexamethasone probably reduces BPD at 36 weeks' PMA (RR 0.76, 95% CI 0.66 to 0.87; 12 studies, 553 infants; moderate‐certainty evidence), but hydrocortisone does not (RR 1.10, 95% CI 0.92 to 1.31; 2 studies, 435 infants; high‐certainty evidence) (P &lt; 0.001 for subgroup interaction). </p> <p>Late systemic corticosteroids overall probably reduce the combined outcome of mortality or BPD at 36 weeks' PMA (RR 0.85, 95% CI 0.79 to 0.92; 14 studies, 988 infants; moderate‐certainty evidence). Dexamethasone probably reduces the combined outcome of mortality or BPD at 36 weeks' PMA (RR 0.75, 95% CI 0.67 to 0.84; 12 studies, 553 infants; moderate‐certainty evidence), but hydrocortisone does not (RR 0.98, 95% CI 0.88 to 1.09; 2 studies, 435 infants; high‐certainty evidence) (P &lt; 0.001 for subgroup interaction). </p> <p>Late systemic corticosteroids overall have little to no effect on cerebral palsy (RR 1.17, 95% CI 0.84 to 1.61; 17 studies, 1290 infants; high‐certainty evidence). We found little evidence for statistical heterogeneity between the dexamethasone and hydrocortisone subgroups (P = 0.63 for subgroup interaction). </p> <p>Late systemic corticosteroids overall have little to no effect on the combined outcome of mortality or cerebral palsy (RR 0.90, 95% CI 0.76 to 1.06; 17 studies, 1290 infants; high‐certainty evidence). We found little evidence for statistical heterogeneity between the dexamethasone and hydrocortisone subgroups (P = 0.42 for subgroup interaction). </p> <p>Studies had few participants who were not intubated at enrolment; hence, it is not possible to make any meaningful comments on the effectiveness of late corticosteroids in preventing BPD in non‐intubated infants, including those who might in the present day be supported by non‐invasive techniques such as nasal continuous positive airway pressure or high‐flow nasal cannula oxygen/air mixture, but who might still be at high risk of later BPD. </p> <p>Results of two ongoing studies are awaited.</p> </section> <section id="CD001145-sec-0007"> <h3 class="title" id="CD001145-sec-0007">Authors' conclusions</h3> <p>Late systemic postnatal corticosteroid treatment (started at seven days or more after birth) reduces the risks of mortality and BPD, and the combined outcome of mortality or BPD, without evidence of increased cerebral palsy. However, the methodological quality of studies determining long‐term outcomes is limited, and no studies were powered to detect increased rates of important adverse long‐term neurodevelopmental outcomes. This review supports the use of late systemic corticosteroids for infants who cannot be weaned from mechanical ventilation. The role of late systemic corticosteroids for infants who are not intubated is unclear and needs further investigation. Longer‐term follow‐up into late childhood is vital for assessment of important outcomes that cannot be assessed in early childhood, such as effects of late systemic corticosteroid treatment on higher‐order neurological functions, including cognitive function, executive function, academic performance, behaviour, mental health, motor function, and lung function. Further RCTs of late systemic corticosteroids should include longer‐term survival free of neurodevelopmental disability as the primary outcome. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001145-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001145-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001145-abs-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001145-abs-0017">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001145-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001145-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001145-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001145-abs-0013">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001145-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD001145-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001145-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001145-abs-0006">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001145-abs-0002" lang="en"> <h3>Late (from the age of seven days) systemic postnatal corticosteroids for preventing bronchopulmonary dysplasia in preterm infants </h3> <p><b>Review question:</b> to determine the benefits and harms associated with treatment consisting of drugs that suppress inflammation, called corticosteroids, given starting seven days of age or later to prevent or treat lung injury, known as bronchopulmonary dysplasia (sometimes also called chronic lung disease), in babies born too early (preterm). </p> <p><b>Background:</b> corticosteroids can reduce lung inflammation in newborns with bronchopulmonary dysplasia but may cause harm. Bronchopulmonary dysplasia is a major problem for newborn babies in neonatal intensive care units, and is associated with both a higher death rate and worse longer‐term outcomes among survivors. Persistent inflammation of the lungs is the most likely cause of bronchopulmonary dysplasia. Corticosteroid drugs have strong anti‐inflammatory effects and so have been used to prevent or to treat bronchopulmonary dysplasia, particularly in babies who cannot be weaned from mechanical ventilation. </p> <p><b>Study characteristics:</b> we reviewed all clinical trials in preterm babies that gave corticosteroids systemically, that is, either as an injection or as a medicine, starting from the first seven days of age, and provided data on rates of bronchopulmonary dysplasia later in the newborn period. We included 23 studies (1817 infants). Search is up‐to‐date as of 25 September 2020. </p> <p><b>Key results:</b> this review indicates that giving systemic corticosteroids to babies starting at seven days or later after birth reduce the risks of death and bronchopulmonary dysplasia, without increasing rates of cerebral palsy (a disorder affecting movement ability) in later childhood. However, the longer‐term outcomes have not been well studied. It seems wise to limit late use of systemic corticosteroids to babies who cannot be weaned from mechanical ventilation, and to minimise the dose and duration of any course of treatment. </p> <p>Results for two ongoing studies are awaited.</p> <p><b>Certainty of evidence:</b> overall the certainty of evidence supporting our conclusions for major outcomes is high. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001145-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001145-sec-0070"></div> <h3 class="title" id="CD001145-sec-0071">Implications for practice</h3> <section id="CD001145-sec-0071"> <p>The condition of the ventilator‐dependent infant with evolving BPD from the age of seven days or later may be at least transiently improved by a course of systemic corticosteroids. High‐quality or moderate‐quality evidence shows that such treatment reduces rates of mortality, BPD, and the combined outcome of mortality or BPD, without evidence of increasing rates of cerebral palsy. However, the methodological quality of studies determining long‐term outcomes is limited: in most reports, surviving children have been assessed predominantly before school age, and no study has been sufficiently powered to detect important adverse long‐term neurodevelopmental outcomes. Given evidence of both benefits and harms of treatment, and limitations of the evidence for long‐term outcomes at present, it appears prudent to reserve the use of late systemic corticosteroids for infants who cannot be weaned from mechanical ventilation via an endotracheal tube from the age of seven days of age, and to minimise the dose and duration of any course of treatment. </p> <p>Evidence is insufficient to guide the use of late systemic corticosteroids to prevent BPD among infants who are not intubated. </p> </section> <h3 class="title" id="CD001145-sec-0072">Implications for research</h3> <section id="CD001145-sec-0072"> <p>Studies are needed to examine the lowest safe dose of corticosteroid. One large ongoing placebo‐controlled trial of systemic hydrocortisone in ventilator‐dependent infants beyond the first week after birth may help to establish the role of hydrocortisone, if any, in intubated infants (<a href="./references#CD001145-bbs2-0071" title="NCT01353313. A randomized controlled trial of the effect of hydrocortisone on survival without bronchopulmonary dysplasia and on neurodevelopmental outcomes at 22 - 26 months of age in intubated infants &lt; 30 weeks' gestation age. clinicaltrials.gov/show/NCT01353313 (first received 20 April 2011). ">NCT01353313</a>). Hydrocortisone at more physiological doses should be compared with dexamethasone at lower doses for ventilator‐dependent infants. Studies of other corticosteroids, such as betamethasone or methylprednisolone, might be worthwhile. Review authors have noted a compelling need for long‐term follow‐up studies among all children who have been enrolled in randomised controlled trials of postnatal corticosteroids. Investigators must examine a broad range of adverse neurodevelopmental outcomes, which include major neurosensory (including cerebral palsy, visual and auditory function) as well as cognitive and behavioural outcomes that may be more evident at older ages. New studies should be designed to assess overall risks and benefits of corticosteroids and should be sufficiently powered to detect important adverse long‐term neurodevelopmental sequelae. </p> <p>Despite increasing use of non‐invasive ventilation, infants still become oxygen‐dependent and may develop BPD. Outcomes of systemic corticosteroids given to infants on non‐invasive ventilation remain to be investigated. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001145-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001145-sec-0008"></div> <div class="table" id="CD001145-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Systemic corticosteroids (dexamethasone or hydrocortisone) compared with control (placebo or nothing) for chronic lung disease in preterm infants</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Systemic corticosteroids (dexamethasone or hydrocortisone) compared with control (placebo or nothing) for chronic lung disease in preterm infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preterm infants with chronic lung disease<br/><b>Setting:</b> multiple neonatal intensive care units from high‐income countries<br/><b>Intervention:</b> systemic corticosteroids (dexamethasone or hydrocortisone)<br/><b>Comparison:</b> control (placebo or nothing) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with control (placebo or nothing)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with systemic corticosteroids (dexamethasone or hydrocortisone)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Mortality at latest reported age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.81<br/>(0.66 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1428<br/>(21 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>228 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>185 per 1000<br/>(151 to 226) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.85<br/>(0.66 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>993<br/>(19 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>193 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>164 per 1000<br/>(128 to 215) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.74<br/>(0.54 to 1.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>305 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>226 per 1000<br/>(165 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>BPD at 36 weeks' PMA</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.89<br/>(0.80 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>988<br/>(14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Strong evidence for subgroup differences (interaction P &lt; 0.001)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>594 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>529 per 1000<br/>(475 to 588) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.76<br/>(0.66 to 0.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>553<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝<br/>MODERATE<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>659 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>501 per 1000<br/>(435 to 573) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.10<br/>(0.92 to 1.31) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>516 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>567 per 1000<br/>(474 to 676) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Mortality or BPD at 36 weeks' PMA</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/>(0.79 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>988<br/>(14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Strong evidence for subgroup differences (interaction P &lt; 0.001)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>771 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>656 per 1000<br/>(609  to 710) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.75<br/>(0.67 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>553<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>787 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>590 per 1000<br/>(527to 661) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.98<br/>(0.88 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>753 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>738 per 1000<br/>(663 to 832) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Cerebral palsy ‐ at latest reported age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/>(0.84 to 1.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1290<br/>(17 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Critical outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000<br/>(78 to 150) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.17<br/>(0.84 to 1.61 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1290<br/>(17 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>121 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>135 per 1000 (95 to 193)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.40</p> <p>(0.60 to 3.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435 (2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>40 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>57 per 1000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Mortality or cerebral palsy ‐ at latest reported age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/>(0.76 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1290<br/>(17 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Critical outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>324 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>291 per 1000<br/>(246 to 343) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.95 (0.77 to 1.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>855 (15 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>312 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>296 per 1000 (240 to 362)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.82 (0.62 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435 (2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>345 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>283 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>BPD:</b> bronchopulmonary dysplasia; <b>CI:</b> confidence interval; <b>PMA:</b> postmenstrual age; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> </p> <p><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level because publication bias was suspected. </p> <p><sup>b</sup>Downgraded one level for moderate heterogeneity. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001145-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001145-sec-0009"></div> <section id="CD001145-sec-0010"> <h3 class="title" id="CD001145-sec-0010">Description of the condition</h3> <p>Surfactant therapy has improved outcomes for preterm infants with respiratory distress syndrome but has only modestly reduced the risk of bronchopulmonary dysplasia (BPD) (<a href="./references#CD001145-bbs2-0085" title="EgbertsJ , BrandR , WaltiH , BevilacquaG , BreartG , GardiniF . Mortality, severe respiratory distress syndrome and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics1997;100(1):E4. [DOI: 10.1542/peds.100.1.e4] [PMID: 9200378]">Egberts 1997</a>). Recent data suggest approximately 50% of infants born at &lt; 28 weeks' gestation who survive to 36 weeks' gestation have BPD, with rates remaining stubbornly high, even since exogenous surfactant and more non‐invasive ventilation have been introduced into clinical care over the past 30 years (<a href="./references#CD001145-bbs2-0077" title="CheongJL , OlsenJE , HuangL , DalzielKM , BolandRA , BurnettAC , et al, Members of the Victorian Infant Collaborative Study Group. Changing consumption of resources for respiratory support and short-term outcomes in four consecutive geographical cohorts of infants born extremely preterm over 25 years since the early 1990s. BMJ Open2020;10(9):e037507. [DOI: 10.1136/bmjopen-2020-037507] [PMID: 32912950]">Cheong 2020</a>). Management BPD in infants is both time‐consuming and costly. The term 'bronchopulmonary dysplasia' describes injury with maldevelopment of the lung that follows preterm birth and is a major problem in neonatal intensive care units. Persistent lung inflammation is the most likely underlying pathogenesis. </p> </section> <section id="CD001145-sec-0011"> <h3 class="title" id="CD001145-sec-0011">Description of the intervention</h3> <p>Postnatal corticosteroid treatment has been shown to have some acute effects on lung function in infants with established BPD, especially among those who are ventilator‐dependent (<a href="./references#CD001145-bbs2-0004" title="Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics1991;88(3):421-7. [PMID: 1881718]JonesR , WincottE , ElbourneD , GrantA . Controlled trial of dexamethasone in neonatal chronic lung disease: a 3 year follow-up. Pediatrics1995;96(5 Pt 1):897-906. [PMID: 7478833]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics2005;116(2):370-8. [DOI: 10.1542/peds.2004-1818] [PMID: 16061591]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure. Pediatrics2005;116(2):379-84. [DOI: 10.1542/peds.2004-1819] [PMID: 16061592]">CDTG 1991</a>; <a href="./references#CD001145-bbs2-0045" title="MammelMC , GreenTP , JohnsonTR , ThompsonTR . Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet1983;1(8338):1356-8. [DOI: 10.1016/s0140-6736(83)92139-6] [PMID: 6134136]">Mammel 1983</a>). Corticosteroids may be given parenterally or enterally. Investigators have expressed concern that the benefits of corticosteroids might not outweigh their adverse effects, which include hypertension, hyperglycaemia, intestinal perforation, and extreme catabolism (<a href="./references#CD001145-bbs2-0072" title="Anonymous. Dexamethasone for neonatal chronic lung disease. Lancet1991;338(8773):982-3. [PMID: 1681347]">Anonymous 1991</a>; <a href="./references#CD001145-bbs2-0100" title="NgPC . The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Archives of Disease of Childhood1993;68(3 Spec No):330-6. [DOI: 10.1136/adc.68.3_spec_no.330] [PMID: 8466274]">Ng 1993</a>). Animal studies have also raised concerns about adverse effects on the central nervous system of corticosteroids given perinatally to immature offspring (<a href="./references#CD001145-bbs2-0086" title="FlagelSB , VazquezDM , Watson SJ Jr, Neal CR Jr. Effects of tapering neonatal dexamethasone on rat growth, neurodevelopment, and stress response. American Journal of Regulatory Integrative Comparative Physiology2002;282(1):R55-66. [DOI: 10.1152/ajpregu.2002.282.1.R55] [PMID: 11742823]">Flagel 2002</a>; <a href="./references#CD001145-bbs2-0089" title="GramsbergenA , MulderEJ . The influence of betamethasone and dexamethasone on motor development in young rats. Pediatric Research1998;44(1):105-10. [DOI: 10.1203/00006450-199807000-00017] [PMID: 9667379]">Gramsbergen 1998</a>). </p> </section> <section id="CD001145-sec-0012"> <h3 class="title" id="CD001145-sec-0012">How the intervention might work</h3> <p>Corticosteroids might prevent or treat BPD through their potent anti‐inflammatory effects. </p> </section> <section id="CD001145-sec-0013"> <h3 class="title" id="CD001145-sec-0013">Why it is important to do this review</h3> <p>Multiple published systematic reviews have examined the use of systemic postnatal corticosteroids in infants with or at risk of BPD (<a href="./references#CD001145-bbs2-0074" title="Arias-CamisonJM , LauJ , ColeCH , Frantz ID 3rd. Meta-analysis of dexamethasone therapy started in the first 15 days of life for prevention of chronic lung disease in premature infants. Pediatric Pulmonology1999;28(3):167-74. [DOI: 10.1002/(sici)1099-0496(199909)28:3&lt;167::aid-ppul2&gt;3.0.co;2-y] [PMID: 10495332]">Arias‐Camison 1999</a>; <a href="./references#CD001145-bbs2-0076" title="BhutaT , OhlssonA . Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Archives of Disease of Childhood. Fetal and Neonatal Edition1998;79(1):F26-3. [DOI: 10.1136/fn.79.1.f26] [PMID: 9797621]">Bhuta 1998</a>; <a href="./references#CD001145-bbs2-0078" title="DoyleLW , DavisPG . Postnatal corticosteroids in preterm infants: systematic review of effects on mortality and motor function. Journal of Paediatrics and Child Health2000;36(2):101-7. [DOI: 10.1046/j.1440-1754.2000.00481.x] [PMID: 10760004]">Doyle 2000</a>; <a href="./references#CD001145-bbs2-0079" title="DoyleLW , EhrenkranzRA , HallidayHL . Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology2010;98(2):111-7. [DOI: 10.1159/000279992] [PMID: 20150750]">Doyle 2010a</a>; <a href="./references#CD001145-bbs2-0080" title="DoyleLW , EhrenkranzRA , HallidayHL . Dexamethasone treatment in the first week of life for preventing bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology2010;98(3):217-24. [DOI: 10.1159/000286210] [PMID: 20389126]">Doyle 2010b</a>; <a href="./references#CD001145-bbs2-0081" title="DoyleLW , EhrenkranzRA , HallidayHL . Dexamethasone treatment after the first week of life for bronchopulmonary dysplasia in preterm infants: a systematic review. Neonatology2010;98(4):289-96. [DOI: 10.1159/000286212] [PMID: 20453523]">Doyle 2010c</a>; <a href="./references#CD001145-bbs2-0082" title="DoyleLW , EhrenkranzRE , HallidayHL . Early (&lt; 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. Art. No: CD001146. [DOI: 10.1002/14651858.CD001146.pub4]">Doyle 2014a</a>; <a href="./references#CD001145-bbs2-0119" title="DoyleLW , EhrenkranzRE , HallidayHL . Late (&gt; 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database of Systematic Reviews2014, Issue 5. Art. No: CD001145. [DOI: 10.1002/14651858.CD001145.pub3]">Doyle 2014b</a>; <a href="./references#CD001145-bbs2-0120" title="DoyleLW , CheongJL , EhrenkranzRA , HallidayHL . Late (&gt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD001145. [DOI: 10.1002/14651858.CD001145.pub4]">Doyle 2017b</a>; <a href="./references#CD001145-bbs2-0091" title="HallidayHL . A review of postnatal corticosteroids for treatment and prevention of chronic lung disease in the preterm infant. Prenatal and Neonatal Medicine1997;2:1-12.">Halliday 1997</a>; <a href="./references#CD001145-bbs2-0092" title="HallidayHL . Clinical trials of postnatal corticosteroids: inhaled and systemic. Biology of the Neonate1999;76(Suppl 1):29-40. [DOI: 10.1159/000047044] [PMID: 10393391]">Halliday 1999</a>; <a href="./references#CD001145-bbs2-0115" title="Tarnow-MordiW , MitraA . Postnatal dexamethasone in preterm infants is potentially lifesaving, but follow up studies are urgently needed. BMJ1999;319(7222):1385-6. [DOI: 10.1136/bmj.319.7222.1385] [PMID: 10574836]">Tarnow‐Mordi 1999</a>). Other systematic reviews have addressed early versus late use of inhaled corticosteroids for preventing BPD (<a href="./references#CD001145-bbs2-0111" title="ShahVS , OhlssonA , HallidayHL , DunnMS . Early administration of inhaled corticosteroids for preventing chronic lung disease in very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD001969. [DOI: 10.1002/14651858.CD001969.pub4]">Shah 2017a</a>), or for treating BPD (<a href="./references#CD001145-bbs2-0104" title="OnlandW , OffringaM , vanKaamA . Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 8. Art. No: CD002311. [DOI: 10.1002/14651858.CD002311.pub4]">Onland 2017a</a>), as well as use of systemic versus inhaled corticosteroids for preventing BPD (<a href="./references#CD001145-bbs2-0112" title="ShahSS , OhlssonA , HallidayHL , ShahVS . Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD002058. [DOI: 10.1002/14651858.CD002058.pub3]">Shah 2017b</a>), or for treating BPD (<a href="./references#CD001145-bbs2-0113" title="ShahSS , OhlssonA , HallidayHL , ShahVS . Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD002057. [DOI: 10.1002/14651858.CD002057.pub4]">Shah 2017c</a>). Another review compared different systemic corticosteroid regimens (<a href="./references#CD001145-bbs2-0105" title="OnlandW , De JaegereAP , OffringaM , vanKaamA . Systemic corticosteroid regimens for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 1. Art. No: CD010941. [DOI: 10.1002/14651858.CD010941.pub2]">Onland 2017b</a>). </p> <p>Two existing Cochrane Reviews have explored trials in which systemic postnatal corticosteroids were started within seven days of birth (<a href="./references#CD001145-bbs2-0083" title="DoyleLW , EhrenkranzRE , HallidayHL . Early (&lt; 8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD001146. [DOI: 10.1002/14651858.CD001146.pub5]">Doyle 2017a</a>), or were started more than seven days after birth (<a href="./references#CD001145-bbs2-0120" title="DoyleLW , CheongJL , EhrenkranzRA , HallidayHL . Late (&gt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD001145. [DOI: 10.1002/14651858.CD001145.pub4]">Doyle 2017b</a>). The present systematic review updates the review of systemic corticosteroids started seven days or more after birth. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001145-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001145-sec-0014"></div> <p>To examine the relative benefits and adverse effects of late (starting at seven or more days after birth) systemic postnatal corticosteroid treatment for preterm infants with evolving or established BPD. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001145-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001145-sec-0015"></div> <section id="CD001145-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001145-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs) of late (seven days or more) systemic postnatal corticosteroid treatment for preterm infants with evolving or established BPD that reported clinically important outcome variables. We did not include cluster randomised, cross‐over, or quasi‐randomised controlled trials. </p> </section> <section id="CD001145-sec-0018"> <h4 class="title">Types of participants</h4> <p>We included preterm infants with evolving or established BPD, defined as oxygen‐dependent, ventilator‐dependent, or both, with or without radiographic changes of BPD. </p> </section> <section id="CD001145-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Treatment with systemic corticosteroids (dexamethasone or hydrocortisone) versus control (placebo or nothing). </p> </section> <section id="CD001145-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>These are divided into primary and secondary outcomes.</p> <section id="CD001145-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001145-list-0001"> <li> <p>Mortality at various ages (including at 28 days after birth, at 36 weeks' postmenstrual age, at discharge home after primary hospitalisation, and at latest age reported) </p> </li> <li> <p>BPD (including at 28 days after birth, at 36 weeks' postmenstrual age, and at 36 weeks' postmenstrual age among survivors) </p> </li> <li> <p>Mortality or BPD (at 28 days after birth and at 36 weeks' postmenstrual age)</p> </li> <li> <p>Longer‐term outcomes into childhood (including blindness, deafness, cerebral palsy, and major neurosensory disability) </p> </li> </ul> </p> </section> <section id="CD001145-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001145-list-0002"> <li> <p>Failure to extubate</p> </li> <li> <p>Late rescue with corticosteroids</p> </li> <li> <p>Need for home oxygen therapy</p> </li> <li> <p>Complications during primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus, severe intraventricular haemorrhage, periventricular leukomalacia, necrotising enterocolitis, sepsis, gastrointestinal bleeding, intestinal perforation, and severe retinopathy of prematurity) </p> </li> <li> <p>Later childhood outcomes, including respiratory function, blood pressure, and growth</p> </li> </ul> </p> </section> </section> </section> <section id="CD001145-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001145-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We conducted a comprehensive updated search in September 2020 including Cochrane Central Register of Controlled Trials (CENTRAL; 2020, Issue 9), in the Cochrane Library; and OVID MEDLINE(R) and Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Daily and Versions(R) (1 January 2016 to 25 September 2020). We have included the search strategies for each database in <a href="./appendices#CD001145-sec-0076">Appendix 1</a>. We did not apply language restrictions. </p> <p>We searched clinical trial registries for ongoing and recently completed trials. We searched the World Health Organization’s International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en/" target="_blank">www.who.int/ictrp/search/en/</a>) and the US National Library of Medicine’s ClinicalTrials.gov (<a href="http://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>), via Cochrane CENTRAL. Additionally, we searched the International Standard Randomized Controlled Trials Number (ISRCTN) Registry (<a href="http://www.isrctn.com/" target="_blank">http://www.isrctn.com/</a>) for any unique trials not found through the Cochrane CENTRAL search. </p> <p>This is the fifth update of this review. Our previous search details are listed in <a href="./appendices#CD001145-sec-0080">Appendix 2</a> and <a href="./appendices#CD001145-sec-0081">Appendix 3</a>. </p> </section> <section id="CD001145-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We also searched the reference lists of all identified publications for additional references not identified by the electronic literature search. </p> </section> </section> <section id="CD001145-sec-0026"> <h3 class="title" id="CD001145-sec-0026">Data collection and analysis</h3> <p>We used the methods of Cochrane Neonatal for data collection and analysis.</p> <section id="CD001145-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We included all RCTS that fulfilled the selection criteria presented in the previous section. Two review authors (LWD and JC) independently reviewed results of the updated search and selected studies for inclusion. We resolved disagreements by discussion. </p> </section> <section id="CD001145-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>For each included trial, we sought information regarding methods of randomisation, blinding, and stratification, and whether the trial was single‐ or multi‐centred. Information on trial participants included birth weight, gestational age, and sex. We analysed information on the following clinical outcomes: mortality, BPD (including BPD at 28 days after birth, BPD at 36 weeks' postmenstrual age, BPD at 36 weeks' postmenstrual age in survivors, late rescue with corticosteroids (among all infants and survivors), and need for home oxygen therapy), mortality or BPD (at 28 days after birth and at 36 weeks' postmenstrual age), and long‐term outcomes (including blindness, deafness, cerebral palsy, and major neurosensory disability). Secondary outcomes included failure to extubate, complications during primary hospitalisation (including infection, hyperglycaemia, glycosuria, hypertension, echodensities on ultrasound scan of brain, necrotising enterocolitis, gastrointestinal bleeding, gastrointestinal perforation, and severe retinopathy of prematurity), and longer‐term outcomes of cognitive delay, respiratory health and function, blood pressure, and growth during childhood. </p> <p>For each study, one review author (LWD) entered final data into Review Manager (RevMan) 5 (<a href="./references#CD001145-bbs2-0108" title="The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>); a second review author (SH) then checked the data for accuracy. We resolved discrepancies through discussion or through consultation with a third assessor (HLH). </p> <p>We attempted to contact the authors of original reports to request further details when information regarding any of the above was unclear. </p> </section> <section id="CD001145-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (LWD and JC) independently assessed risk of bias (low, high, or unclear) of all included trials using the Cochrane ‘Risk of bias’ tool for the following domains (<a href="./references#CD001145-bbs2-0093" title="HigginsJP , AltmanDG , SterneJA , on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8. Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). </p> <p> <ul id="CD001145-list-0003"> <li> <p>Sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessment (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias).</p> </li> <li> <p>Any other bias.</p> </li> </ul> </p> <p>We resolved disagreements by discussion or by consultation with a third assessor. See <a href="./appendices#CD001145-sec-0082">Appendix 4</a> for a more detailed description of risk of bias for each domain.  </p> </section> <section id="CD001145-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used the standard methods of Cochrane Neonatal to analyse data.</p> <p>We performed statistical analyses using Review Manager (RevMan) 5 (<a href="./references#CD001145-bbs2-0108" title="The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We analysed dichotomous data using risk ratio (RR), risk difference (RD), and the number needed to treat for an additional beneficial outcome (NNTB), or the number needed to treat for an additional harmful outcome (NNTH). We reported the 95% confidence interval (CI) for all estimates. </p> <p>We analysed continuous data using mean difference (MD), or standardised mean difference (SMD) to combine trials that measured the same outcome using different methods. </p> </section> <section id="CD001145-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>For clinical outcomes such as episodes of sepsis, we analysed the data as proportions of neonates having one or more episodes. </p> </section> <section id="CD001145-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. When we had concern regarding the impact of including studies with high levels of missing data in the overall assessment of treatment effect, we planned to explore this concern using sensitivity analysis. </p> <p>We performed all outcome analyses on an intention‐to‐treat basis (i.e. we included in the analyses all participants randomised to each group). The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD001145-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity between trials by inspecting forest plots and quantifying the impact of heterogeneity using the I² statistic. If noted, we planned to explore possible causes of statistical heterogeneity using prespecified subgroup analysis (e.g. differences in study quality, participants, intervention regimens, outcome assessments). </p> </section> <section id="CD001145-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We assessed possible publication bias and other biases by examining symmetry/asymmetry on funnel plots. In addition, we computed Egger's statistic on funnel plots to assess the strength of the evidence for publication bias. </p> <p>For included trials that were recently performed (and therefore prospectively registered), we used the websites <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a> and <a href="http://www.controlled-trials.com" target="_blank">www.controlled-trials.com</a> to explore possible selective reporting of study outcomes by comparing primary and secondary outcomes for reports in which primary and secondary outcomes were proposed at trial registration. If we found such discrepancies, we planned to contact the primary investigators to request missing data on outcomes prespecified at trial registration. </p> </section> <section id="CD001145-sec-0035"> <h4 class="title">Data synthesis</h4> <p>When we judged meta‐analysis to be appropriate, we carried out the analysis using Review Manager (RevMan) 5, supplied by Cochrane (<a href="./references#CD001145-bbs2-0108" title="The Cochrane CollaborationReview Manager 5 (RevMan 5). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). We used the Mantel‐Haenszel method for estimates of typical RR and RD. We analysed continuous measures using the inverse variance method, and we computed MDs or SMDs.  </p> <p>We used the fixed‐effect model for all meta‐analyses.</p> </section> <section id="CD001145-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We included subgroup analyses by type of corticosteroid used (dexamethasone or hydrocortisone) if we identified a sufficient number of trials to make such subgroup analyses meaningful. </p> </section> <section id="CD001145-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses for situations where this might affect interpretation of significant results (e.g. when risk of bias was associated with the quality of some of included trials). </p> </section> <section id="CD001145-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE approach, as outlined in the GRADE Handbook (<a href="./references#CD001145-bbs2-0110" title="SchünemannH , BrożekJ , GuyattG , OxmanA , editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.">Schünemann 2013</a>), to assess the certainty of evidence for the following (clinically relevant) outcomes: mortality, BPD (including BPD at 28 days after birth, BPD at 36 weeks' postmenstrual age, BPD at 36 weeks' postmenstrual age in survivors, late rescue with corticosteroids (among all infants and survivors), and need for home oxygen therapy), mortality or BPD (at 28 days after birth and at 36 weeks' postmenstrual age), and long‐term outcomes (including blindness, deafness, cerebral palsy, and major neurosensory disability). </p> <p>Two review authors (LWD and JC) independently assessed the certainty of evidence for each of the outcomes above. We considered evidence from RCTs as high certainty but downgraded the evidence one level for serious (or two levels for very serious) limitations based upon the following: design (risk of bias), consistency across studies, directness of evidence, precision of estimates, and presence of publication bias. We used the <a href="./references#CD001145-bbs2-0088" title="GRADE Working Group, McMaster University (developed by Evidence Prime)GRADEpro GDT. Version accessed 21 February 2017. Hamilton (ON): GRADE Working Group, McMaster University (developed by Evidence Prime).">GRADEpro GDT</a> Guideline Development Tool to create <a href="./full#CD001145-tbl-0001">summary of findings Table 1</a> to report the certainty of evidence. </p> <p>The GRADE approach results in an assessment of the certainty of a body of evidence as one of four grades. </p> <p> <ul id="CD001145-list-0004"> <li> <p>High certainty: further research is very unlikely to change our confidence in the estimate of effect. </p> </li> <li> <p>Moderate certainty: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> </li> <li> <p>Low certainty: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> </li> <li> <p>Very low certainty: we are very uncertain about the estimate.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001145-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001145-sec-0039"></div> <section id="CD001145-sec-0040"> <h3 class="title">Description of studies</h3> <p>Up to the 2014 update of this review, 21 studies had been included.</p> <p>For the 2017 update of this review, database searches for the calendar years 2013‐2017 identified 4930 references; other search sources identified 102 additional references. After removing 852 duplicate records, 4180 title abstracts were screened, 4166 full texts were excluded, 14 full text articles were assessed for eligibility, and no new studies were included at that time. </p> <section id="CD001145-sec-0041"> <h4 class="title">Results of the search</h4> <p>For the current update of this review, database searches for the calendar years 2016‐2020 identified 3760 references; other search sources identified no additional references. After removing 404 duplicate records, 3356 title abstracts were screened, 3351 full texts were excluded, five full text articles were assessed for eligibility, and two new studies were included. See <a href="#CD001145-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD001145-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram: review update." data-id="CD001145-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram: review update.</p> </div> </div> </div> <p> With addition of the two new RCTs, we have included in this updated review 23 RCTs, in total, that have recruited 1817 infants. These trials enrolled preterm infants who were oxygen‐ or ventilator‐dependent (or both) beyond six days of age. Investigators typically used dexamethasone at an initial dose of 0.5 to 1.0 mg/kg/d, with initial duration of therapy ranging from three days to six weeks. In two studies, the corticosteroid was hydrocortisone (<a href="./references#CD001145-bbs2-0015" title="HalbmeijerNM , OnlandW , CoolsF , SwarteR , van derHeide-JalvingM , MerkusMP , van Kaam AH Stop-BPD Trial Collaborators. Effect of systemic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years' corrected age: Follow-up of a randomized clinical trial. JAMA2021;326(4):355-357. OnlandW , CoolsF , KroonA , RademakerK , MerkusMP , DijkPH , et al, Stop-BPD Study Group. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial. JAMA2019;321(4):354-63. [DOI: 10.1001/jama.2018.21443] [PMID: 30694322]">Onland 2019</a>; <a href="./references#CD001145-bbs2-0017" title="ParikhNA , KennedyKA , LaskyRE , McDavidGE , TysonJE . Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes. Journal of Pediatrics2013;162(4):685-90. [DOI: 10.1016/j.jpeds.2012.09.054] [PMID: 23140612]ParikhNA , KennedyKA , LaskyRE , TysonJE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS One2015;10(9):e0137051. [DOI: 10.1371/journal.pone.0137051] [PMID: 26376074]">Parikh 2013</a>). Details are given below and in the <a href="./references#CD001145-sec-0099" title="">Characteristics of included studies</a> table. </p> <p>We discuss the excluded trials below and in the <a href="./references#CD001145-sec-0100" title="">Characteristics of excluded studies</a> table. </p> <p>We identified two ongoing RCTs of hydrocortisone to prevent or treat BPD (<a href="./references#CD001145-bbs2-0070" title="HeY , ZhangY , GaoS , WangX , HeN , ZhangD , et al. Hydrocortisone to treat early bronchopulmonary dysplasia in very preterm infants: study protocol for a randomized controlled trial. Trials2020;21(1):762. [DOI: 10.1186/s13063-020-04698-0] [PMID: 32883333]">He 2020</a>; <a href="./references#CD001145-bbs2-0071" title="NCT01353313. A randomized controlled trial of the effect of hydrocortisone on survival without bronchopulmonary dysplasia and on neurodevelopmental outcomes at 22 - 26 months of age in intubated infants &lt; 30 weeks' gestation age. clinicaltrials.gov/show/NCT01353313 (first received 20 April 2011). ">NCT01353313</a>). See <a href="./references#CD001145-sec-0101" title="">Characteristics of ongoing studies</a>. </p> </section> <section id="CD001145-sec-0042"> <h4 class="title">Included studies</h4> <p>We included 23 RCTs (1817 infants) in this updated review.</p> <p><a href="./references#CD001145-bbs2-0001" title="AriagnoRL , SweeneyTE , BaldwinRB , InguilloD , MartinD . Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia: lung function, clinical course and outcome at three years. Unpublished manuscript supplied by authors2000. AriagnoRL , SweeneyTJ , BaldwinRB , InguilloD , MartinD . Dexamethasone effects on lung function and risks in 3 week old ventilatory dependent preterm infants. American Reviews of Respiratory Disease1987;135:A125. [CENTRAL: CN-00295119] ">Ariagno 1987</a> was updated with more data provided by investigators in September 2000. Investigators randomised 34 preterm infants of less than 1501 grams birth weight who were ventilator‐dependent and were not weaning from mechanical ventilation at three weeks of age to parenteral dexamethasone (n = 17) or placebo (n = 17) groups. Treated babies received one of two regimens: a 10‐day course of 1.0 mg/kg/d for four days and 0.5 mg/kg/d for six days ((total dose 7 mg/kg dexamethasone over 10 days), or a seven‐day course of 1.0 mg/kg/d for three days followed by 0.5 mg/kg/d for four days (total dose 8.5 mg/kg dexamethasone over 10 days). Researchers calculated total respiratory system compliance from a pneumotachometer and made airway pressure measurements during mechanical inflation before and after seven days of treatment. Outcomes included mortality, duration of ventilation and oxygen therapy, and complications of prematurity and treatment. Country: USA. </p> <p><a href="./references#CD001145-bbs2-0002" title="AveryGB , FletcherAB , CaplanM , BrudnoDS . Control trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75(1):106-11. [PMID: 3880879]">Avery 1985</a> enrolled 16 infants with birth weight less than 1500 grams, a clinical and radiographic diagnosis of respiratory distress syndrome, inability to be weaned from the ventilator after two weeks, and radiological evidence of stage II or III BPD (<a href="./references#CD001145-bbs2-0102" title="Northway WH Jr, RosanRC , PorterDY . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. New England Journal of Medicine1967;276(7):357-68. [DOI: 10.1056/NEJM196702162760701] [PMID: 5334613]">Northway 1967</a>). Researchers excluded babies if they had patent ductus arteriosus, congenital heart disease, sepsis, or pneumonia; had received intravenous lipids for at least 24 hours; and were over six weeks of age. To those randomised to receive dexamethasone (n = 8), investigators gave 0.5 mg/kg/d intravenously in two divided doses for three days, followed by 0.3 mg/kg/d for a further three days, thereafter decreased by 10% of the current dose every three days until a dose of 0.1 mg/kg/d was reached. At that point, they gave the drug on alternate days for one week, then discontinued (total dose approximately 8 mg/kg dexamethasone over 42 days). Control infants (n = 8) did not receive a placebo. Country: USA. </p> <p><a href="./references#CD001145-bbs2-0003" title="BrozanskiBS , JonesJG , GilmoreCH , BalsanMJ , VazquezRL , IsraelBA , et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infant. Journal of Pediatrics1995;126(5 Pt 1):769-76. [DOI: 10.1016/s0022-3476(95)70410-8] [PMID: 7752005]GilmourCH , Sentipal-WaleriusJM , JonesJG , DoyleJM , BrozanskiBS , BalsanMJ , et al. Pulse dexamethasone does not impair growth and body composition of very low birth weight infants. Journal of the American College of Nutrition1995;14(5):455-62. [10.1080/07315724.1995.10718536] [PMID: 8522724]HofkoshD , BrozanskiBS , EdwardsMD , WilliamsLA , JonesJG , ChengKP . One year outcome of infants treated with pulse dexamethasone for prevention of BPD. Pediatric Research1995;37(4):259A. ">Brozanski 1995</a> was a prospective randomised double‐blind trial conducted to assess the efficacy and safety of pulse doses of dexamethasone for survival without supplemental oxygen given to very low birth weight infants at high risk of BPD. Trial authors randomly assigned 78 infants with birth weight less than 1501 grams, who were ventilator‐dependent at seven days, to receive pulse doses of dexamethasone 0.5 mg/kg/d 12‐hourly or an equivalent volume of a saline placebo for three days at 10‐day intervals, until they no longer required supplemental oxygen or mechanical ventilation, or had reached 36 weeks' postmenstrual age (total minimum dose 3 mg/kg dexamethasone over three days). Infants were excluded from the study if they had complex congenital anomalies, pulmonary hypoplasia, or haemodynamic instability. Country: USA. Participants were recruited between March 1991 and April 1993. Supported by grants from the Magee‐Women's Health Foundation Research Fund and the GCRC/National Institutes of Health 5M0 IRR00084. </p> <p><a href="./references#CD001145-bbs2-0004" title="Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics1991;88(3):421-7. [PMID: 1881718]JonesR , WincottE , ElbourneD , GrantA . Controlled trial of dexamethasone in neonatal chronic lung disease: a 3 year follow-up. Pediatrics1995;96(5 Pt 1):897-906. [PMID: 7478833]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics2005;116(2):370-8. [DOI: 10.1542/peds.2004-1818] [PMID: 16061591]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure. Pediatrics2005;116(2):379-84. [DOI: 10.1542/peds.2004-1819] [PMID: 16061592]">CDTG 1991</a> (Collaborative Dexamethasone Trial Group 1991) was a multi‐centre trial conducted at 31 centres in six countries (UK, Ireland, Belgium, Germany, Canada, and USA) over a period of two and a half years from August 1986 to January 1989. A total of 287 infants who were oxygen‐dependent and had been in a static or deteriorating condition over the preceding week were eligible for trial entry from around three weeks of age. Study authors excluded infants with major malformations (n = 2), and they delayed trial entry to allow treatment of any intercurrent infection or heart failure. Infants did not have to require mechanical ventilation ‐ at the time of entry approximately two‐thirds of infants were intubated and one‐third were not. Those allocated to the dexamethasone group (n = 143) received 0.6 mg/kg/d intravenously (or orally if there was no intravenous line) for one week (total dose 4.2 mg/kg dexamethasone over seven days). There was an option to give a second tapering nine‐day course (0.6, 0.4, and 0.2 mg/kg/d for three days each) if, after initial improvement, relapse occurred. Control infants (n = 142) received an equivalent volume of saline placebo. Supported by Action Research for Crippled Children. </p> <p><a href="./references#CD001145-bbs2-0005" title="CummingsJJ , D'EugenioDB , GrossSJ . A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine1989;320(23):1505-10. [DOI: 10.1056/NEJM198906083202301] [PMID: 2657423]CummingsJJ . Personal communication. email2002. GrossSJ , AnbarRD , MettelmanBB . Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics2005;115(3):681-7. [DOI: 10.1542/peds.2004-0956] [PMID: 15741372]">Cummings 1989</a> randomised 36 preterm infants with birth weight less than 1251 grams and gestational age less than 31 weeks, who were dependent on oxygen (&gt; 29%) and mechanical ventilation (rate &gt; 14 per minute with no evidence of weaning during the previous 72 hours) at two weeks of age, to receive a 42‐day course of dexamethasone or an 18‐day course of dexamethasone or saline placebo. They did not include infants with symptomatic patent ductus arteriosus, renal failure, or sepsis. To infants in the 42‐day group (n = 13), researchers administered dexamethasone at a dose of 0.5 mg/kg/d for three days and 0.3 mg/kg/d for the next three days. They then reduced the dose by 10% every three days until a dose of 0.1 mg/kg was reached on Day 34. After three days at this dose, the drug was given on alternate days for one week and then was stopped (total dose 7.9 mg/kg dexamethasone over 42 days). Infants in the 18‐day dexamethasone group (n = 12) received the same initial dose of 0.5 mg/kg/d for three days, but their dose was then decreased more rapidly by 50% every three days until a dose of 0.06 mg/kg was reached on Day 10. After three days at this dose, study authors gave the drug on alternate days for one week and then stopped (total dose 3 mg/kg dexamethasone over 18 days). For the remaining four treatment days, those infants received saline placebo. Infants in the control group (n = 11) received saline placebo for 42 days. Researchers combined the two treatment groups for the purposes of this meta‐analysis and provided additional data on some short‐term and long‐term outcomes for inclusion in this review. Country: USA. Participants were recruited between January 1986 and June 1987. </p> <p><a href="./references#CD001145-bbs2-0006" title="DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter international randomized controlled trial. Pediatrics2006;117(1):75-83. [DOI: 10.1542/peds.2004-2843] [PMID: 16396863]DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics2007;119(4):716-21. [DOI: 10.1542/peds.2006-2806] [PMID: 17403842]">Doyle 2006</a> included a total of 70 infants of less than 1000 grams birth weight or born at less than 28 weeks' gestation, who were at least seven days of age and were ventilator‐dependent and considered eligible for postnatal corticosteroids. Exclusions were few and comprised only those with congenital anomalies likely to adversely affect long‐term neurological outcomes. Trialists worked at 11 collaborating centres within Australia, New Zealand, and Canada and performed stratification by centre. They randomly allocated infants to twice‐daily doses of a 10‐day tapering course of dexamethasone sodium phosphate (0.15 mg/kg/d for three days, 0.10 mg/kg/d for three days, 0.05 mg/kg/d for two days, 0.02 mg/kg/d for two days (total dose 0.89 mg/kg dexamethasone over 10 days) (n = 35 infants)) or to an equivalent volume of 0.9% saline placebo (n = 35 infants). A repeat course of the same blinded drug was a therapeutic option for attending physicians. The dexamethasone preparation did not contain bisulphite preservative. Researchers based the sample size calculation for the original trial on detecting improvement in survival free of major neurosensory disability from 50% to 60%, with a two‐sided type I error rate of 5% and 80% power, and required that a total of 814 infants be recruited. This study was stopped early at 70 infants, not only because less than 10% of the initial sample had been recruited after 2.5 years (March 2000 to October 2002), making it unlikely that the total sample size of 814 would be achieved within a reasonable time, but also because the rate of recruitment had fallen ‐ not increased ‐ even though more centres had entered the study from the time of its inception. Countries: Australia, New Zealand, Canada. Supported by the National Health ad Medical Research Council of Australia (Project Grant 108700). </p> <p><a href="./references#CD001145-bbs2-0007" title="DurandM , SardesiS , McEvoyC . Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized controlled trial. Pediatrics1995;95(4):584-90. [PMID: 7700763]DurandM . Personal communication. email2012. ">Durand 1995</a> was a prospective randomised trial of 44 infants of birth weight 501 grams to 1500 grams and gestational age between 24 and 32 weeks who failed to be weaned from the ventilator at 7 to 14 days; one infant was excluded after randomisation because of birth weight &lt; 500 grams, and hence data were reported for 43 infants. Their oxygen requirement was &gt; 29% and ventilator rate &gt; 14 per minute. Investigators excluded infants with documented sepsis, evidence of systemic hypertension, congenital heart disease, renal failure, intraventricular haemorrhage (grade IV), and multiple congenital anomalies. Infants in the treatment group (n = 23) received dexamethasone 0.5 mg/kg/d 12‐hourly intravenously for the first three days, 0.25 mg/kg/d for the next three days, and 0.10 mg/kg/d on the seventh day of treatment (total dose 2.35 mg/kg dexamethasone over seven days). Controls (n = 20) received no placebo and no dexamethasone during the seven‐day study period. At the end of the study week, the attending clinician could start dexamethasone treatment for controls. Country: USA. Participants were recruited between December 1990 and November 1992. </p> <p><a href="./references#CD001145-bbs2-0008" title="HarkavyKL , ScanlowJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants. A controlled trial. Journal of Pediatrics1989;115(6):979-83. [DOI: 10.1016/s0022-3476(89)80754-1] [PMID: 2685220]HarkavyKL . Personal communication. email2002. ">Harkavy 1989</a> randomised 21 preterm infants who were ventilator‐ and oxygen‐dependent at 30 days of age to receive dexamethasone or placebo. They gave dexamethasone 0.5 mg/kg/d in two or more doses either intravenously or by mouth (total dose 1 mg/kg dexamethasone or more over 2 days), and they gave an equivalent volume of saline to controls. Country: USA. Participants were recruited between April 1983 and July 1987. Supported by a grant from the Columbia Hospital for Women Research Foundation. </p> <p><a href="./references#CD001145-bbs2-0009" title="KariMA , HeinonenKO , IkonenRS , KoivistoM , RaivioKO . Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Archives of Disease of Childhood1993;68(5 Spec No):566-9. [DOI: 10.1136/adc.68.5_spec_no.566] [PMID: 8323356]KariMA , RaivioKO , VengeP , HallmanM . Dexamethasone treatment of infants at risk of chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatric Research1994;36(3):387-93. [DOI: 10.1203/00006450-199409000-00020] [PMID: 7808837]MieskonenS , EronenM , MalmbergLP , TurpeinenM , KariMA , HallmanM . Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth. Acta Paediatrica2003;92(8):896-904. [PMID: 12948063]">Kari 1993</a> was a randomised double‐blind placebo‐controlled trial that enrolled 41 infants with birth weight less than 1501 grams, gestational age greater than 23 weeks, dependence on mechanical ventilation at 10 days, and no signs of patent ductus arteriosus, sepsis, gastrointestinal bleeding, or major malformations. Infants in the dexamethasone group (n = 17) received 0.5 mg/kg/d intravenously in two doses for seven days (total dose 3.5 mg/kg dexamethasone over seven days), whereas the placebo group (n = 24) received normal saline. Country: Finland. Participants were recruited between January 1989 and February 1991. Supported by The Foundation for Pediatric Research, The Academy of Finland, and The Sigfrid Juselius Foundation. </p> <p>In <a href="./references#CD001145-bbs2-0010" title="KazziNJ , BransYW , PolandRL . Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics1990;86(5):722-7. [PMID: 2235226]">Kazzi 1990</a>, 23 preterm infants with birth weight less than 1500 grams and radiological findings consistent with a diagnosis of BPD who were ventilator‐dependent at three to four weeks of age were eligible for study entry provided they needed more than 34% oxygen and had a ventilator rate greater than 14 per minute or peak inspiratory pressure &gt; 17 cmH₂O. Infants had to show lack of improvement in ventilator dependency during the preceding five days. Infants in the treatment group (n = 12) received dexamethasone 0.50 mg/kg/d for three days, given as a single daily dose by nasogastric tube. The dose was tapered to 0.40 mg/kg/d for two days, then to 0.25 mg/kg/d for two days (total dose 2.8 mg/kg dexamethasone over seven days). Thereafter, infants received hydrocortisone administered in four divided doses every six hours, beginning with 8 mg/kg/d for two days and tapered by 50% of the dose every other day until 0.5 mg/kg/d was reached (total dose 31 mg/kg hydrocortisone over 10 days). After a total of 17 days, treatment was discontinued. Infants in the control group (n = 11) received equal volumes of saline. In subgroup analysis by type of corticosteroid, this study is included in the dexamethasone subgroup because the dose of corticosteroid received comprised more dexamethasone than it did hydrocortisone. Country: USA. Participants were recruited between August 1986 and February 1989. </p> <p><a href="./references#CD001145-bbs2-0011" title="BenskyAS , KothadiaJM , CovitzW . Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics1996;97(6 Pt 1):818-21. [PMID: 8657520]GoldsteinDJ , WaldrepEL , VanPeltJC , O'SheaTM . Developmental outcome at 5 years following dexamethasone use for very low birth weight infants. Pediatric Research2000;47(4):310A. Abstract 1832. [DOI: CN-00708985]KothadiaJM , O'SheaTM , RobertsD , AuringerST , WeaverRG , DillardRG . Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants. Pediatrics1999;104(1 Pt 1):22-7, Erratum in: Pediatrics 2004;114(6):1746. [DOI: 10.1542/peds.104.1.22] [PMID: 10390255]NixonPA , WashburnLK , SchechterMS , O'SheaTM . Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. Journal of Pediatrics2007;150(4):345-50. [DOI: 10.1016/j.jpeds.2006.12.013] [PMID: 17382108]O'SheaTM , GoldsteinDJ , JacksonBG , KothadiaJM , DillardRG . Randomized trial of a 42-day tapering course of dexamethasone in very low birth weight infants: neurological, medical and functional outcome at 5 years of age. Pediatric Research2000;47:319A. Abstract 1883. [DOI: CN-00712055]O'SheaTM , KothadiaJM , KlinepeterKL , GoldsteinDJ , JacksonBG , Weaver RG 3rd, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics1999;104(1 Pt 1):15-21. [DOI: 10.1542/peds.104.1.15] [PMID: 10390254]WashburnLK , NixonPA , O'SheaTM . Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age. Pediatrics2006;118(4):1592-9. [DOI: 10.1542/peds.2006-0973] [PMID: 17015551]">Kothadia 1999</a> randomly allocated 118 preterm infants (birth weight &lt; 1501 grams) between 15 and 25 days of age who were ventilator‐dependent to receive a 42‐day tapering course of dexamethasone (n = 57) or saline placebo (n = 61). The dosage schedule was 0.25 mg/kg 12‐hourly for three days and 0.15 mg/kg 12‐hourly for three days, followed by a 10% reduction in dose every three days until a dose of 0.1 mg/kg had been received for three days, from which time they received 0.1 mg/kg every other day until 42 days after entry (total dose 7.9 mg/kg dexamethasone over 42 days). Study authors provided additional data on some short‐term outcomes for inclusion in this review. Country: USA. Participants were recruited between April 1992 and May 1995. Supported by the Brenner Children's Hospital, Winston‐Salem, North Carolina. </p> <p><a href="./references#CD001145-bbs2-0012" title="KovacsL , DavisGM , FaucherD , PapageorgiouA . Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatrica1998;87(7):792-8. [DOI: 10.1080/080352598750013905] [PMID: 9722255]KovacsLB . Personal communication. email2002. ">Kovacs 1998</a> was a double‐blind RCT conducted to assess the efficacy of a combination of prophylactic systemic dexamethasone and nebulised budesonide in reducing the incidence and severity of BPD in infants at less than 30 weeks' gestation and weighing less than 1501 grams who were ventilator‐dependent at the age of seven days. Thirty infants received dexamethasone 0.25 mg/kg twice daily for three days (total dose 1.5 mg/kg dexamethasone over three days), followed by nebulised budesonide 500 µg twice daily for 18 days. Thirty control infants received systemic and inhaled saline. Study authors provided additional data on some short‐term and long‐term outcomes for inclusion in this review. Country: Canada. Participants were recruited between March 1993 and October 1995. </p> <p><a href="./references#CD001145-bbs2-0013" title="Noble-JamiesonCM , RegevR , SilvermanM . Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. European Journal of Pediatrics1989;148(4):365-7. [DOI: 10.1007/BF00444135] [PMID: 2651132]">Noble‐Jamieson 1989</a> enrolled 18 infants over four weeks of age who required more than 30% oxygen delivered by a headbox (oxyhood). Congenital infection, gastric erosion, and necrotising enterocolitis were absolute contraindications to trial entry; investigators excluded one infant because of necrotising enterocolitis. Entry was postponed if an infant had a central venous catheter, active infection, untreated patent ductus arteriosus, glucose intolerance, or major segmental pulmonary collapse. Trial entry was postponed for 11 infants, mainly because of suspected sepsis. Researchers randomly allocated infants to receive either dexamethasone (n = 9) or saline (n = 9). They gave dexamethasone orally or intravenously at a dose of 0.25 mg/kg twice daily for the first week, 0.125 mg/kg twice daily for the second week, and 0.10 mg/kg daily for the third week (total dose 3.325 mg/kg dexamethasone over 21 days). Twice‐weekly cranial ultrasound scans were performed on all infants, with scans analysed blinded to treatment allocation after completion of the study. Country: England. </p> <p><a href="./references#CD001145-bbs2-0014" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatrica1992;81(10):751-6. [DOI: 10.1111/j.1651-2227.1992.tb12096.x] [PMID: 1421877]OhlssonA . A Randomized Controlled Trial of Dexamethasone Treatment in Very Low Birthweight Infants With Ventilator Dependent Chronic Lung Disease [Masters of Science Thesis]. Hamilton (ON): McMaster University, 1990. ">Ohlsson 1992</a> enrolled 25 infants with birth weight less than 1501 grams after receiving parental informed consent, if the following criteria were met: postnatal age 21 to 35 days, inspired oxygen greater than 29%, chest radiograph consistent with BPD, and treatment with diuretics resulting in no signs of improvement in ventilator requirements during the previous 72 hours. Researchers excluded infants if they had a diagnosis of suspected or proven infection, significant congenital malformation, or clinical evidence of patent ductus arteriosus, necrotising enterocolitis, and gastrointestinal haemorrhage or perforation. The treatment group (n = 12) received dexamethasone 0.50 mg/kg 12‐hourly for three days, 0.25 mg/kg 12‐hourly for three days, 0.125 mg/kg 12‐hourly for three days, and 0.125 mg/kg daily for three days (total dose 5.625 mg/kg dexamethasone over 12 days). Investigators gave dexamethasone intravenously at a standard volume of 1 mL. The Research Ethical Committee did not permit use of an intravenous placebo, so a physician not involved in subsequent care of the infant gave a sham injection of 1 mL of normal saline into the bed in the control group (n = 13). Study authors provided additional data for some short‐term outcomes for inclusion in this review. Country: Canada. Participants were recruited between April 1986 and June 1988. Supported by a grant from the Dean's Fund of the University of Toronto. </p> <p><a href="./references#CD001145-bbs2-0015" title="HalbmeijerNM , OnlandW , CoolsF , SwarteR , van derHeide-JalvingM , MerkusMP , van Kaam AH Stop-BPD Trial Collaborators. Effect of systemic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years' corrected age: Follow-up of a randomized clinical trial. JAMA2021;326(4):355-357. OnlandW , CoolsF , KroonA , RademakerK , MerkusMP , DijkPH , et al, Stop-BPD Study Group. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial. JAMA2019;321(4):354-63. [DOI: 10.1001/jama.2018.21443] [PMID: 30694322]">Onland 2019</a> was a double‐blind RCT conducted to compare hydrocortisone with placebo in infants &lt; 1250 grams birth weight or &lt; 30 weeks' gestational age who were ventilator‐dependent between 7 and 14 days of age and at high risk of developing BPD. Infants were ineligible if they had chromosomal defects or major congenital malformations or had received corticosteroids for improving lung function in the first week of life. A total of 181 infants received a total dose of 72.5 mg/kg of hydrocortisone over 22 days, and 190 infants received placebo. The primary endpoint was mortality or BPD at 36 weeks' postmenstrual age. Countries: Netherlands and Belgium. Participants were recruited from 15 November 2011 to 23 December 2016. Supported by a project grant from The Netherlands Organization for Health Research and Development (priority medicines for children grant 11‐32010‐02). </p> <p><a href="./references#CD001145-bbs2-0016" title="PapileLA , TysonJE , StollBJ , WrightLL , DonovanEF , BauerCR , et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. New England Journal of Medicine1998;338(16):1112-8. [DOI: 10.1056/NEJM199804163381604] [PMID: 9545359]StollBJ , TemprosaM , TysonJE , PapileLA , WrightLL , BauerCR , et al. Dexamethasone therapy increases infection in low birth weight infants. Pediatrics1999;104(5):e63. [DOI: 10.1542/peds.104.5.e63] [PMID: 10545589]">Papile 1998</a> was a double‐blind RCT conducted to compare the benefits and hazards of initiating dexamethasone therapy at two weeks of age versus four weeks of age to 371 ventilator‐dependent very low birth weight (501 grams to 1500 grams) infants who had respiratory index scores (mean airway pressure (MAP) × fraction of inspired oxygen) ≥ 2.4 at 13 to 15 days of age that had been increasing or minimally decreasing during the previous 48 hours, or a score of 4.0, even if there had been improvement during the preceding 48 hours; had received no glucocorticoid treatment after birth; had no evidence or suspicious signs of sepsis as judged by the treating physician; and had no major congenital anomaly of the cardiovascular, pulmonary, or central nervous system. A total of 182 infants received dexamethasone for two weeks followed by placebo for two weeks, and 189 infants received placebo for two weeks followed by either dexamethasone (those with a respiratory index score ≥ 2.4 on treatment Day 14) or additional placebo for two weeks. The dexamethasone dose was 0.5 mg/kg/d intravenously or orally for five days, then 0.3 mg/kg for three days, 0.14 mg/kg for three days, and 0.06 mg/kg for three days (total dose 4.0 mg/kg dexamethasone over 14 days). Only outcome data at 28 days were eligible for inclusion in this review (see below). Country: USA. Participants were recruited from September 1992 to July 1995. Supported by cooperative agreements (U10 HD27881, U10 HD21373, U10 HD27851, U10 HD27853, U10 HD21397, U10 HD19897, U10 HD21415, U10 HD27856, U10 HD21364, U10 HD27880, U10 HD27904, U10 HD27871, and U10 HD21385) with the National Institute of Child Health and Human Development and by General Clinical Research Center grants MO1 RR 00997, MO1 RR 08084, MO1 RR 00750, MO1 RR 00070, and MO1 RR 06022. Dexamethasone was provided by Merck Sharp &amp; Dohme. </p> <p><a href="./references#CD001145-bbs2-0017" title="ParikhNA , KennedyKA , LaskyRE , McDavidGE , TysonJE . Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes. Journal of Pediatrics2013;162(4):685-90. [DOI: 10.1016/j.jpeds.2012.09.054] [PMID: 23140612]ParikhNA , KennedyKA , LaskyRE , TysonJE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS One2015;10(9):e0137051. [DOI: 10.1371/journal.pone.0137051] [PMID: 26376074]">Parikh 2013</a> was a double‐blind RCT of hydrocortisone versus saline placebo given to 64 infants with birth weight ≤ 1000 grams who were ventilator‐dependent between 10 and 21 days of age and at high risk of developing BPD, with the primary outcome of differences in brain tissue volumes on magnetic resonance imaging (MRI) at term‐equivalent age. Infants were excluded if they were at &lt; 23 weeks' gestation at birth, were previously treated with corticosteroids, were receiving indomethacin treatment or were likely to receive it within seven days, had presumed sepsis or necrotising enterocolitis, or had a major congenital anomaly of the cardiopulmonary or central nervous system. Thirty‐one infants received a total of 17 mg/kg of hydrocortisone over seven days, and 33 infants received an identical volume of saline placebo. This trial included follow‐up at 18 to 22 months of age, corrected for prematurity. Country: USA. Participants were recruited between 11 October 2005 and 8 September 2008. Supported by National Institutes of Neurological Disorders and Stroke (K23‐NS048152) and National Center for Research Resources (UL1RR024148 to University of Texas Health Science Center at Houston Center for Clinical and Translational Sciences). </p> <p><a href="./references#CD001145-bbs2-0018" title="RomagnoliC , VentoG , Zecca E, PapacciP , De CarolisMP , MaggioL , et al. Dexamethasone for the prevention of chronic lung disease in preterm neonates: a prospective randomized study [II desametazone nella prevenzione della patologia polmonare cronica del neonato pretermine: studio prospettico randomizzato]. Rivista Italiana di Pediatria [Italian Journal of Pediatrics]1997;24:283-8. [ISSN: 0392-5161]RomagnoliC , ZeccaE , LucianoR , TorrioliG , TortoroloG . A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Archives of Disease in Childhood. Fetal and Neonatal Edition2002;87(1):F55-8. [DOI: 10.1136/fn.87.1.f55] [PMID: 12091294]RomagnoliC , ZeccaE , VentoG , MaggioL , PapacciP , TortoroloG . Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology1999;59(5):266-74. [10.1159/000028329] [PMID: 10529659]">Romagnoli 1997</a> was a randomised trial of 30 preterm infants who were ventilator‐ and oxygen‐dependent at 10 days and were at 90% risk of developing BPD based on the trial authors' own scoring system. Fifteen infants received dexamethasone 0.5 mg/kg/d for six days, 0.25 mg/kg/d for six days, and 0.125 mg/kg/d for two days (total dose 4.75 mg/kg dexamethasone over 14 days). Control infants (n = 15) did not receive any steroid. Study authors provided additional data on some short‐term outcomes for inclusion in this review. Country: Italy. Participants were recruited between April 1996 and June 1997. </p> <p><a href="./references#CD001145-bbs2-0019" title="ScottSM , BackstromC , BessmanS . Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations. Journal of Perinatology1997;17(1):24-8. [PMID: 9069060]">Scott 1997</a> was a double‐blind RCT of dexamethasone versus saline placebo given to 15 infants who were ventilator‐dependent between 11 and 14 days of age with an inspired oxygen requirement greater than 60%. The primary outcome was cortisol response to adrenocorticotrophic hormone (ACTH). Infants with lethal anomalies were excluded. Ten infants received a total of 1.9 mg/kg of dexamethasone over five days, and five infants received an identical volume of saline placebo. Country: USA. Participants were recruited between 11 October 2005 and 8 September 2008. Supported by a Bristol‐Myers Research Grant and the General Clinical Research Center of the University of New Mexico, Program DRR (NIH 5M01RR00997‐14‐18). </p> <p><a href="./references#CD001145-bbs2-0020" title="VentoG , MatassaPG , ZeccaE , TortoroloL , MartelliM , De CarolisMP , et al. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology2004;71(3):113-9. [DOI: 10.1159/000077444] [PMID: 15161992]VentoG . Personal communication. email2012. ">Vento 2004</a> was a randomised trial of 20 neonates with birth weight &lt; 1251 grams and gestation &lt; 33 weeks who were oxygen‐ and ventilator‐dependent on the 10th day of life. Infants received dexamethasone 0.5 mg/kg/d for three days, 0.25 mg/kg/d for three days, and 0.125 mg/kg/d for one day (total dose 2.375 mg/kg dexamethasone over seven days) (n = 10), or they received no steroid treatment (n = 10). Country: Italy. Participants were recruited between August 1998 and July 2000. </p> <p>In <a href="./references#CD001145-bbs2-0021" title="VincerMJ , AllenAC . Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW &lt; 1500 grams) who are ventilator dependent at 4 weeks of age. Pediatric Research1998;43:201A. [CENTRAL: CN-00295187] VincerMJ . Personal communication. email2002. ">Vincer 1998</a>, researchers randomly assigned 20 very low birth weight infants who were ventilator‐dependent at 28 days to receive either a six‐day course of intravenous dexamethasone 0.5 mg/kg/d for three days followed by 0.3 mg/kg/d for the final three days (total dose 2.4 mg/kg dexamethasone over six days) (n = 11), or an equal volume of saline placebo (n = 9). This trial included a two‐year follow‐up. Study authors provided additional data on some short‐term outcomes for inclusion in this review. Country: Canada. </p> <p><a href="./references#CD001145-bbs2-0022" title="WaltherF . Personal communication. email2012. WaltherFJ , FindlayRD , DurandM . Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Human Development2003;74(1):37-45. [DOI: 10.1016/s0378-3782(03)00082-3] [PMID: 14512180]">Walther 2003</a> was a double‐blind randomised clinical trial involving 36 preterm infants with birth weight &gt; 599 grams, gestation of 24 to 32 weeks, and respiratory distress syndrome requiring mechanical ventilation with oxygen &gt; 29% or respiratory index &gt; 1.7 between 7 and 14 days of life. Exclusion criteria were sepsis or other documented infection, congenital heart disease, systemic hypertension, unstable clinical status (renal failure, grade IV intraventricular haemorrhage), or multiple congenital anomalies. Eligible infants received dexamethasone 0.2 mg/kg/d for four days, 0.15 mg/kg/d for four days, 0.1 mg/kg for four days, and 0.05 mg/kg for two days (total dose 1.9 mg/kg over 14 days) (n = 19 infants), or saline placebo (n = 17 infants). Country: USA. Participants were recruited between December 1996 and November 1999. Supported by NIH grant P20 RR11145 and GCRC grant M01 RR00425. </p> <p><a href="./references#CD001145-bbs2-0023" title="YatesH , ChiocchiaV , LinsellL , OrsiN , JuszczakE , JohnsonK , et al. Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT. NIHR Journals Library. Efficacy and Mechanism Evaluation2019;6. [DOI: 10.3310/eme06080] [ISSN: 2050-4365; 2050-4373 ] [PMID: 31479218]">Yates 2019</a> was a multi‐centre randomised blinded parallel‐group placebo‐controlled feasibility study, designed to be the forerunner of a larger RCT. Eligible infants were at &lt; 30 weeks’ gestational age with postnatal age from 10 to 24 days, were ventilator‐dependent and receiving at least 30% inspired oxygen, and were at high risk of developing BPD. Excluded were infants who had received previous courses of postnatal steroids for respiratory disease; and those who had a severe congenital anomaly affecting the lungs, heart, or central nervous system; who had a surgical abdominal procedure or patent ductus arteriosus ligation; or who had an illness or medication for which postnatal corticosteroid would be contraindicated. Eligible infants were randomised to very low‐dose dexamethasone (0.05 mg/kg daily for 10 days, then every second day on Days 12, 14, and 16 after trial entry (total dose 0.65 mg/kg dexamethasone over 16 days) (n = 12 infants)), or saline placebo (n = 10 infants). Country: England. Participants were recruited between 21 July 2017 and 14 April 2018. Supported by the Efficacy and Mechanism Evaluation (EME) programme ‐ a Medical Research Council and National Institute for Health Research (NIHR) partnership. </p> </section> <section id="CD001145-sec-0043"> <h4 class="title">Excluded studies</h4> <p>In total, we excluded 46 studies. <a href="./references#CD001145-bbs2-0020" title="VentoG , MatassaPG , ZeccaE , TortoroloL , MartelliM , De CarolisMP , et al. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology2004;71(3):113-9. [DOI: 10.1159/000077444] [PMID: 15161992]VentoG . Personal communication. email2012. ">Vento 2004</a> was listed as excluded and provided data for two separate cohorts of infants ‐ the first cohort randomised at 10 days of age (those data are included in this "Late" review), and the second cohort randomised at four days of age (hence these data are included in the "Early" review (<a href="./references#CD001145-bbs2-0084" title="DoyleLW , CheongJLY , HayS , ManleyBJ , HallidayHL . Early (&lt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2021 [in press].">Doyle 2021</a>)). </p> <p>We excluded 32 studies that were included in <a href="./references#CD001145-bbs2-0084" title="DoyleLW , CheongJLY , HayS , ManleyBJ , HallidayHL . Early (&lt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews 2021 [in press].">Doyle 2021</a>. That Cochrane Review addressed the use of postnatal corticosteroids commenced in the first six days after birth to prevent BPD in preterm infants (<a href="./references#CD001145-bbs2-0024" title="AnttilaE , PeltoniemiO , HaumontD , HertingE , ter HorstH , HeinonenK , et al. Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy. European Journal of Pediatrics2005;164(8):472-81. [DOI: 10.1007/s00431-005-1645-8] [PMID: 15864643]">Anttila 2005</a>; <a href="./references#CD001145-bbs2-0027" title="BadenM , BauerCR , ColleE , KleinG , Taeusch HW Jr, SternL . A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics1972;50(4):526-34. [PMID: 4561296]FitzhardingePM , EisenA , LejtenyiC , MetrakosK , RamsayM . Sequelae of early steroid administration to the newborn infant. Pediatrics1974;53(6):877-83. [PMID: 4598934]">Baden 1972</a>; <a href="./references#CD001145-bbs2-0028" title="BattonBJ , LiL , NewmanNS , DasA , WatterbergKL , YoderBA , et al, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Feasibility study of early blood pressure management in extremely preterm infants. Journal of Pediatrics2012;161(1):65-9.e1. [DOI: 10.1016/j.jpeds.2012.01.014] [PMID: 22336574]">Batton 2012</a>; <a href="./references#CD001145-bbs2-0029" title="BaudO , MauryL , LebailF , RamfulD , El Moussawi F, Nicaise C, et al, Premiloc Trial Study Group. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet2016;387(10030):1827-36. [DOI: S0140-6736(16)00202-6 [pii]] [PMID: 26916176]">Baud 2016</a>; <a href="./references#CD001145-bbs2-0030" title="BiswasS , BufferyJ , EnochH , BlandM , MarkiewiczM , WaltersD . Pulmonary effects of triiodothyronine (T3) and hydrocortisone (HC) supplementation in preterm infants less than 30 weeks' gestation: results of the THORN trial - thyroid hormone replacement in neonates. Pediatric Research2003;53(1):48-56. [DOI: 10.1203/00006450-200301000-00011] [PMID: 12508081]">Biswas 2003</a>; <a href="./references#CD001145-bbs2-0032" title="BonsanteF , LatorreG , IacobelliS , ForziatiV , LaforgiaN , EspositoL , et al. Early low-dose hydrocortisone in very preterm infants: a randomized, placebo-controlled trial. Neonatology2007;91(4):217-21. [DOI: 10.1159/000098168] [PMID: 17568152]">Bonsante 2007</a>; <a href="./references#CD001145-bbs2-0036" title="EfirdMM , HeerensAT , GordonPV , BoseCL , YoungDA . A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. Journal of Perinatology2005;25(2):119-24. [DOI: 10.1038/sj.jp.7211193] [PMID: 15329742]">Efird 2005</a>; <a href="./references#CD001145-bbs2-0038" title="GarlandJS , AlexCP , PaulyTH , WhiteheadVL , BrandJ , WinstonJF , et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics1999;104(1 Pt 1):91-9. [DOI: 10.1542/peds.104.1.91] [PMID: 10390266]">Garland 1999</a>; <a href="./references#CD001145-bbs2-0040" title="HalacE , HalacJ , BegueEF , CasanasJM , IndiveriDR , PetitJF , et al. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: a controlled trial. Journal of Pediatrics1990;117(1 Pt 1):132-8. [DOI: 10.1016/s0022-3476(05)72461-6] [PMID: 2196355]">Halac 1990</a>; <a href="./references#CD001145-bbs2-0041" title="Hochwald O, PalegraG , OsiovichH . Adding hydrocortisone as 1st line of inotropic treatment for hypotension in very low birth weight infants. Indian Journal of Pediatrics2014;81:808-10. [DOI: 10.1007/s12098-013-1151-3 [doi];] [PMID: 23904065]">Hochwald 2014</a>; <a href="./references#CD001145-bbs2-0042" title="KopelmanAE , MoiseAA , HolbertD , HegemierSE . A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. Journal of Pediatrics1999;135(3):345-50. [DOI: 10.1016/s0022-3476(99)70132-0] [PMID: 10484801]">Kopelman 1999</a>; <a href="./references#CD001145-bbs2-0043" title="Lauterbach R, Szymura-Oleksiak J, PawlikD , Warchol J, Lisowska-Miszczyk I, RytlewskiK . Nebulized pentoxifylline for prevention of bronchopulmonary dysplasia in very low birth weight infants: a pilot clinical study. Journal of Maternal-Fetal &amp; Neonatal Medicine2006;19(7):433-8. [DOI: 10.1080/14767050600736754] [PMID: 16923699]">Lauterbach 2006</a>; <a href="./references#CD001145-bbs2-0044" title="LinYJ , YehTF , HsiehWS , ChiYC , LinHC , LinCH . Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy. Pediatric Pulmonology1999;27(1):21-6. [DOI: 10.1002/(sici)1099-0496(199901)27:1&lt;21::aid-ppul5&gt;3.0.co;2-y] [PMID: 10023787]">Lin 1999</a>; <a href="./references#CD001145-bbs2-0048" title="MukhopadhyayK , KumarP , NarangA . Role of early postnatal dexamethasone in respiratory distress syndrome. Indian Pediatrics1998;35(2):117-22. [PMID: 9707853]">Mukhopadhyay 1998</a>; <a href="./references#CD001145-bbs2-0049" title='NgPC , LeeCH , BnurFL , ChanIH , LeeAW , WongE , et al. A double-blind, randomized, controlled study of a "stress dose" of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics2006;117(2):367-75. [DOI: 10.1542/peds.2005-0869] [PMID: 16452355]'>Ng 2006</a>; <a href="./references#CD001145-bbs2-0051" title="PeltoniemiO , KariMA , HeinonenK , SaarelaT , NikolajevK , AnderssonS , et al. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. Journal of Pediatrics2005;146(5):632-7. [DOI: 10.1016/j.jpeds.2004.12.040] [PMID: 15870666]PeltoniemiOM , LanoA , PuosiR , YlihervaA , BonsanteF , KariMA , et al, Neonatal Hydrocortisone Working Group. Trial of early neonatal hydrocortisone: two-year follow-up. Neonatology2009;95(3):240-7. [DOI: 10.1159/000164150] [PMID: 18931525]">Peltoniemi 2005</a>; <a href="./references#CD001145-bbs2-0052" title="MoralesP , RastogiA , BezML , AkintorinSM , PyatiS , AndesSM , et al. Effect of dexamethasone therapy on the neonatal ductus arteriosus. Pediatric Cardiology1998;19(3):225-9. [DOI: 10.1007/s002469900290] [PMID: 9568218]RastogiA , AkintorinSM , BezML , MoralesP , PildesRS . A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics1996;98(2 Pt 1):204-10. [PMID: 8692619]">Rastogi 1996</a>; <a href="./references#CD001145-bbs2-0053" title="RomagnoliC , ZeccaE , LucianoR , TorrioliG , TortoroloG . Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. Pediatrics2002;109(6):e85. [DOI: 10.1542/peds.109.6.e85] [PMID: 12042579]RomagnoliC , ZeccaE , VentoG , De CarolisMP , PapacciP , TortoroloG . Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants. Intensive Care Medicine1999;25(7):717-21. [DOI: 10.1007/s001340050935] [PMID: 10470576]RomagnoliC , ZeccaE , VentoG , MaggioL , PapacciP , TortoroloG . Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology1999;59(5):266-74. [DOI: 10.1159/000028329] [PMID: 10529659]">Romagnoli 1999</a>; <a href="./references#CD001145-bbs2-0054" title="SandersRJ , CoxC , PhelpsDL , SinkinRA . Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatric Research1994;36(1 Pt 1):122-8. [DOI: 10.1203/00006450-199407001-00022] [PMID: 7936832]">Sanders 1994</a>; <a href="./references#CD001145-bbs2-0055" title="ShinwellES , KarplusM , ReichD , WeintraubZ , BlazerS , BaderD , et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Archives of Disease in Childhood. Fetal and Neonatal Edition2000;83(3):F177-81. [DOI: 10.1136/fn.83.3.f177] [PMID: 11040164]ShinwellES , KarplusM , ZmoraE , ReichD , RothschildA , BlazerS , et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Archives of Disease in Childhood. Fetal and Neonatal Edition1996;74(1):F33-7. [DOI: 10.1136/fn.74.1.f33] [PMID: 8653433]ShinwellES . Early dexamethasone therapy is associated with increased incidence of cerebral palsy. Hot Topics '99 in Neonatology1999:240-54. ">Shinwell 1996</a>; <a href="./references#CD001145-bbs2-0056" title="D'AngioCT , ManiscalcoWM , RyanRM , AvissarNE , BasavegowdaK , SinkinRA . Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone. Biology of the Neonate1999;76(5):266-73. [DOI: 10.1159/000014168] [PMID: 10516393]SinkinRA , DweckHS , HorganMJ , GallaherKJ , CoxC , ManiscalcoWM , et al. Early dexamethasone - attempting to prevent chronic lung disease. Pediatrics2000;105(3 Pt 1):542-8. [DOI: 10.1542/peds.105.3.542] [PMID: 10699107]">Sinkin 2000</a>; <a href="./references#CD001145-bbs2-0057" title="SollRF , Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatric Research1999;45:226A. Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics2001;108(3):741-8. [DOI: 10.1542/peds.108.3.741] [PMID: 11533345]">Soll 1999</a>; <a href="./references#CD001145-bbs2-0058" title="StarkAR , CarloWA , TysonJE , PapileLA , WrightLL , ShankaranS , et al, National Institute of Child Health and Human Development Neonatal Research Network. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. New England Journal of Medicine2001;344(2):95-101. [DOI: 10.1056/NEJM200101113440203] [PMID: 11150359]StarkAR , CarloWA , VohrBR , PapileLA , SahaS , BauerCR , et al, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Death or neurodevelopmental impairment at 18 to 22 months corrected age in a randomized trial of early dexamethasone to prevent death or chronic lung disease in extremely low birth weight infants. Journal of Pediatrics2014;164(1):34-39.e2. [DOI: 10.1016/j.jpeds.2013.07.027] [PMID: 23992673]">Stark 2001</a>; <a href="./references#CD001145-bbs2-0059" title="SubhedarNV , BennettAJ , WardleSP , ShawNJ . More trials on early treatment with corticosteroids are needed. BMJ (Clinical Research Ed.)2000;320(7239):941. [PMID: 10742018]SubhedarNV , RyanSW , ShawNJ . Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Archives of Disease in Childhood. Fetal and Neonatal Edition1997;77(3):F185-90. [DOI: 10.1136/fn.77.3.f185] [PMID: 9462187]">Subhedar 1997</a>; <a href="./references#CD001145-bbs2-0060" title="SuskeG , OestreichK , VarnholtV , LaschP , KachelW . Influence of early postnatal dexamethasone therapy on ventilator dependency in surfactant-substituted preterm infants. Acta Paediatrica1996;85(6):713-8. [DOI: 10.1111/j.1651-2227.1996.tb14132.x] [PMID: 8816210]">Suske 1996</a>; <a href="./references#CD001145-bbs2-0061" title="TapiaJL , RamirezR , CifuentesJ , FabresJ , HubnerME , BancalariA , et al. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. Journal of Pediatrics1998;132(1):48-52. [DOI: 10.1016/s0022-3476(98)70483-4] [PMID: 9469999]">Tapia 1998</a>; <a href="./references#CD001145-bbs2-0062" title="VentoG , MatassaPG , ZeccaE , TortoroloL , MartelliM , De CarolisMP , et al. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology2004;71(3):113-9. [DOI: 10.1159/000077444] [PMID: 15161992]">Vento 2004a</a>; <a href="./references#CD001145-bbs2-0063" title="WangJY , YehTF , LinYC , MiyamuraK , HolmskovU , ReidKB . Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax1996;51(9):907-13. [DOI: 10.1136/thx.51.9.907] [PMID: 8984701]WangJY , YehTF , LinYJ , ChenWY , LinCH . Early postnatal dexamethasone therapy may lessen lung inflammation in premature infants with respiratory distress syndrome on mechanical ventilation. Pediatrics1997;23(3):193-7. [DOI: 10.1002/(sici)1099-0496(199703)23:3&lt;193::aid-ppul4&gt;3.0.co;2-p] [PMID: 9094727]">Wang 1996</a>; <a href="./references#CD001145-bbs2-0064" title="WatterbergKL , GerdesJS , GiffordKL , LinHM . Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics1999;104(6):1258-63. [DOI: 10.1542/peds.104.6.1258] [PMID: 10585975]">Watterberg 1999</a>; <a href="./references#CD001145-bbs2-0065" title="WatterbergKL , GerdesJS , ColeCH , AucottSW , ThiloEH , MammelMC , et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics2004;114(6):1649-57. [DOI: 10.1542/peds.2004-1159] [PMID: 15574629]WatterbergKL , ShafferML , MishefskeMJ , LeachCL , MammelMC , CouserRJ , et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics2007;120(1):40-8. [DOI: 10.1542/peds.2006-3158] [PMID: 17606560]">Watterberg 2004</a>; <a href="./references#CD001145-bbs2-0067" title="YehTF , TorreJA , RastogiA , AnyebunoMA , PildesRS . Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. Journal of Pediatrics1990;117(2 Pt 1):273-82. [DOI: 10.1016/s0022-3476(05)80547-5] [PMID: 2199642]">Yeh 1990</a>; <a href="./references#CD001145-bbs2-0068" title="LinYJ , LinCH , WuJM , TsaiWH , YehTF . The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study. Acta Paediatrica2005;94(3):310-6. [DOI: 10.1111/j.1651-2227.2005.tb03073.x] [PMID: 16028649]LinYJ , YehTF , LinHC , WuJM , LinCH , YuCY . Effects of early postnatal dexamethasone therapy on calcium homeostasis and bone growth in preterm infants with respiratory distress syndrome. Acta Paediatrica1998;87(10):1061-5. [DOI: 10.1080/080352598750031383] [PMID: 9825973]PengCT , LinHC , LinYJ , TsaiCH , YehTF . Early dexamethasone therapy and blood cell count in preterm infants. Pediatrics1999;104(3 Pt 1):476-81. [DOI: 10.1542/peds.104.3.476] [PMID: 10469772]YehTF , LinIJ , HsiehWS , LinH , LinC , ChenJ , et al. Prevention of chronic lung disease (CLD) in premature RDS infants with early and prolonged dexamethasone (D) therapy - a multicenter double-blind controlled study. Pediatric Research1994;35(4):262A. YehTF , LinYJ , HsiehWS , LinHC , LinCH , ChenJY , et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics1997;100(4):E3. [DOI: 10.1542/peds.100.4.e3] [PMID: 9310536]YehTF , LinYJ , HuangCC , ChenYJ , LinCH , LinHC , et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics1998;101(5):E7. [DOI: 10.1542/peds.101.5.e7] [PMID: 9565440]YehTF , LinYJ , LinHC , HuangCC , HsiehWS , LinCH , et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. New England Journal of Medicine2004;350(13):1304-13. [DOI: 10.1056/NEJMoa032089] [PMID: 15044641]">Yeh 1997</a>). </p> <p>We excluded an additional study because it compared two different dosages of dexamethasone only (<a href="./references#CD001145-bbs2-0046" title="MarrBL , MettelmanBB , BodeMM , GrossSJ . Randomized trial of 42-day compared with 9-day courses of dexamethasone for the treatment of evolving bronchopulmonary dysplasia in extremely preterm infants. Journal of Pediatrics2019;211:20-6.e1. [DOI: 10.1016/j.jpeds.2019.04.047] [PMID: 31349916]">Marr 2019</a>). We excluded other studies for a variety of reasons. See <a href="./references#CD001145-sec-0100" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD001145-sec-0044"> <h3 class="title">Risk of bias in included studies</h3> <p>Overall most studies had low risk of bias (<a href="#CD001145-fig-0002">Figure 2</a>; <a href="#CD001145-fig-0003">Figure 3</a>). All were RCTs, although the method of random allocation was not always clear. Allocation concealment applied to most studies. Blinding of investigators and others was achieved most often with the use of placebo, usually saline solution. Follow‐up reporting for short‐term outcomes during primary hospitalisation most often was complete but was more variable for long‐term outcomes beyond discharge and later into childhood. </p> <div class="figure" id="CD001145-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="original image" data-id="CD001145-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> <div class="figure" id="CD001145-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001145-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p><a href="./references#CD001145-bbs2-0001" title="AriagnoRL , SweeneyTE , BaldwinRB , InguilloD , MartinD . Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia: lung function, clinical course and outcome at three years. Unpublished manuscript supplied by authors2000. AriagnoRL , SweeneyTJ , BaldwinRB , InguilloD , MartinD . Dexamethasone effects on lung function and risks in 3 week old ventilatory dependent preterm infants. American Reviews of Respiratory Disease1987;135:A125. [CENTRAL: CN-00295119] ">Ariagno 1987</a> was a double‐blind trial in which the pharmacist performed randomisation. Trialists provided outcomes for all enrolled infants. Follow‐up consisted of the following: investigators assessed surviving children at 12, 24, and 36 months of age, corrected for prematurity, in the High‐Risk Follow‐Up Clinic. Data included cerebral palsy and auditory status, but criteria were not defined. Personnel involved and blinding of assessors to treatment groups were unclear. The follow‐up rate of survival was 96% (23/24) (<a href="./references#CD001145-bbs2-0073" title="AriagnoRL , SweeneyTE , BaldwinRB , InguilloD , MartinD . Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia: lung function, clinical course and outcome at three years. Unpublished manuscript supplied by authors2000.">Ariagno 2000</a>). </p> <p><a href="./references#CD001145-bbs2-0002" title="AveryGB , FletcherAB , CaplanM , BrudnoDS . Control trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75(1):106-11. [PMID: 3880879]">Avery 1985</a> paired and compared treatment and control infants for success in weaning. Investigators stratified infants at entry by weight into three categories: less than 1000 grams, 1000 grams to 1250 grams, and 1251 grams to 1500 grams. Within each weight group, equal numbers of treatment cards and control cards were placed into envelopes for random selection. The first treated infant and the first control infant within a given weight category made the first pair, and researchers considered in the sequential analysis only infants who were paired for weaning success. If both infants in a pair were successful or had treatment failure, the result was a tie and the pair was discarded. If one infant weaned and the other did not, the pair was scored as favouring treatment or control. The study was stopped when significance was reached from weaning from the ventilator in the sequential analysis of untied pairs. At that time, 16 infants had been studied and 14 had been matched to form seven pairs. Study authors reported no follow‐up component. </p> <p>In <a href="./references#CD001145-bbs2-0003" title="BrozanskiBS , JonesJG , GilmoreCH , BalsanMJ , VazquezRL , IsraelBA , et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infant. Journal of Pediatrics1995;126(5 Pt 1):769-76. [DOI: 10.1016/s0022-3476(95)70410-8] [PMID: 7752005]GilmourCH , Sentipal-WaleriusJM , JonesJG , DoyleJM , BrozanskiBS , BalsanMJ , et al. Pulse dexamethasone does not impair growth and body composition of very low birth weight infants. Journal of the American College of Nutrition1995;14(5):455-62. [10.1080/07315724.1995.10718536] [PMID: 8522724]HofkoshD , BrozanskiBS , EdwardsMD , WilliamsLA , JonesJG , ChengKP . One year outcome of infants treated with pulse dexamethasone for prevention of BPD. Pediatric Research1995;37(4):259A. ">Brozanski 1995</a>, researchers achieved randomisation by using a random numbers table and stratified infants according to sex and birth weight (&lt; 1000 grams versus &gt; 999 grams). They reported treatment allocation on cards inside sequentially numbered envelopes that were kept in the pharmacy where randomisation took place. Investigators enrolled 88 infants but provided outcome data, apart from survival without supplemental oxygen at 36 weeks' postmenstrual age, for only 78 infants. They withdrew 10 infants during the study because of pharmacy error (dexamethasone group two infants, placebo group one infant), parental choice (placebo group two infants), or attending physician request (dexamethasone group one infant, placebo group four infants). All five infants withdrawn from the study by the attending physician subsequently received an extended course of dexamethasone. Follow‐up consisted of the following (<a href="./references#CD001145-bbs2-0095" title="HofkoshD , BrozanskiBS , EdwardsMD , WilliamsLA , JonesJG , ChengKP . One year outcome of infants treated with pulse dexamethasone for prevention of BPD. Pediatric Research1995;37(4):259A.">Hofkosh 1995</a>): unknown observer(s) blinded to treatment group allocation saw survivors at 12 months of age, corrected for prematurity. The follow‐up rate of survivors was 68% (44/65). Study authors did not specify criteria for the diagnosis of cerebral palsy. Psychological assessment included the Mental Developmental Index (MDI) of the Bayley Scales of Infant Development (BSID). Study authors provided no data on major neurodevelopmental disability. </p> <p><a href="./references#CD001145-bbs2-0004" title="Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics1991;88(3):421-7. [PMID: 1881718]JonesR , WincottE , ElbourneD , GrantA . Controlled trial of dexamethasone in neonatal chronic lung disease: a 3 year follow-up. Pediatrics1995;96(5 Pt 1):897-906. [PMID: 7478833]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics2005;116(2):370-8. [DOI: 10.1542/peds.2004-1818] [PMID: 16061591]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure. Pediatrics2005;116(2):379-84. [DOI: 10.1542/peds.2004-1819] [PMID: 16061592]">CDTG 1991</a> assigned groups by telephone call to the Clinical Trial Service Unit in Oxford. Investigators stratified infants by clinical centre and by whether or not they were ventilator‐dependent. After completion of the trial, clinicians could give open steroids if this was clinically indicated because of life‐threatening deterioration. Researchers retained infants in the group to which they had been allocated for the purpose of analysis. They enrolled 287 infants in the trial; two were ineligible because of major malformations (Fallot's tetralogy, oesophageal atresia), leaving 285 infants included in the analysis. Follow‐up consisted of the following (<a href="./references#CD001145-bbs2-0096" title="JonesR , WincottE , ElbourneD , GrantA . Controlled trial of dexamethasone in neonatal chronic lung disease: a 3 year follow-up. Pediatrics1995;96(5 Pt 1):897-906. [PMID: 7478833]">Jones 1995</a>): researchers provided data on survivors at 36 months of age, not corrected for prematurity. Primary sources of data, obtained in the UK and in Ireland, were healthcare provider visitors, who provided data on major neurosensory diagnoses or other chronic problems, and general practitioners, who provided data on health and hospitalisations. Parents completed questionnaires, including the Minnesota Child Development Inventory (CDI). Parents, healthcare visitors, and general practitioners (GPs) were unaware of treatment group allocation. In some countries, investigators sought data from paediatricians only (&lt; 10% cases). The follow‐up rate of survivors was 94% (209/223). Trialists did not specify criteria for the diagnosis of cerebral palsy or blindness, but they defined severe hearing loss (deafness) as hearing loss requiring either hearing aids or special schooling. Major disability comprised any types of non‐ambulant cerebral palsy at three years of age, &lt; 50% of age level on the CDI, or predicted special schooling for sensory or other impairment. Further follow‐up at 13 to 17 years of age consisted of the following (<a href="./references#CD001145-bbs2-0097" title="JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics2005;116(2):370-8. [DOI: 10.1542/peds.2004-1818] [PMID: 16061591]">Jones 2005a</a>; <a href="./references#CD001145-bbs2-0098" title="JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure. Pediatrics2005;116(2):379-84. [DOI: 10.1542/peds.2004-1819] [PMID: 16061592]">Jones 2005b</a>): assessors who were blinded to treatment group allocation assessed surviving children from the 25 individual British and Irish study centres at 13 to 17 years of age. Families completed a questionnaire on functional status, diagnoses of potentially disabling conditions (visual or hearing impairment, learning disabilities, cerebral palsy, and epilepsy), and the child's schooling. Study authors asked GPs to complete a questionnaire to report known functional problems, diagnoses, and hospital admissions. The paediatrician responsible for each child's care made the diagnosis of cerebral palsy. One of three research nurses blinded to the children's original treatment allocation visited surviving children at home. They administered a non‐verbal reasoning test and the British Picture Vocabulary Scale and averaged these scores as a proxy for IQ. Investigators defined moderate disability as consisting of one or two of the following: IQ 2 to 3 standard deviations (SD) below the mean, ambulatory cerebral palsy, hearing deficits corrected with hearing aids, impaired vision, or a behaviour disorder with a major impact on schooling. They defined severe disability as any of the following: IQ &gt; 3 SDs below the mean, wheelchair‐dependent cerebral palsy, uncorrectable hearing loss, blindness (perception of light only), or three moderate disabilities. Respiratory function included spirometry to measure forced expiratory volume in one second (FEV₁), forced vital capacity (FVC), the FEV₁/FVC ratio, and forced expired flow from 25% to 75% (FEF)<sub>25%-75%</sub>; study authors expressed results and growth measurements as standardised scores (z‐scores). They assessed other outcomes, but we did not include them in the review. These included data on types of schooling, teacher questionnaires on a child's ability, and the Strengths and Difficulties Questionnaire. The follow‐up rate of eligible survivors at 13 to 17 years was 77% (150/195), including data from five severely disabled children at three years of age who were not contacted as teenagers. </p> <p>In <a href="./references#CD001145-bbs2-0005" title="CummingsJJ , D'EugenioDB , GrossSJ . A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine1989;320(23):1505-10. [DOI: 10.1056/NEJM198906083202301] [PMID: 2657423]CummingsJJ . Personal communication. email2002. GrossSJ , AnbarRD , MettelmanBB . Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics2005;115(3):681-7. [DOI: 10.1542/peds.2004-0956] [PMID: 15741372]">Cummings 1989</a>, investigators achieved randomisation by sequential assignment from a table of random numbers known only to a pharmacist who had no knowledge of the clinical status of infants. Study authors present outcome data for all 36 infants enrolled in the study. This trial included two experimental groups: one treated for 18 days, and the other treated for 42 days, compared with a single control group. For these analyses, we combined treatment groups (n = 25) and compared the combined data with data from the control group (n = 11). Follow‐up consisted of the following: a paediatrician and an occupational therapist saw survivors at 15 months of age, corrected for prematurity. Observers were blinded to treatment group allocation. The follow‐up rate of survivors was 100% (23/23). Researchers specified criteria for the diagnosis of cerebral palsy but did not specify criteria for blindness or deafness. Psychological assessment included the MDI and the Psychomotor Developmental Index (PDI) of the BSID. Major disability comprised any of the following: cerebral palsy or MDI or PDI &lt; 1 SD. Investigators later assessed survivors at four years of age and confirmed neurological status for all participants (Cummings 2002 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0005" title="CummingsJJ , D'EugenioDB , GrossSJ . A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine1989;320(23):1505-10. [DOI: 10.1056/NEJM198906083202301] [PMID: 2657423]CummingsJJ . Personal communication. email2002. GrossSJ , AnbarRD , MettelmanBB . Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics2005;115(3):681-7. [DOI: 10.1542/peds.2004-0956] [PMID: 15741372]">Cummings 1989</a>)). Researchers provided further follow‐up at 15 years of age (<a href="./references#CD001145-bbs2-0090" title="GrossSJ , AnbarRD , MettelmanBB . Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics2005;115(3):681-7. [DOI: 10.1542/peds.2004-0956] [PMID: 15741372]">Gross 2005</a>). Assessors were blinded to treatment group allocation. Outcomes included growth (body size converted to z‐scores), general health, respiratory morbidity, and respiratory function testing. Cognition was assessed by the Wechsler Intelligence Scale for Children ‐ Third Edition (WISC‐III). Teachers completed data on class repetition, performance, and behaviour. Pulmonary function testing included spirometry to measure FEV₁, FVC, and FEF<sub>25%-75%</sub>, along with measurement of lung volumes (total lung capacity (TLC) and residual volume (RV)) by nitrogen washout; study authors expressed results as % predicted for age, height, and sex. Trial authors reported numbers of surviving children with ongoing respiratory symptoms of wheezing or congestion and interpreted these as a diagnosis of asthma for meta‐analysis. They defined intact survival as a normal neurological examination, IQ &gt; 70, and receiving education in a normal classroom. For the meta‐analysis, investigators defined major neurological disability as any of an abnormal neurological examination (i.e. cerebral palsy), cognitive delay (IQ &lt; 71), or not in a regular classroom (with or without additional help). They did not measure blood pressure. </p> <p><a href="./references#CD001145-bbs2-0006" title="DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter international randomized controlled trial. Pediatrics2006;117(1):75-83. [DOI: 10.1542/peds.2004-2843] [PMID: 16396863]DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics2007;119(4):716-21. [DOI: 10.1542/peds.2006-2806] [PMID: 17403842]">Doyle 2006</a> was a double‐blind trial with randomisation performed centrally by non‐clinical staff independent of the chief investigators, with random variation in block sizes of two to eight for each centre. Syringes were prepared and labelled identically within the pharmacy department at the centre, concealing treatment allocation from study site investigators and the infant's caregivers. They discouraged but did not prohibit open‐label corticosteroids after randomisation; some infants may have received both a second course of their initially allocated study drug and open‐label corticosteroids. No one apart from the pharmacists at individual study sites had access to the treatment code. Trial authors reported short‐term outcomes for all enrolled infants. Follow‐up included the following (Doyle 2007 (follow‐up publication of <a href="./references#CD001145-bbs2-0006" title="DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter international randomized controlled trial. Pediatrics2006;117(1):75-83. [DOI: 10.1542/peds.2004-2843] [PMID: 16396863]DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics2007;119(4):716-21. [DOI: 10.1542/peds.2006-2806] [PMID: 17403842]">Doyle 2006</a>)): paediatricians and psychologists who were blinded to treatment group allocation assessed surviving children at 24 months of age, corrected for prematurity, at individual study sites. They considered children to have a neurosensory impairment if they had cerebral palsy (criteria included abnormalities of tone and motor dysfunction), blindness (bilateral vision worse than 6/60), deafness requiring hearing aids or worse, or developmental delay (defined as a MDI on the BSID &lt; 85 (&lt; ‐1 SD) (<a href="./references#CD001145-bbs2-0075" title="BayleyN . Bayley Scales of Infant Development. 2nd edition. San Antonio: The Psychological Corporation, 1993.">Bayley 1993</a>). Researchers graded severity of the neurosensory disability imposed by the impairment as follows: severe ‐ bilateral blindness, cerebral palsy with the child unlikely ever to walk, or MDI &lt; 55 (&lt; ‐3 SD); moderate ‐ deafness, cerebral palsy in children not walking at two years but expected to walk, or MDI from 55 to &lt; 70 (‐3 SD to &lt; ‐2 SD); mild ‐ cerebral palsy but walking at two years with only minimal limitation of movement or MDI 70 to &lt; 85 (&lt; ‐2 SD to ‐1 SD). They considered the remaining children to have no neurosensory disability. Major neurosensory disability comprised moderate or severe disability. The follow‐up rate of survivors at two years was 98% (58/59). </p> <p>In <a href="./references#CD001145-bbs2-0007" title="DurandM , SardesiS , McEvoyC . Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized controlled trial. Pediatrics1995;95(4):584-90. [PMID: 7700763]DurandM . Personal communication. email2012. ">Durand 1995</a>, investigators performed randomisation via blind drawing of random cards contained in sealed envelopes. Clinical personnel were not aware of the group assignment of any infant. Study authors present outcome data for 43 of the 44 enrolled infants. They excluded one infant in the control group from all analyses as the result of birth weight &lt; 500 grams. Follow‐up consisted of the following (Durand 2012 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0007" title="DurandM , SardesiS , McEvoyC . Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized controlled trial. Pediatrics1995;95(4):584-90. [PMID: 7700763]DurandM . Personal communication. email2012. ">Durand 1995</a>)): a developmental paediatrician, a paediatric neurologist, and other specialised personnel (including a psychologist) assessed surviving children at 12 months of age, corrected for prematurity. A paediatric ophthalmologist performed all eye examinations. All staff were blinded to treatment group allocation. Children were considered to have a neurosensory impairment if they had cerebral palsy (defined as non‐progressive motor impairment with abnormal muscle tone and decreased range of movement), blindness (bilateral vision worse than 6/60), deafness requiring hearing aids or worse, or developmental delay (defined as MDI &lt; 70 on the BSID). The follow‐up rate of survivors at 12 months was 78% (29/37). </p> <p><a href="./references#CD001145-bbs2-0008" title="HarkavyKL , ScanlowJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants. A controlled trial. Journal of Pediatrics1989;115(6):979-83. [DOI: 10.1016/s0022-3476(89)80754-1] [PMID: 2685220]HarkavyKL . Personal communication. email2002. ">Harkavy 1989</a> achieved randomisation by using random numbers held in the pharmacy. Clinicians and investigators were unaware of treatment assignments. Study authors provided outcome data for 21 of the 22 enrolled infants. One infant died after consent but before random assignment to a treatment group. Follow‐up consisted of the following (Harkavy 2002 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0008" title="HarkavyKL , ScanlowJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants. A controlled trial. Journal of Pediatrics1989;115(6):979-83. [DOI: 10.1016/s0022-3476(89)80754-1] [PMID: 2685220]HarkavyKL . Personal communication. email2002. ">Harkavy 1989</a>)): a neonatologist and an occupational therapist saw survivors at ages ranging from 6 to 24 months, corrected for prematurity. Observers were blinded to treatment group allocation. The follow‐up rate of survivors was 32% (6/19). Trialists did not specify criteria for the diagnosis of cerebral palsy, blindness, or deafness. Psychological assessment included the MDI of the BSID. Study authors did not define major disability. </p> <p>In <a href="./references#CD001145-bbs2-0009" title="KariMA , HeinonenKO , IkonenRS , KoivistoM , RaivioKO . Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Archives of Disease of Childhood1993;68(5 Spec No):566-9. [DOI: 10.1136/adc.68.5_spec_no.566] [PMID: 8323356]KariMA , RaivioKO , VengeP , HallmanM . Dexamethasone treatment of infants at risk of chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatric Research1994;36(3):387-93. [DOI: 10.1203/00006450-199409000-00020] [PMID: 7808837]MieskonenS , EronenM , MalmbergLP , TurpeinenM , KariMA , HallmanM . Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth. Acta Paediatrica2003;92(8):896-904. [PMID: 12948063]">Kari 1993</a>, researchers performed randomisation in blocks of 10 for each participating hospital. Clinicians and investigators were unaware of treatment assignments. Study authors present outcomes for all 41 infants enrolled in the trial. The number of infants recruited was only 25% of the estimate required for the sample size. Therefore, the study was discontinued after 26 months. Follow‐up consisted of the following (<a href="./references#CD001145-bbs2-0099" title="MieskonenS , EronenM , MalmbergLP , TurpeinenM , KariMA , HallmanM . Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth. Acta Paediatrica2003;92(8):896-904. [PMID: 12948063]">Mieskonen 2003</a>): only one of four centres in this multi‐centre study provided follow‐up; this centre contributed 23 of the 41 participants to the original study. Three infants died before discharge (one dexamethasone; two placebo). No late deaths in childhood are known. Survivors were followed in the hospital's outpatient clinic. One child in the dexamethasone group had deafness requiring a hearing aid, seizures treated with anticonvulsants, and attention deficit hyperactivity disorder, and required assistance with schooling but did not have cerebral palsy at 7.8 years of age. This child would not co‐operate with the respiratory component of the study. Another child in the dexamethasone group had no confirmed cerebral palsy at 2.6 years of age and was not traced at school age but was said to be attending normal school. One child in the placebo group had multiple difficulties in speech and cognitive function at five years of age and was expected to require extra help at school but refused further follow‐up. Another child in the placebo group had minor difficulties in comprehension at five years of age but was lost to further follow‐up. In total, 16 children participated in the follow‐up study at seven to nine years of age. Neurological status at five years of age was obtained from hospital records, including assessments for cerebral palsy (abnormal muscle tone, increased tendon reflexes and positive Babinski sign, or persistent or exaggerated primitive reflexes, dyskinesia, or ataxia), visual or hearing deficits, and school maturity (details of testing not given). Severe disability comprised any of more than mild cerebral palsy, severe global delay (not defined), or sensory or other impairment requiring special schooling; moderate disability comprised any of mild cerebral palsy, severe deafness, moderate global delay (extra help needed at school, assessment of global retardation or language problems), or home oxygen beyond three years of age. For this meta‐analysis, we have extracted data for major neurological disability for those with more than mild cerebral palsy, blindness, or deafness, or needing extra help with schooling. One investigator blinded to neonatal details then assessed children at 7.8 to 9.2 years of age, including presumably treatment group allocation. Age was not corrected for prematurity. Study authors measured children for height and weight and performed lung function tests, electrocardiography (ECG), and echocardiography. </p> <p>In <a href="./references#CD001145-bbs2-0010" title="KazziNJ , BransYW , PolandRL . Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics1990;86(5):722-7. [PMID: 2235226]">Kazzi 1990</a>, randomisation was assigned by drawing a pre‐coded card prepared from a table of random numbers. Infants were stratified by birth weight into three groups: less than 1000 grams, 1000 grams to 1250 grams, and 1251 grams to 1500 grams. The pharmacist drew the card from the appropriate group, and neither investigators nor nursery staff were aware of the treatment group. Study authors provided outcome data for all 23 enrolled infants and reported no follow‐up component. </p> <p>In <a href="./references#CD001145-bbs2-0011" title="BenskyAS , KothadiaJM , CovitzW . Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics1996;97(6 Pt 1):818-21. [PMID: 8657520]GoldsteinDJ , WaldrepEL , VanPeltJC , O'SheaTM . Developmental outcome at 5 years following dexamethasone use for very low birth weight infants. Pediatric Research2000;47(4):310A. Abstract 1832. [DOI: CN-00708985]KothadiaJM , O'SheaTM , RobertsD , AuringerST , WeaverRG , DillardRG . Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants. Pediatrics1999;104(1 Pt 1):22-7, Erratum in: Pediatrics 2004;114(6):1746. [DOI: 10.1542/peds.104.1.22] [PMID: 10390255]NixonPA , WashburnLK , SchechterMS , O'SheaTM . Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. Journal of Pediatrics2007;150(4):345-50. [DOI: 10.1016/j.jpeds.2006.12.013] [PMID: 17382108]O'SheaTM , GoldsteinDJ , JacksonBG , KothadiaJM , DillardRG . Randomized trial of a 42-day tapering course of dexamethasone in very low birth weight infants: neurological, medical and functional outcome at 5 years of age. Pediatric Research2000;47:319A. Abstract 1883. [DOI: CN-00712055]O'SheaTM , KothadiaJM , KlinepeterKL , GoldsteinDJ , JacksonBG , Weaver RG 3rd, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics1999;104(1 Pt 1):15-21. [DOI: 10.1542/peds.104.1.15] [PMID: 10390254]WashburnLK , NixonPA , O'SheaTM . Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age. Pediatrics2006;118(4):1592-9. [DOI: 10.1542/peds.2006-0973] [PMID: 17015551]">Kothadia 1999</a>, researchers randomised infants within six strata, defined in terms of birth weight (500 grams to 800 grams, 801 grams to 1100 grams, and 1101 grams to 1500 grams) and sex, with a block size of eight. They did not describe the exact method of randomisation. Control infants were given an equal volume of normal saline. Investigators assessed outcome data in a blinded fashion. Study authors initially described zero cross‐over in this trial, but review of data at age 19 years revealed that one child who was randomised to placebo received a 42‐day tapering course of placebo, then subsequently a 12‐day tapering course of dexamethasone. In addition, three of the children randomised to placebo received 24‐hour courses of dexamethasone for upper airway oedema. Follow‐up consisted of the following: a developmental paediatrician or one of two neonatologists and a physical therapist saw survivors at 12 months of age, corrected for prematurity, if any neurological abnormality was detected. Observers were blind to treatment group allocation. The follow‐up rate of survivors at 12 months of age was 98% (93/95). Trialists specified criteria for the diagnosis of cerebral palsy. Paediatric ophthalmologists diagnosed blindness. Study authors did not define deafness. Psychological assessment included the MDI of the BSID; investigators assessed the first 10 infants using the original Bayley Scales, and the remainder using BSID‐II. Major disability comprised any of cerebral palsy, blindness, or an MDI &lt; ‐2 SD. Children were assessed again at 4 to 6 years of age and at 8 to 11 years of age (<a href="./references#CD001145-bbs2-0101" title="NixonPA , WashburnLK , SchechterMS , O'SheaTM . Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. Journal of Pediatrics2007;150(4):345-50. [DOI: 10.1016/j.jpeds.2006.12.013] [PMID: 17382108]">Nixon 2007</a>; <a href="./references#CD001145-bbs2-0103" title="O'SheaTM , WashburnLK , NixonPA , GoldsteinDJ . Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age. Pediatrics2007;120(3):594-602. [DOI: 10.1542/peds.2007-0486] [PMID: 17766533]">O'Shea 2007</a>; <a href="./references#CD001145-bbs2-0117" title="WashburnLK , NixonPA , O'SheaTM . Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age. Pediatrics2006;118(4):1592-9. [DOI: 10.1542/peds.2006-0973] [PMID: 17015551]">Washburn 2006</a>). Parents, children, and follow‐up examiners were not aware of children's randomisation assignment. Investigators diagnosed cerebral palsy at four to six years if the child had a neuromotor abnormality detected on neurological examination by a nurse with specialised training in neurodevelopmental follow‐up, and if the parent reported that the child was receiving treatment for cerebral palsy. A parent was interviewed again at the 8‐ to 11‐year visit as to whether a diagnosis of cerebral palsy had ever been made. For intelligence and academic achievement, at the four‐ to six‐year visit, a child psychologist assessed the child using the Differential Abilities Scales (DAS), the Kaufman Survey of Early Academic and Language Skills (K‐SEALS), and the Vineland Adaptive Behavioral Scales (VABS). At the 8‐ to 11‐year visit, a child psychologist assessed the child using the Wechsler Individual Achievement Tests (WIAT), the Wechsler Intelligence Scale for Children ‐ Third Edition (WISC‐III), and the Vineland Adaptive Behavior Scale (VABS). Investigators defined a major neurodevelopmental impairment at 4 to 6 years and/or at 8 to 11 years as cerebral palsy, and at 4 to 6 years of age as mental retardation (IQ &lt; 70 on either the DAS (n = 11 participants) or the WISC‐III (n = 71 participants) and a VABS composite score &lt; 70) at last follow‐up. For five dexamethasone‐treated and eight placebo‐treated children who did not undergo intelligence testing at 4 to 6 years or at 8 to 11 years of age, they defined major neurodevelopmental impairment as blindness, cerebral palsy (at the most recent visit), or a Bayley MDI &lt; 70 for adjusted age. All survivors were assessed at least once at or beyond one year of age. The follow‐up rate at 4 to 11 years of age was 88% (84/95). Respiratory data were collected at 8 to 11 years of age via pulmonary function testing. Researchers obtained forced expiratory flow rates and volumes (FVC, FEV₁, FEV₁/FVC ratio, and FEF<sub>25% -75%</sub>) expressed as % of predicted as appropriate, and considered abnormal if below the fifth percentile. They determined TLC and RV from body plethysmography and expressed these as a ratio (RV/TLC), as well as pulmonary diffusing capacity (diffusing capacity of the lungs for carbon monoxide (DLCO)) via the single‐breath carbon monoxide technique. However, most children could not cope with plethysmography and the single‐breath diffusion manoeuvre, hence study authors did not analyse TLC, RV, and diffusing capacity data. Investigators also assessed asthma diagnosis and airway reactivity<i>.</i> They categorised children as having asthma if the parent or guardian reported that the child had asthma, had used medications for asthma treatment, or both. A sub‐sample of children underwent maximal progressive exercise testing on a cycle ergometer as part of the larger study. Researchers repeated spirometry immediately and five minutes post exercise, as well as 20 minutes following three puffs of albuterol delivered with a spacer. They used a 15% decrease in FEV₁ from pre‐exercise values as the criterion to define exercise‐induced bronchoconstriction, and they considered a 12% increase in FEV₁ from pre‐exercise levels to be a positive bronchodilator response. The follow‐up rate at 8 to 11 years of age for respiratory data was 72% (68/95) but was 66% (63/95) for respiratory function testing.  </p> <p><a href="./references#CD001145-bbs2-0012" title="KovacsL , DavisGM , FaucherD , PapageorgiouA . Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatrica1998;87(7):792-8. [DOI: 10.1080/080352598750013905] [PMID: 9722255]KovacsLB . Personal communication. email2002. ">Kovacs 1998</a> assigned eligible infants using a "blocked" randomisation procedure, and only the designated pharmacist who prepared all study medications was aware of group assignments. Researchers stratified infants before randomisation into two categories according to gestational age (22 to 26 weeks versus 27 to 29 weeks). Follow‐up consisted of the following (Kovacs 2002 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0012" title="KovacsL , DavisGM , FaucherD , PapageorgiouA . Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatrica1998;87(7):792-8. [DOI: 10.1080/080352598750013905] [PMID: 9722255]KovacsLB . Personal communication. email2002. ">Kovacs 1998</a>)): study authors obtained data from the regular follow‐up clinic at ages up to 90 months in 70% (33/47) of survivors and did not specify personnel involved, blinding of assessors to treatment group, and criteria for various diagnoses, including cerebral palsy and major disability. </p> <p><a href="./references#CD001145-bbs2-0013" title="Noble-JamiesonCM , RegevR , SilvermanM . Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. European Journal of Pediatrics1989;148(4):365-7. [DOI: 10.1007/BF00444135] [PMID: 2651132]">Noble‐Jamieson 1989</a> did not describe the method of randomisation. Medical and nursing staff were unaware of the drug given. Study authors provided outcome data for all 18 enrolled infants and reported no follow‐up component. </p> <p><a href="./references#CD001145-bbs2-0014" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatrica1992;81(10):751-6. [DOI: 10.1111/j.1651-2227.1992.tb12096.x] [PMID: 1421877]OhlssonA . A Randomized Controlled Trial of Dexamethasone Treatment in Very Low Birthweight Infants With Ventilator Dependent Chronic Lung Disease [Masters of Science Thesis]. Hamilton (ON): McMaster University, 1990. ">Ohlsson 1992</a> performed randomisation by using computer‐generated random numbers and wrote down allocation groups on cards enclosed in opaque envelopes and kept under lock in the pharmacy. Envelopes were available only to the pharmacist who drew the appropriate card and distributed the study drug. We have described under <a href="#CD001145-sec-0040">Description of studies</a> the problem of administering placebo. Trialists discontinued treatment for suspected infection in one infant in each group and treatment for blood transfusion‐derived cytomegalovirus in one infant in the study group. They provided outcome data for all enrolled infants. Follow‐up consisted of the following (Ohlsson 1990 (additional publication of <a href="./references#CD001145-bbs2-0014" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatrica1992;81(10):751-6. [DOI: 10.1111/j.1651-2227.1992.tb12096.x] [PMID: 1421877]OhlssonA . A Randomized Controlled Trial of Dexamethasone Treatment in Very Low Birthweight Infants With Ventilator Dependent Chronic Lung Disease [Masters of Science Thesis]. Hamilton (ON): McMaster University, 1990. ">Ohlsson 1992</a>)): researchers saw survivors in the regular follow‐up clinic up to at least 18 months of age in 96% (23/24) of cases; the remaining survivor was developing normally when last seen at 12 months of age. Age was probably not corrected for prematurity. Study authors did not specify personnel involved nor blinding of observers, neither did they specify criteria for the diagnoses of cerebral palsy and blindness. Psychological assessment included the MDI of the BSID. </p> <p>In <a href="./references#CD001145-bbs2-0015" title="HalbmeijerNM , OnlandW , CoolsF , SwarteR , van derHeide-JalvingM , MerkusMP , van Kaam AH Stop-BPD Trial Collaborators. Effect of systemic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years' corrected age: Follow-up of a randomized clinical trial. JAMA2021;326(4):355-357. OnlandW , CoolsF , KroonA , RademakerK , MerkusMP , DijkPH , et al, Stop-BPD Study Group. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial. JAMA2019;321(4):354-63. [DOI: 10.1001/jama.2018.21443] [PMID: 30694322]">Onland 2019</a>, the randomisation schedule was computer‐generated, with stratification for study centre and gestational age in two groups (&lt; 27 weeks and &gt; 26 weeks), The allocation ratio was 1:1 with block randomisation using variable block sizes. Multiple birth infants were randomised independently, unless parents or caretakers explicitly demanded that siblings should be in the same treatment arm. Infants’ parents and all members of the child's medical team and investigators were blinded to group allocation throughout the study. Survivors were assessed at two years' corrected age. Neurodevelopmental impairment was defined as presence of one or more of the following: cognitive and/or motor composite score less than 85 on the Bayley Scales of Infant and Toddler Development Third Edition (Dutch version), cerebral palsy greater than level II in the Gross Motor Function Classification System, or hearing or visual impairment. Additional data were obtained from the authors on the rates of cerebral palsy (personal communication, September 2021). </p> <p>In <a href="./references#CD001145-bbs2-0016" title="PapileLA , TysonJE , StollBJ , WrightLL , DonovanEF , BauerCR , et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. New England Journal of Medicine1998;338(16):1112-8. [DOI: 10.1056/NEJM199804163381604] [PMID: 9545359]StollBJ , TemprosaM , TysonJE , PapileLA , WrightLL , BauerCR , et al. Dexamethasone therapy increases infection in low birth weight infants. Pediatrics1999;104(5):e63. [DOI: 10.1542/peds.104.5.e63] [PMID: 10545589]">Papile 1998</a>, random assignment took place at each centre's pharmacy via the urn method ‐ a procedure that promotes equal distribution of participants among treatment groups. To blind clinical staff to treatment group assignment, investigators prepared different volumes of placebo (saline) to match the various doses of dexamethasone. They reported no follow‐up component. </p> <p>In <a href="./references#CD001145-bbs2-0017" title="ParikhNA , KennedyKA , LaskyRE , McDavidGE , TysonJE . Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes. Journal of Pediatrics2013;162(4):685-90. [DOI: 10.1016/j.jpeds.2012.09.054] [PMID: 23140612]ParikhNA , KennedyKA , LaskyRE , TysonJE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS One2015;10(9):e0137051. [DOI: 10.1371/journal.pone.0137051] [PMID: 26376074]">Parikh 2013</a>, an individual not involved in the study generated the randomisation sequence, but study authors did not specify the precise method. They described two strata ‐ one for birth weight (&lt; 751 grams versus 751 to 1000 grams) and one for respiratory index score (2 to 4 versus &gt; 4). Access to the randomisation assignment was limited to two study pharmacists, and blinding was maintained by using an identical volume of saline placebo. Follow‐up consisted of the following (<a href="./references#CD001145-bbs2-0017" title="ParikhNA , KennedyKA , LaskyRE , McDavidGE , TysonJE . Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes. Journal of Pediatrics2013;162(4):685-90. [DOI: 10.1016/j.jpeds.2012.09.054] [PMID: 23140612]ParikhNA , KennedyKA , LaskyRE , TysonJE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS One2015;10(9):e0137051. [DOI: 10.1371/journal.pone.0137051] [PMID: 26376074]">Parikh 2013</a>; <a href="./references#CD001145-bbs2-0107" title="ParikhNA , KennedyKA , LaskyRE , TysonJE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS One2015;10(9):e0137051. [DOI: 10.1371/journal.pone.0137051] [PMID: 26376074]">Parikh 2015</a>): certified examiners assessed survivors at 18 to 22 months' corrected age and were blinded to group allocation. Certified examiners diagnosed cerebral palsy and specified the criteria for diagnosis. Study authors defined bilateral deafness as bilateral hearing loss requiring amplification, and bilateral blindness as bilateral vision loss with only form or shadow vision or no useful vision. Psychological assessment included the Bayley Scales of Infant and Toddler Development ‐ Third Edition (Bayley III). Investigators defined any neurodevelopmental impairment as any of cerebral palsy, cognitive delay, language delay, blindness, or deafness. </p> <p><a href="./references#CD001145-bbs2-0018" title="RomagnoliC , VentoG , Zecca E, PapacciP , De CarolisMP , MaggioL , et al. Dexamethasone for the prevention of chronic lung disease in preterm neonates: a prospective randomized study [II desametazone nella prevenzione della patologia polmonare cronica del neonato pretermine: studio prospettico randomizzato]. Rivista Italiana di Pediatria [Italian Journal of Pediatrics]1997;24:283-8. [ISSN: 0392-5161]RomagnoliC , ZeccaE , LucianoR , TorrioliG , TortoroloG . A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Archives of Disease in Childhood. Fetal and Neonatal Edition2002;87(1):F55-8. [DOI: 10.1136/fn.87.1.f55] [PMID: 12091294]RomagnoliC , ZeccaE , VentoG , MaggioL , PapacciP , TortoroloG . Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology1999;59(5):266-74. [10.1159/000028329] [PMID: 10529659]">Romagnoli 1997</a> achieved random allocation by opening numbered, sealed envelopes. Researchers did not give placebo to control infants. They reported outcome measures for all 30 infants included in the study. Follow‐up consisted of the following (<a href="./references#CD001145-bbs2-0109" title="RomagnoliC , ZeccaE , LucianoR , TorrioliG , TortoroloG . A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Archives of Disease of Childhood. Fetal and Neonatal Edition2002;87(1):F55-8. [DOI: 10.1542/peds.109.6.e85] [PMID: 12091294]">Romagnoli 2002</a>): one paediatrician and one neurologist saw survivors at 36 to 42 months of age, corrected for prematurity, with observers blinded to treatment group allocation. The follow‐up rate of survivors was 100% (30/30). The neurologist made the diagnosis of cerebral palsy, but study authors did not specify the criteria used and reported no specific criteria for blindness and deafness. Psychological assessment included the Stanford Binet Test ‐ Third Revision. Study authors provided no data on major disability. </p> <p><a href="./references#CD001145-bbs2-0019" title="ScottSM , BackstromC , BessmanS . Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations. Journal of Perinatology1997;17(1):24-8. [PMID: 9069060]">Scott 1997</a> achieved randomisation using a random numbers table. Blinding was maintained by using an identical volume of saline placebo. There was no follow‐up component. </p> <p><a href="./references#CD001145-bbs2-0020" title="VentoG , MatassaPG , ZeccaE , TortoroloL , MartelliM , De CarolisMP , et al. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology2004;71(3):113-9. [DOI: 10.1159/000077444] [PMID: 15161992]VentoG . Personal communication. email2012. ">Vento 2004</a> did not state the method of randomisation. It is not clear whether clinicians caring for infants or those assessing outcomes were blinded to treatment group assignment. The control group did not receive a placebo. Follow‐up consisted of the following (Vento 2012 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0020" title="VentoG , MatassaPG , ZeccaE , TortoroloL , MartelliM , De CarolisMP , et al. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology2004;71(3):113-9. [DOI: 10.1159/000077444] [PMID: 15161992]VentoG . Personal communication. email2012. ">Vento 2004</a>)): a paediatric neurologist who was blinded to treatment group allocation assessed surviving children between one and four years of age, corrected for prematurity up to two years. They considered children to have a major neurosensory impairment if they had non‐ambulant cerebral palsy, blindness (bilateral vision worse than 6/60), deafness requiring hearing aids or worse, or severe cognitive delay (defined as IQ &lt; 55). The follow‐up rate of survivors at a mean age of 26 months was 100% (18/18). </p> <p><a href="./references#CD001145-bbs2-0021" title="VincerMJ , AllenAC . Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW &lt; 1500 grams) who are ventilator dependent at 4 weeks of age. Pediatric Research1998;43:201A. [CENTRAL: CN-00295187] VincerMJ . Personal communication. email2002. ">Vincer 1998</a> achieved random allocation but did not describe in the abstract the method used. Control infants were given equal volumes of saline placebo, which concealed treatment allocation. Follow‐up consisted of the following (Vincer 2002 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0021" title="VincerMJ , AllenAC . Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW &lt; 1500 grams) who are ventilator dependent at 4 weeks of age. Pediatric Research1998;43:201A. [CENTRAL: CN-00295187] VincerMJ . Personal communication. email2002. ">Vincer 1998</a>)): one of two neonatologists saw survivors at 24 months of age, corrected for prematurity. They referred children with a developmental abnormality to a neurologist. Observers were blind to treatment group allocation. The follow‐up rate of survivors was 100% (17/17). Study authors specified criteria for the diagnosis of cerebral palsy, but not for blindness or deafness. Psychological assessment included the MDI of the BSID. Major disability comprised any of moderate or severe cerebral palsy, bilateral blindness, deafness, or MDI &lt; 2 SD. </p> <p>In <a href="./references#CD001145-bbs2-0022" title="WaltherF . Personal communication. email2012. WaltherFJ , FindlayRD , DurandM . Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Human Development2003;74(1):37-45. [DOI: 10.1016/s0378-3782(03)00082-3] [PMID: 14512180]">Walther 2003</a>, a staff pharmacist was in charge of randomisation and drug preparation. Investigators and clinical caregivers were unaware of treatment allocation. Infants in the control group received a saline placebo. Open‐label steroid therapy was used only if it became essential for management of ventilator dependency, ideally seven days after completion of therapy and at the discretion of the attending neonatologist. Follow‐up consisted of the following (Walther 2012 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0022" title="WaltherF . Personal communication. email2012. WaltherFJ , FindlayRD , DurandM . Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Human Development2003;74(1):37-45. [DOI: 10.1016/s0378-3782(03)00082-3] [PMID: 14512180]">Walther 2003</a>)): surviving children were assessed at between one and four years of age with no details provided about correction for prematurity and personnel involved; however, trial personnel were blinded to knowledge of treatment group allocation. They defined developmental delay as MDI &lt; 70 on the BSID. The follow‐up rate of survivors was 78% (25/32). </p> <p>In <a href="./references#CD001145-bbs2-0023" title="YatesH , ChiocchiaV , LinsellL , OrsiN , JuszczakE , JohnsonK , et al. Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT. NIHR Journals Library. Efficacy and Mechanism Evaluation2019;6. [DOI: 10.3310/eme06080] [ISSN: 2050-4365; 2050-4373 ] [PMID: 31479218]">Yates 2019</a>, randomisation was managed via a secure web‐based randomisation facility hosted centrally, with continuous telephone backup available. The randomisation programme used a minimisation algorithm to ensure balance between trial groups, with respect to collaborating hospital, sex, multiple births, gestational age at birth, and existing diuretic therapy for the 24 hours before randomisation. Multiple births from the same family were randomised individually. Dexamethasone and saline placebo were supplied in identical vials, and hence staff were unaware of treatment allocation. Open‐label treatment was allowed after the 16‐day intervention period had elapsed; however open‐label could start earlier at clinician discretion. There was no long‐term follow‐up component. </p> <section id="CD001145-sec-0045"> <h4 class="title">Allocation</h4> <p>We found little evidence of allocation bias overall; most studies had no evidence of allocation bias, and in a small minority the risk was unclear. </p> </section> <section id="CD001145-sec-0046"> <h4 class="title">Blinding</h4> <p>We found little evidence of blinding bias overall; most studies had no evidence of blinding bias, but small minorities had unclear or high risk of blinding bias. </p> </section> <section id="CD001145-sec-0047"> <h4 class="title">Incomplete outcome data</h4> <p>We found little evidence of attrition bias overall; most studies had no evidence of attrition bias, and a small minority had unclear risk. </p> </section> <section id="CD001145-sec-0048"> <h4 class="title">Selective reporting</h4> <p>Just over one‐half of studies had no evidence of selective reporting bias, and the remainder had unclear risk of selective reporting bias. </p> </section> <section id="CD001145-sec-0049"> <h4 class="title">Other potential sources of bias</h4> <p>A majority of studies used a valid method of random sequence generation, but in approximately 40% of studies, the methods used for randomisation were unclear. </p> </section> </section> <section id="CD001145-sec-0050"> <h3 class="title" id="CD001145-sec-0050">Effects of interventions</h3> <p>See: <a href="./full#CD001145-tbl-0001"><b>Summary of findings 1</b> Systemic corticosteroids (dexamethasone or hydrocortisone) compared with control (placebo or nothing) for chronic lung disease in preterm infants</a> </p> <section id="CD001145-sec-0051"> <h4 class="title">Results of meta‐analysis</h4> <p>Meta‐analysis of these 23 studies yielded the following results.</p> <section id="CD001145-sec-0052"> <h5 class="title">Mortality</h5> <p>Evidence indicates that late systemic corticosteroid treatment was associated with reduced mortality at all ages: 28 days (typical risk ratio (RR) 0.60, 95% confidence interval (CI) 0.40 to 0.89; typical risk difference (RD) ‐0.04, 95% CI ‐0.09 to ‐0.00; 7 studies, 970 infants; <a href="./references#CD001145-fig-0009" title="">Analysis 1.1</a>), 36 weeks' postmenstrual age (typical RR 0.70, 95% CI 0.52 to 0.94; typical RD ‐0.05, 95% CI ‐0.10 to ‐0.01; 15 studies, 1029 infants; <a href="./references#CD001145-fig-0010" title="">Analysis 1.2</a>), before hospital discharge (typical RR 0.79, 95% CI 0.63 to 0.98; typical RD ‐0.04, 95% CI ‐0.08 to ‐0.00; 20 studies, 1406 infants; <a href="./references#CD001145-fig-0011" title="">Analysis 1.3</a>), and at latest reported age (RR 0.81, 95% CI 0.66 to 0.99; RD ‐0.05, 95% CI ‐0.09 to ‐0.00; 21 studies, 1428 infants; <a href="./references#CD001145-fig-0012" title="">Analysis 1.4</a>). </p> <p>No evidence suggests publication bias for mortality at latest reported age upon examination of a funnel plot (Egger test, P = 0.78) (<a href="#CD001145-fig-0004">Figure 4</a>). </p> <div class="figure" id="CD001145-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Mortality, outcome: 1.4 Mortality at latest reported age." data-id="CD001145-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Mortality, outcome: 1.4 Mortality at latest reported age. </p> </div> </div> </div> </section> <section id="CD001145-sec-0053"> <h5 class="title">Bronchopulmonary dysplasia</h5> <p>The incidence of BPD was significantly decreased at 28 days of life (typical RR 0.90, 95% CI 0.84 to 0.95; typical RD ‐0.11, 95% CI ‐0.17 to ‐0.05; 7 studies, 994 infants; <a href="./references#CD001145-fig-0013" title="">Analysis 2.1</a>), and at 36 weeks' postmenstrual age (typical RR 0.89, 95% CI 80 to 0.99; typical RD ‐0.07, 95% CI ‐0.13 to ‐0.01; 14 studies, 988 infants; <a href="./references#CD001145-fig-0014" title="">Analysis 2.2</a>), but the evidence was not as strong at 36 weeks' postmenstrual age among survivors (typical RR 0.91, 95% CI 0.82 to 1.01; typical RD ‐0.06, 95% CI ‐0.13 to 0.01; 9 studies, 624 infants; <a href="./references#CD001145-fig-0015" title="">Analysis 2.3</a>). We noted strong evidence of publication bias upon examining a funnel plot for BPD at 36 weeks (Egger test, P &lt; 0.001) (<a href="#CD001145-fig-0005">Figure 5</a>). Data show reduced need for late rescue with corticosteroids (typical RR 0.48, 95% CI 0.41 to 0.57; typical RD ‐0.20, 95% CI ‐0.24 to ‐0.16; 15 studies, 1489 infants; <a href="./references#CD001145-fig-0016" title="">Analysis 2.4</a>) and reduced need for home oxygen both overall (typical RR 0.71, 95% CI 0.54 to 0.94; typical RD ‐0.08, 95% CI ‐0.14 to ‐0.01; 7 studies, 611 infants; <a href="./references#CD001145-fig-0017" title="">Analysis 2.5</a>) and for survivors only (typical RR 0.69, 95% CI 0.51 to 0.94; typical RD ‐0.13, 95% CI ‐0.24 to ‐0.03; 6 studies, 277 infants; <a href="./references#CD001145-fig-0018" title="">Analysis 2.6</a>). </p> <div class="figure" id="CD001145-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 2 Bronchopulmonary dysplasia (BPD), outcome: 2.2 BPD at 36 weeks' postmenstrual age." data-id="CD001145-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Bronchopulmonary dysplasia (BPD), outcome: 2.2 BPD at 36 weeks' postmenstrual age. </p> </div> </div> </div> </section> <section id="CD001145-sec-0054"> <h5 class="title">Mortality or bronchopulmonary dysplasia</h5> <p>Strong evidence indicates that the combined outcome of mortality or BPD was decreased both at 28 days of life (typical RR 0.87, 95% CI 0.83 to 0.91; typical RD ‐0.12 to 95% CI ‐0.16 to ‐0.08; 6 studies, 934 infants; <a href="./references#CD001145-fig-0019" title="">Analysis 3.1</a>) and at 36 weeks' postmenstrual age (RR 0.85, 95% CI 0.79 to 0.92; RD ‐0.12, 95% CI ‐0.17 to ‐0.07; 14 studies, 988 infants; <a href="./references#CD001145-fig-0020" title="">Analysis 3.2</a>). We found little evidence of publication bias upon examining a funnel plot for mortality or BPD at 36 weeks (Egger test, P = 0.33) (<a href="#CD001145-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD001145-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 3 Mortality or BPD, outcome: 3.2 Mortality or BPD at 36 weeks' postmenstrual age." data-id="CD001145-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Mortality or BPD, outcome: 3.2 Mortality or BPD at 36 weeks' postmenstrual age. </p> </div> </div> </div> </section> <section id="CD001145-sec-0055"> <h5 class="title">Failure to extubate</h5> <p>Failure to extubate was significantly decreased at three days (typical RR 0.83, 95% CI 0.78 to 0.88; typical RD ‐0.16, 95% CI ‐0.21 to ‐0.11; 10 studies, 764 infants; <a href="./references#CD001145-fig-0021" title="">Analysis 4.1</a>), at seven days (typical RR 0.67, 95% CI 0.62 to 0.73; typical RD ‐0.27, 95% CI ‐0.32 to ‐0.22; 17 studies, 1130 infants; <a href="./references#CD001145-fig-0022" title="">Analysis 4.2</a>), at 14 days (typical RR 0.65, 95% CI 0.53 to 0.80; typical RD ‐0.19, 95% CI ‐0.28 to ‐0.10; 5 studies, 458 infants; <a href="./references#CD001145-fig-0023" title="">Analysis 4.3</a>), and at 28 days (typical RR 0.57, 95% CI 0.37 to 0.89; typical RD ‐0.14, 95% CI ‐0.25 to ‐0.03; 3 studies, 236 infants; <a href="./references#CD001145-fig-0024" title="">Analysis 4.4</a>). </p> </section> <section id="CD001145-sec-0056"> <h5 class="title">Complications during primary hospitalisation</h5> <section id="CD001145-sec-0057"> <h6 class="title">Metabolic complications</h6> <p>Results show increased risks of hyperglycaemia (typical RR 1.59, 95% CI 1.34 to 1.89; typical RD 0.10, 95% CI 0.07 to 0.14; 19 studies, 1684 infants; <a href="./references#CD001145-fig-0026" title="">Analysis 5.2</a>) and glycosuria (typical RR 8.03, 95% CI 2.43 to 26.5; typical RD 0.72, 95% CI 0.52 to 0.91; 2 studies, 48 infants; <a href="./references#CD001145-fig-0027" title="">Analysis 5.3</a>), as well as increased risk of hypertension (typical RR 1.67, 95% CI 1.19 to 2.33; typical RD 0.04, 95% CI 0.01 to 0.06; 17 studies, 1628 infants; <a href="./references#CD001145-fig-0028" title="">Analysis 5.4</a>). </p> </section> <section id="CD001145-sec-0058"> <h6 class="title">Gastrointestinal complications</h6> <p>We found little evidence for differences in gastrointestinal complications: necrotising enterocolitis (typical RR 0.92, 95% CI 0.62 to 1.38; 11 studies, 1409 infants; <a href="./references#CD001145-fig-0030" title="">Analysis 5.6</a>), gastrointestinal bleeding (typical RR 1.33, 95% CI 0.97 to 1.83; 9 studies, 1385 infants; <a href="./references#CD001145-fig-0031" title="">Analysis 5.7</a>), or gastrointestinal perforation (RR 0.67, 95% CI 0.26 to 1.70; 5 studies, 552 infants; <a href="./references#CD001145-fig-0032" title="">Analysis 5.8</a>). </p> </section> <section id="CD001145-sec-0059"> <h6 class="title">Other complications</h6> <p>No evidence suggests that infection rates were different between groups (typical RR 1.03, 95% CI 0.91 to 1.16; 20 studies, 1742 infants; <a href="./references#CD001145-fig-0025" title="">Analysis 5.1</a>). Evidence indicates an increase in severe retinopathy of prematurity overall (typical RR 1.27, 95% CI 1.03 to 1.58; typical RD 0.06, 95% CI 0.01 to 0.12; 13 studies, 929 infants; <a href="./references#CD001145-fig-0033" title="">Analysis 5.9</a>), but not among survivors (typical RR 1.17, 95% CI 0.94 to 1.45; 10 studies, 697 infants; <a href="./references#CD001145-fig-0034" title="">Analysis 5.10</a>). Evidence shows an increase in hypertrophic cardiomyopathy (typical RR 2.76, 95% CI 1.33 to 5.74; typical RD 0.13, 95% CI 0.05 to 0.20; 4 studies, 238 infants; <a href="./references#CD001145-fig-0035" title="">Analysis 5.11</a>). We found little evidence for real reductions in pneumothorax (typical RR 0.89, 95% CI 0.53 to 1.49; 3 studies, 157 infants; <a href="./references#CD001145-fig-0036" title="">Analysis 5.12</a>) or in severe intraventricular haemorrhage (typical RR 0.54, 95% CI 0.26 to 1.11; 7 studies, 639 infants; <a href="./references#CD001145-fig-0037" title="">Analysis 5.13</a>). </p> </section> </section> </section> <section id="CD001145-sec-0060"> <h4 class="title">Follow‐up data</h4> <p> <ul id="CD001145-list-0005"> <li> <p>Rates of children with low cut‐off scores for the Mental Developmental Index on the Bayley Scales were little affected overall (typical RR 0.81, 95% CI 0.47 to 1.38; 7 studies, 333 infants; <a href="./references#CD001145-fig-0039" title="">Analysis 6.1</a>) or among survivors assessed (typical RR 0.74, 95% CI 0.45 to 1.22; 7 studies, 232 infants; <a href="./references#CD001145-fig-0040" title="">Analysis 6.2</a>). Rates of children with low cut‐off scores for the Psychomotor Developmental Index on the Bayley Scales were little affected overall (typical RR 0.78, 95% CI 0.34 to 1.80; 1 study, 118 infants; <a href="./references#CD001145-fig-0041" title="">Analysis 6.3</a>) or among survivors assessed (typical RR 0.67, 95% CI 0.30 to 1.50; 1 study, 90 infants; <a href="./references#CD001145-fig-0042" title="">Analysis 6.4</a>) </p> </li> <li> <p>The increase in retinopathy of prematurity did not translate into a significant increase in blindness overall (typical RR 0.78, 95% CI 0.35 to 1.73; 13 studies, 784 infants; <a href="./references#CD001145-fig-0043" title="">Analysis 6.5</a>) or among survivors assessed (typical RR 0.77, 95% CI 0.35 to 1.67; 13 studies, 539 infants; <a href="./references#CD001145-fig-0044" title="">Analysis 6.6</a>) </p> </li> <li> <p>We found little evidence for a difference in rates of deafness overall (typical RR 0.56, 95% CI 0.26 to 1.27; 9 studies, 936 infants; <a href="./references#CD001145-fig-0045" title="">Analysis 6.7</a>) or among survivors assessed (typical RR 0.62, 95% CI 0.29 to 1.36; 9 studies, 616 infants; <a href="./references#CD001145-fig-0046" title="">Analysis 6.8</a>) </p> </li> <li> <p>We found little evidence for a difference in rates of cerebral palsy at the latest reported age overall (typical RR 1.17, 95% CI 0.84 to 1.61; 17 studies, 1290 infants; <a href="./references#CD001145-fig-0048" title="">Analysis 6.10</a>) or among survivors assessed at the latest reported age (typical RR 1.15, 95% CI 0.81 to 1.61; 16 studies, 628 infants; <a href="./references#CD001145-fig-0054" title="">Analysis 6.16</a>). A funnel plot for the outcome of cerebral palsy at latest reported age provided little evidence of publication bias (Egger test, P = 0.13) (<a href="#CD001145-fig-0007">Figure 7</a>). Cerebral palsy was not significantly increased in studies limited to the first three years after birth (typical RR 1.11, 95% CI 0.81 to 1.51; 16 studies, 1311 infants; <a href="./references#CD001145-fig-0047" title="">Analysis 6.9</a>), or among survivors assessed at 1‐3 years of age (typical RR 1.08, 95% CI 0.79 to 1.47; 16 studies, 923 infants; <a href="./references#CD001145-fig-0053" title="">Analysis 6.15</a>. The combined rate of mortality or cerebral palsy was little affected in studies limited to the first three years after birth (typical RR 0.89, 95% CI 0.76 to 1.04; 16 studies, 1311 infants; <a href="./references#CD001145-fig-0051" title="">Analysis 6.13</a>). The combined rate of either mortality or cerebral palsy at latest reported age was not significantly different (typical RR 0.90, 95% CI 0.76 to 1.06; 16 studies, 1290 infants; <a href="./references#CD001145-fig-0052" title="">Analysis 6.14</a>). A funnel plot for the outcome mortality or cerebral palsy at latest reported age provided little evidence of publication bias (Egger test, P = 0.99) (<a href="#CD001145-fig-0008">Figure 8</a>) </p> </li> <li> <p>Major neurosensory disability was not significantly different overall (typical RR 1.09, 95% CI 0.88 to 1.34; 10 studies, 1090 infants; <a href="./references#CD001145-fig-0055" title="">Analysis 6.17</a>) or among survivors assessed (typical RR 1.01, 95% CI 0.83 to 1.22; 10 studies, 778 infants; <a href="./references#CD001145-fig-0058" title="">Analysis 6.20</a>). The combined rate of mortality or major neurosensory disability was not significantly different (typical RR 0.96, 95% CI 0.85 to 1.08; 10 studies, 1090 infants; <a href="./references#CD001145-fig-0057" title="">Analysis 6.19</a>) </p> </li> <li> <p>The rate of abnormal neurological examination overall was increased (typical RR 1.81, 95% CI 1.05 to 3.11; typical RD 0.13, 95% CI 0.02 to 0.24; 4 studies, 200 infants; <a href="./references#CD001145-fig-0059" title="">Analysis 6.21</a>), but the clinical importance of this finding is unclear in the absence of important increases in cerebral palsy or major neurosensory disability. Rates of the combined outcome of mortality or abnormal neurological examination were not significantly different between groups (typical RR 0.96, 95% CI 0.71 to 1.31; 4 studies, 200 infants; <a href="./references#CD001145-fig-0061" title="">Analysis 6.23</a>) </p> </li> <li> <p>The only study reporting re‐hospitalisation rates over the first five years noted little evidence of a difference between groups (<a href="./references#CD001145-fig-0063" title="">Analysis 6.25</a>; <a href="./references#CD001145-fig-0064" title="">Analysis 6.26</a>). The same study with follow‐up of survivors to five years noted little evidence for increased maternal reports of wheezing (RR 1.47, 95% CI 0.82 to 2.64; 1 study, 74 infants; <a href="./references#CD001145-fig-0065" title="">Analysis 7.1</a>), need for corrective lenses (RR 1.61, 95% CI 0.82 to 3.13; 1 study, 74 infants; <a href="./references#CD001145-fig-0066" title="">Analysis 7.2</a>), and need for physical therapy (RR 1.49, 95% CI 0.71 to 3.11; 1 study, 74 infants; <a href="./references#CD001145-fig-0067" title="">Analysis 7.3</a>), and a non‐significant decrease in the need for speech therapy (RR 0.46, 95% CI 0.21 to 1.02; 1 study, 74 infants; <a href="./references#CD001145-fig-0068" title="">Analysis 7.4</a>) </p> </li> <li> <p>Data show no substantial differences between groups for other outcomes in later childhood, including IQ, respiratory health or function, blood pressure, and growth, with the exceptions of a significant reduction in rates of children with FEV₁ &lt; ‐2 SD (typical RR 0.58, 95% CI 0.36 to 0.94; 2 studies, 187 infants; <a href="./references#CD001145-fig-0072" title="">Analysis 8.2</a>), increased standardised mean difference for FEV₁ (standardised mean difference (SMD) 0.28, 95% CI 0.01 to 0.55; 4 studies, 222 participants; <a href="./references#CD001145-fig-0075" title="">Analysis 8.5</a>), and increased mean difference for forced vital capacity (MD 7.68% predicted, 95% CI 1.69 to 13.68; 3 studies, 98 participants; <a href="./references#CD001145-fig-0077" title="">Analysis 8.7</a>). </p> </li> </ul> </p> <div class="figure" id="CD001145-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.10 Cerebral palsy at latest reported age." data-id="CD001145-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-07.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.10 Cerebral palsy at latest reported age. </p> </div> </div> </div> <div class="figure" id="CD001145-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.14 Mortality or cerebral palsy at latest reported age." data-id="CD001145-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-08.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.14 Mortality or cerebral palsy at latest reported age. </p> </div> </div> </div> </section> <section id="CD001145-sec-0061"> <h4 class="title">Differences by type of corticosteroid used</h4> <p>When such comparisons were possible, there were few outcomes for which evidence shows differences in treatment effects between RCTs involving dexamethasone and those involving only hydrocortisone. Notable exceptions were that effects of corticosteroids in reducing BPD at 36 weeks (<a href="./references#CD001145-fig-0014" title="">Analysis 2.2</a>), in reducing mortality or BPD at 36 weeks (<a href="./references#CD001145-fig-0020" title="">Analysis 3.2</a>), and in increasing the rate of hypertension (<a href="./references#CD001145-fig-0028" title="">Analysis 5.4</a>) all arose from treatment with dexamethasone ‐ not with hydrocortisone.  </p> </section> <section id="CD001145-sec-0062"> <h4 class="title">Sensitivity analysis, excluding studies with higher risk of bias</h4> <p>Two studies had higher risk of bias largely because they included no control groups, and hence blinding to knowledge of treatment allocation was not possible (<a href="./references#CD001145-bbs2-0007" title="DurandM , SardesiS , McEvoyC . Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized controlled trial. Pediatrics1995;95(4):584-90. [PMID: 7700763]DurandM . Personal communication. email2012. ">Durand 1995</a>; <a href="./references#CD001145-bbs2-0018" title="RomagnoliC , VentoG , Zecca E, PapacciP , De CarolisMP , MaggioL , et al. Dexamethasone for the prevention of chronic lung disease in preterm neonates: a prospective randomized study [II desametazone nella prevenzione della patologia polmonare cronica del neonato pretermine: studio prospettico randomizzato]. Rivista Italiana di Pediatria [Italian Journal of Pediatrics]1997;24:283-8. [ISSN: 0392-5161]RomagnoliC , ZeccaE , LucianoR , TorrioliG , TortoroloG . A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Archives of Disease in Childhood. Fetal and Neonatal Edition2002;87(1):F55-8. [DOI: 10.1136/fn.87.1.f55] [PMID: 12091294]RomagnoliC , ZeccaE , VentoG , MaggioL , PapacciP , TortoroloG . Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology1999;59(5):266-74. [10.1159/000028329] [PMID: 10529659]">Romagnoli 1997</a>). Both studies involved dexamethasone only. Excluding these two studies from major outcomes of mortality at latest age, BPD at 36 weeks, combined mortality or BPD at 36 weeks, cerebral palsy, or mortality or cerebral palsy had little effect on most odds ratios or on any CIs, and altered no conclusions, with one exception; for outcomes of BPD at 36 weeks for all studies combined, the typical RR was 0.89 (95% CI 0.80 to 0.99) with all studies included (<a href="./references#CD001145-fig-0014" title="">Analysis 2.2</a>), but was changed slightly to typical RR 0.93 (95% CI 0.83 to 1.03) when the two studies were excluded. </p> </section> <section id="CD001145-sec-0063"> <h4 class="title">Results of individual trials</h4> <p><a href="./references#CD001145-bbs2-0001" title="AriagnoRL , SweeneyTE , BaldwinRB , InguilloD , MartinD . Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia: lung function, clinical course and outcome at three years. Unpublished manuscript supplied by authors2000. AriagnoRL , SweeneyTJ , BaldwinRB , InguilloD , MartinD . Dexamethasone effects on lung function and risks in 3 week old ventilatory dependent preterm infants. American Reviews of Respiratory Disease1987;135:A125. [CENTRAL: CN-00295119] ">Ariagno 1987</a>: total respiratory system compliance improved in the dexamethasone group (P &lt; 0.05). Time from initiation of treatment to first extubation was shorter for the dexamethasone group (6 versus 45 days; P = 0.0006), but time to final extubation was not significantly different (30 versus 48 days). Data show 10 deaths ‐ five in the dexamethasone group and five in the control group ‐ all occurring after the treatment period. Proportionate weight gain was greater among control infants (P &lt; 0.003) during treatment. Five dexamethasone‐treated infants had infection, as did two in the control group. Hyperglycaemia and hypertension were similar between groups. At follow‐up, cerebral palsy was detected in one child in the dexamethasone group at 36 months of age and in three controls at 12 months of age. </p> <p><a href="./references#CD001145-bbs2-0002" title="AveryGB , FletcherAB , CaplanM , BrudnoDS . Control trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics1985;75(1):106-11. [PMID: 3880879]">Avery 1985</a>: sequential analysis exceeded the criterion (P &lt; 0.005) when seven consecutive untied pairs showed weaning with dexamethasone and failure to wean in control infants. Pulmonary compliance improved by 64% in the treated group and by 5% in the control group (P &lt; 0.01). Results show no significant intergroup differences in mortality, length of hospital stay, sepsis, hypertension, hyperglycaemia, or electrolyte abnormalities. </p> <p><a href="./references#CD001145-bbs2-0003" title="BrozanskiBS , JonesJG , GilmoreCH , BalsanMJ , VazquezRL , IsraelBA , et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infant. Journal of Pediatrics1995;126(5 Pt 1):769-76. [DOI: 10.1016/s0022-3476(95)70410-8] [PMID: 7752005]GilmourCH , Sentipal-WaleriusJM , JonesJG , DoyleJM , BrozanskiBS , BalsanMJ , et al. Pulse dexamethasone does not impair growth and body composition of very low birth weight infants. Journal of the American College of Nutrition1995;14(5):455-62. [10.1080/07315724.1995.10718536] [PMID: 8522724]HofkoshD , BrozanskiBS , EdwardsMD , WilliamsLA , JonesJG , ChengKP . One year outcome of infants treated with pulse dexamethasone for prevention of BPD. Pediatric Research1995;37(4):259A. ">Brozanski 1995</a>: at 36 weeks' postmenstrual age, results show a significant increase in survival rates without oxygen supplementation (17/39 versus 7/39; P = 0.03) and a significant decrease in the incidence of BPD (46% versus 23%; P = 0.047) in the group that received pulse dexamethasone therapy. Supplemental oxygen requirements were less throughout the study period in the dexamethasone group (P = 0.013). Mortality and durations of supplemental oxygen, ventilator support, and hospital stay did not differ significantly between groups. The need for insulin therapy for hyperglycaemia was increased in the dexamethasone group (P &lt; 0.05). At follow‐up, data show no significant differences between groups in rate of cerebral palsy among survivors assessed (20% versus 21%). Rate of death or survival among randomised children with cerebral palsy was lower in the dexamethasone group (23% versus 33%), but this difference was not statistically significant. The mean Mental Developmental Index (MDI) was 89.5 (SD 23.7) in the dexamethasone group and 80.8 (SD 26.0) in the control group ‐ a non‐significant difference. </p> <p><a href="./references#CD001145-bbs2-0004" title="Collaborative Dexamethasone Trial Group. Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics1991;88(3):421-7. [PMID: 1881718]JonesR , WincottE , ElbourneD , GrantA . Controlled trial of dexamethasone in neonatal chronic lung disease: a 3 year follow-up. Pediatrics1995;96(5 Pt 1):897-906. [PMID: 7478833]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics2005;116(2):370-8. [DOI: 10.1542/peds.2004-1818] [PMID: 16061591]JonesRA , Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: II. Respiratory status, growth, and blood pressure. Pediatrics2005;116(2):379-84. [DOI: 10.1542/peds.2004-1819] [PMID: 16061592]">CDTG 1991</a>: dexamethasone treatment significantly reduced the duration of mechanical ventilation among infants who were ventilator‐dependent at entry (median days for survivors, 11 versus 17.5). Data show no statistically significant differences between total groups of survivors in time receiving supplemental oxygen and length of stay in hospital, although trends favoured the dexamethasone group. Twenty‐five infants in each group died before hospital discharge; most were ventilator‐dependent at trial entry. Open treatment with steroids was later given to 18% of the dexamethasone group and 43% of the placebo group (P &lt; 0.001). We found little evidence of serious side effects and noted that infection rates in particular were similar in the two groups. At follow‐up, results show no clear differences between randomised groups in the original study for outcomes at three years. This conclusion held when data for cerebral palsy, blindness, and deafness were updated on the basis of results obtained at 13 to 17 years of age. Rates of intellectual impairment and moderate and severe disability at 13 to 17 years of age were similar in both groups, and data reveal no substantial differences in lung function or growth z‐scores, nor in proportions with high blood pressure. </p> <p><a href="./references#CD001145-bbs2-0005" title="CummingsJJ , D'EugenioDB , GrossSJ . A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine1989;320(23):1505-10. [DOI: 10.1056/NEJM198906083202301] [PMID: 2657423]CummingsJJ . Personal communication. email2002. GrossSJ , AnbarRD , MettelmanBB . Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics2005;115(3):681-7. [DOI: 10.1542/peds.2004-0956] [PMID: 15741372]">Cummings 1989</a>: infants in the 42‐day dexamethasone group, but not those in the 18‐day group, were weaned from mechanical ventilation significantly faster than controls (median 29, 73, and 84 days, respectively; P &lt; 0.05) and from supplemental oxygen (medians 65, 190, and 136 days, respectively; P &lt; 0.05). No clinical complications of steroid administration were noted. At follow‐up, combining both dexamethasone groups revealed no significant differences between dexamethasone‐treated and control children for rates of cerebral palsy, blindness, deafness, developmental delay, or major neurosensory disability among survivors, or for death or survival with cerebral palsy, or for death or survival with major disability among those randomised. Neurological status was confirmed at four years of age for all children (Cummings 2002 (personal communication follow‐up of <a href="./references#CD001145-bbs2-0005" title="CummingsJJ , D'EugenioDB , GrossSJ . A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New England Journal of Medicine1989;320(23):1505-10. [DOI: 10.1056/NEJM198906083202301] [PMID: 2657423]CummingsJJ . Personal communication. email2002. GrossSJ , AnbarRD , MettelmanBB . Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics2005;115(3):681-7. [DOI: 10.1542/peds.2004-0956] [PMID: 15741372]">Cummings 1989</a>)). Data show no significant differences in psychometric test scores at 15 months or 4 years of age. Between 4 and 15 years, one child in the 18‐day group had died, leaving 22 survivors, all of whom (100%) were assessed at 15 years of age. There were no significant differences between dexamethasone groups combined and the placebo group for any of the major neurological outcomes, nor for growth or respiratory function. </p> <p><a href="./references#CD001145-bbs2-0006" title="DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter international randomized controlled trial. Pediatrics2006;117(1):75-83. [DOI: 10.1542/peds.2004-2843] [PMID: 16396863]DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics2007;119(4):716-21. [DOI: 10.1542/peds.2006-2806] [PMID: 17403842]">Doyle 2006</a>: substantially more infants were extubated successfully by 10 days in the dexamethasone group than in the control group (odds ratio (OR) 11.2, 95% confidence interval (CI) 3.2 to 39.0; P &lt; 0.001). Twelve of 21 dexamethasone‐treated infants were re‐intubated after initial extubation compared with one of four placebo‐treated infants. Mortality was reduced but not significantly in the dexamethasone group (OR 0.52, 95% CI 0.14 to 1.95; P = 0.33), and the same was true for BPD among survivors (OR 0.58, 95% CI 0.08 to 3.32; P = 0.71). Combined rates of death or BPD (86% versus 91%; P = 0.45) and death or severe BPD (34% versus 46%; P = 0.33) were not different between groups. During the first 10 days, mean airway pressure (MAP), peak inspiratory pressure, and inspired oxygen concentration all decreased significantly in the dexamethasone group compared with the placebo group. Data show no differences between groups in rates of high blood glucose levels or high blood pressure. Open‐label use of corticosteroids, sepsis, necrotising enterocolitis, patent ductus arteriosus, and severe retinopathy of prematurity were similar for the two groups. No infant had gastrointestinal perforation or bleeding. One infant in the placebo group had cardiac hypertrophy, but none in the dexamethasone group. At follow‐up, rates of cerebral palsy, blindness, and deafness, of Bayley MDI or PDI &lt; ‐1 SD, or of major neurological disability were similar in the two groups, as were combined rates of death or cerebral palsy, or death or major disability. </p> <p><a href="./references#CD001145-bbs2-0007" title="DurandM , SardesiS , McEvoyC . Effect of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized controlled trial. Pediatrics1995;95(4):584-90. [PMID: 7700763]DurandM . Personal communication. email2012. ">Durand 1995</a>: data show significant differences in compliance and tidal volume in the dexamethasone group compared with the control group (P &lt; 0.001). Dexamethasone also significantly decreased inspired oxygen concentration and MAP (both P &lt; 0.001) and facilitated successful weaning from mechanical ventilation. BPD (supplemental oxygen at 36 weeks' postmenstrual age, chest radiograph changes) was significantly decreased in the dexamethasone group (2/21 versus 8/17; P &lt; 0.01). Survival with BPD was also better in the dexamethasone group (19/23 versus 9/20; P &lt; 0.02). Except for transient increases in blood pressure and plasma glucose, we found no evidence of adverse effects of treatment and no significant differences in rates of infection, intraventricular haemorrhage, and retinopathy of prematurity. Thirteen infants in the control group subsequently received dexamethasone. </p> <p><a href="./references#CD001145-bbs2-0008" title="HarkavyKL , ScanlowJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants. A controlled trial. Journal of Pediatrics1989;115(6):979-83. [DOI: 10.1016/s0022-3476(89)80754-1] [PMID: 2685220]HarkavyKL . Personal communication. email2002. ">Harkavy 1989</a>: dexamethasone treatment reduced age at extubation (39.4 days versus 57.2 days) compared with placebo. Average oxygen requirements for the steroid‐treated group were significantly lower during the first 10 days of treatment, but data show no significant differences between groups in age of weaning to room air (74.9 days versus 95.5 days), age at discharge (111 days versus 119 days), or number of deaths (1 (11%) versus 2 (17%)). Dexamethasone therapy was associated with a significantly increased incidence of hyperglycaemia (89% versus 8%; P = 0.01) but did not influence significantly the incidence of hypertension, intraventricular haemorrhage, infection, or retinopathy of prematurity. Steroid‐treated infants had a significant delay in weight gain (P &lt; 0.02) during the first three weeks of treatment. Among the small number of children followed up, cerebral palsy was diagnosed in one of three in the dexamethasone group and in two of three controls. </p> <p><a href="./references#CD001145-bbs2-0009" title="KariMA , HeinonenKO , IkonenRS , KoivistoM , RaivioKO . Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Archives of Disease of Childhood1993;68(5 Spec No):566-9. [DOI: 10.1136/adc.68.5_spec_no.566] [PMID: 8323356]KariMA , RaivioKO , VengeP , HallmanM . Dexamethasone treatment of infants at risk of chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatric Research1994;36(3):387-93. [DOI: 10.1203/00006450-199409000-00020] [PMID: 7808837]MieskonenS , EronenM , MalmbergLP , TurpeinenM , KariMA , HallmanM . Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth. Acta Paediatrica2003;92(8):896-904. [PMID: 12948063]">Kari 1993</a>: at 28 days of life, pulmonary outcome was significantly better among girls treated with dexamethasone but not in all infants. Data show no significant differences between groups in long‐term outcomes, except a shorter duration of supplemental oxygen among dexamethasone‐treated female infants. After one week of dexamethasone treatment, results show significant but short‐lived suppression of basal cortisol concentrations and of the adrenal response to ACTH. Investigators observed no serious side effects. At follow‐up, the only hospital providing follow‐up data reported no significant differences between dexamethasone and control children in rates of mortality, cerebral palsy, blindness, deafness, or major neurological disability, nor of death or survival with cerebral palsy or death or survival with major neurological disability, among those randomised. At seven to nine years of age, data show some improvement in lung function among eight steroid‐treated children compared with seven controls, and no substantial differences in height or weight between steroid and placebo groups, but data were not reported in a form that would allow meta‐analysis. No children had hypertrophic cardiomyopathy. </p> <p><a href="./references#CD001145-bbs2-0010" title="KazziNJ , BransYW , PolandRL . Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics1990;86(5):722-7. [PMID: 2235226]">Kazzi 1990</a>: infants who received dexamethasone required less oxygen on Days 8 and 17 (P &lt; 0.005) and were more likely to be extubated eight days after therapy (8/12 versus 3/11; P &lt; 0.05, P = 0.12 after Yates correction) compared with infants in the control group. Dexamethasone significantly shortened the duration of mechanical ventilation (median 4 versus 22 days; P &lt; 0.05), but we found no evidence of effects on duration of oxygen therapy, hospitalisation, or home oxygen therapy, nor on the occurrence and severity of retinopathy of prematurity, rate of growth, or mortality. </p> <p><a href="./references#CD001145-bbs2-0011" title="BenskyAS , KothadiaJM , CovitzW . Cardiac effects of dexamethasone in very low birth weight infants. Pediatrics1996;97(6 Pt 1):818-21. [PMID: 8657520]GoldsteinDJ , WaldrepEL , VanPeltJC , O'SheaTM . Developmental outcome at 5 years following dexamethasone use for very low birth weight infants. Pediatric Research2000;47(4):310A. Abstract 1832. [DOI: CN-00708985]KothadiaJM , O'SheaTM , RobertsD , AuringerST , WeaverRG , DillardRG . Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birthweight infants. Pediatrics1999;104(1 Pt 1):22-7, Erratum in: Pediatrics 2004;114(6):1746. [DOI: 10.1542/peds.104.1.22] [PMID: 10390255]NixonPA , WashburnLK , SchechterMS , O'SheaTM . Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years. Journal of Pediatrics2007;150(4):345-50. [DOI: 10.1016/j.jpeds.2006.12.013] [PMID: 17382108]O'SheaTM , GoldsteinDJ , JacksonBG , KothadiaJM , DillardRG . Randomized trial of a 42-day tapering course of dexamethasone in very low birth weight infants: neurological, medical and functional outcome at 5 years of age. Pediatric Research2000;47:319A. Abstract 1883. [DOI: CN-00712055]O'SheaTM , KothadiaJM , KlinepeterKL , GoldsteinDJ , JacksonBG , Weaver RG 3rd, et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics1999;104(1 Pt 1):15-21. [DOI: 10.1542/peds.104.1.15] [PMID: 10390254]WashburnLK , NixonPA , O'SheaTM . Follow-up of a randomized, placebo-controlled trial of postnatal dexamethasone: blood pressure and anthropometric measurements at school age. Pediatrics2006;118(4):1592-9. [DOI: 10.1542/peds.2006-0973] [PMID: 17015551]">Kothadia 1999</a>: infants treated with dexamethasone were on mechanical ventilation and supplemental oxygen for fewer days after study entry (median days on ventilator: 5th and 95th centiles, 13 (1 to 64) versus 25 (6 to 104); days on oxygen: 59 (6 to 247) versus 100 (11 to 346)). Fewer infants in the dexamethasone group had failed to be extubated by the third day (82% versus 97%) or the seventh day (63% versus 90%). Data show no significant differences in rates of death, infection, or severe retinopathy of prematurity. At one‐year follow‐up, more surviving dexamethasone‐treated infants had cerebral palsy (24% versus 7%) and abnormal findings on neurological examination (42% versus 18%). However, deaths before one year were more frequent in the placebo group (26%) than in the dexamethasone group (12%); thus, rates of the combined outcome, death or cerebral palsy at one year, were not significantly different (dexamethasone 33% versus placebo 31%). An additional child in the placebo group was reported to have cerebral palsy at age four to six years. Risk of cerebral palsy was higher among surviving dexamethasone‐treated children at four to six years of age, although cognitive, functional, and medical outcomes were not significantly different between treated and non‐treated survivors. The combined outcome, death or cerebral palsy, was also similar at four‐ to six‐year follow‐up. Results show no substantial differences in rates of asthma, nor in blood pressure or growth. Fewer participants in the dexamethasone group had a low value for FEV₁ at between 8 and 11 years (dexamethasone 40% versus placebo 68%). </p> <p><a href="./references#CD001145-bbs2-0012" title="KovacsL , DavisGM , FaucherD , PapageorgiouA . Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatrica1998;87(7):792-8. [DOI: 10.1080/080352598750013905] [PMID: 9722255]KovacsLB . Personal communication. email2002. ">Kovacs 1998</a>: mortality in hospital was not significantly different in the two groups (27% dexamethasone versus 17% controls). It is not possible to determine precisely when infants died, and hence this study cannot contribute to mortality at 28 days or at 36 weeks. Steroid‐treated infants required less ventilatory support between 9 and 17 days of age, and less supplemental oxygen between 8 and 10 days of age. Fewer infants in the dexamethasone group had failed to be extubated by the seventh day (73% versus 93%). Infants in this group also had better pulmonary compliance at 10 days, but comparison with controls revealed that all improvements were not maintained over ensuing weeks. Incidences of BPD at 28 days of life and at 36 weeks' postmenstrual age among survivors were not significantly different between groups (80% versus 87% at 28 days of life; 45% versus 56% at 36 weeks' postmenstrual age). We found no evidence of steroid‐related adverse effects, other than transient glycosuria. At follow‐up, data show no significant differences between dexamethasone‐treated and control children in rates of cerebral palsy, blindness, deafness, developmental delay, or major neurosensory disability among survivors assessed, nor in death or survival with cerebral palsy or death or survival with major disability among those randomised. </p> <p><a href="./references#CD001145-bbs2-0013" title="Noble-JamiesonCM , RegevR , SilvermanM . Dexamethasone in neonatal chronic lung disease: pulmonary effects and intracranial complications. European Journal of Pediatrics1989;148(4):365-7. [DOI: 10.1007/BF00444135] [PMID: 2651132]">Noble‐Jamieson 1989</a>: dexamethasone‐treated infants showed more rapid improvement in ventilation requirements during the first week of treatment, although the overall duration of oxygen therapy was similar in both groups. Cranial ultrasound examination revealed new periventricular abnormalities in three out of five dexamethasone‐treated infants with previous normal scans, compared with none of four placebo‐treated infants. </p> <p><a href="./references#CD001145-bbs2-0014" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatrica1992;81(10):751-6. [DOI: 10.1111/j.1651-2227.1992.tb12096.x] [PMID: 1421877]OhlssonA . A Randomized Controlled Trial of Dexamethasone Treatment in Very Low Birthweight Infants With Ventilator Dependent Chronic Lung Disease [Masters of Science Thesis]. Hamilton (ON): McMaster University, 1990. ">Ohlsson 1992</a>: dexamethasone facilitated weaning from mechanical ventilation (P = 0.015). The incidence of infection was not significantly increased, although glycosuria (P = 0.0002) and systolic blood pressure (P = 0.003) were increased and heart rate (P = 0.0001) and weight gain (P = 0.0002) were decreased in the dexamethasone‐treated group. At follow‐up among survivors, cerebral palsy was diagnosed in one of 11 children in the dexamethasone group, and in three of 13 controls. </p> <p><a href="./references#CD001145-bbs2-0015" title="HalbmeijerNM , OnlandW , CoolsF , SwarteR , van derHeide-JalvingM , MerkusMP , van Kaam AH Stop-BPD Trial Collaborators. Effect of systemic hydrocortisone initiated 7 to 14 days after birth in ventilated preterm infants on mortality and neurodevelopment at 2 years' corrected age: Follow-up of a randomized clinical trial. JAMA2021;326(4):355-357. OnlandW , CoolsF , KroonA , RademakerK , MerkusMP , DijkPH , et al, Stop-BPD Study Group. Effect of hydrocortisone therapy initiated 7 to 14 days after birth on mortality or bronchopulmonary dysplasia among very preterm infants receiving mechanical ventilation: a randomized clinical trial. JAMA2019;321(4):354-63. [DOI: 10.1001/jama.2018.21443] [PMID: 30694322]">Onland 2019</a>: hydrocortisone was associated with reduction in mortality at 36 weeks' postmenstrual age (15% versus 24%; P = 0.048) but a higher rate of BPD (55% versus 50%; P = 0.31) and no substantial effect on the primary endpoint of death or BPD (71% versus 74%; P = 0.54). Short‐term benefits included higher rates of successful extubation over the first 14 days of treatment and a reduction in treatment with open‐label steroids (28% versus 57%; P &lt; 0.001), but adverse effects included more hyperglycaemia requiring insulin treatment (18% versus 8%; P = 0.004). At follow‐up, rates of neurodevelopmental impairment, cerebral palsy, and visual and hearing impairment were similar in the two groups, as were combined rates of death or cerebral palsy, or death or neurodevelopmental impairment. </p> <p><a href="./references#CD001145-bbs2-0016" title="PapileLA , TysonJE , StollBJ , WrightLL , DonovanEF , BauerCR , et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. New England Journal of Medicine1998;338(16):1112-8. [DOI: 10.1056/NEJM199804163381604] [PMID: 9545359]StollBJ , TemprosaM , TysonJE , PapileLA , WrightLL , BauerCR , et al. Dexamethasone therapy increases infection in low birth weight infants. Pediatrics1999;104(5):e63. [DOI: 10.1542/peds.104.5.e63] [PMID: 10545589]">Papile 1998</a>: as infants in the early group were given dexamethasone from 14 days, they can be considered as having been treated late by our definition (&gt; 7 days of age). Upon examination of only 28‐day outcomes, babies in this study's late group can be considered as controls, as they did not receive dexamethasone until after 28 days. Mortality at 28 days was 7/182 in the early group (treated) compared with 16/189 in the late group (controls). Oxygen was required on Day 28 in 141/182 versus 168/189, and the combination of 28‐day mortality or oxygen requirement was evident in 147/182 versus 184/189; the latter was significant (P &lt; 0.001). It is not possible to use long‐term follow‐up data in this meta‐analysis, as all infants were eligible for dexamethasone after 28 days. </p> <p><a href="./references#CD001145-bbs2-0017" title="ParikhNA , KennedyKA , LaskyRE , McDavidGE , TysonJE . Pilot randomized trial of hydrocortisone in ventilator-dependent extremely preterm infants: effects on regional brain volumes. Journal of Pediatrics2013;162(4):685-90. [DOI: 10.1016/j.jpeds.2012.09.054] [PMID: 23140612]ParikhNA , KennedyKA , LaskyRE , TysonJE . Neurodevelopmental outcomes of extremely preterm infants randomized to stress dose hydrocortisone. PLoS One2015;10(9):e0137051. [DOI: 10.1371/journal.pone.0137051] [PMID: 26376074]">Parikh 2013</a>: data show no substantial differences in brain tissue volume between groups. Low‐dose hydrocortisone had little effect on any other reported outcomes, including mortality, BPD, and acute complications. The follow‐up rate of survivors was 86% overall (37/43). Cerebral palsy was diagnosed in 15% (3/20) of survivors in the steroid group and in 6% (1/17) of those in the placebo group. Rates of cognitive and language delay, defined as &lt; 80 on the Bayley III, were 21% versus 47% and 50% versus 59% in steroid and placebo groups, respectively. Rates of cognitive and language delay could not be pooled with others in the meta‐analysis that used earlier versions of the Bayley Scales, because tests and definitions were different. Rates of any neurodevelopmental impairment were similar between the two groups. </p> <p><a href="./references#CD001145-bbs2-0018" title="RomagnoliC , VentoG , Zecca E, PapacciP , De CarolisMP , MaggioL , et al. Dexamethasone for the prevention of chronic lung disease in preterm neonates: a prospective randomized study [II desametazone nella prevenzione della patologia polmonare cronica del neonato pretermine: studio prospettico randomizzato]. Rivista Italiana di Pediatria [Italian Journal of Pediatrics]1997;24:283-8. [ISSN: 0392-5161]RomagnoliC , ZeccaE , LucianoR , TorrioliG , TortoroloG . A three year follow-up of preterm infants after moderately early treatment with dexamethasone. Archives of Disease in Childhood. Fetal and Neonatal Edition2002;87(1):F55-8. [DOI: 10.1136/fn.87.1.f55] [PMID: 12091294]RomagnoliC , ZeccaE , VentoG , MaggioL , PapacciP , TortoroloG . Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. Pharmacology1999;59(5):266-74. [10.1159/000028329] [PMID: 10529659]">Romagnoli 1997</a>: treated infants showed an increase in dynamic respiratory compliance and a decreased incidence of BPD at 28 days of life and at 36 weeks' postmenstrual age. Fewer infants in the dexamethasone group had failed to be extubated by the seventh day (40% versus 87%). Dexamethasone‐treated infants had lower weight gain during treatment and a significantly higher incidence of hypertrophic cardiomyopathy compared with controls. Data show no significant differences between groups regarding incidence of hypertension, sepsis, necrotising enterocolitis, or hyperglycaemia. At follow‐up, data show no significant differences between dexamethasone‐treated and control children for rates of cerebral palsy, blindness, deafness, or intellectual impairment among survivors assessed, or for death or survival with cerebral palsy among those randomised. </p> <p><a href="./references#CD001145-bbs2-0019" title="ScottSM , BackstromC , BessmanS . Effect of five days of dexamethasone therapy on ventilator dependence and adrenocorticotropic hormone-stimulated cortisol concentrations. Journal of Perinatology1997;17(1):24-8. [PMID: 9069060]">Scott 1997</a>: cortisol responses to ACTH were lower in the dexamethasone group than in the placebo group. On Day 28 of life, eight of 10 infants in the dexamethasone group no longer required mechanical ventilation, compared with none of five infants in the placebo group (P = 0.04, as reported by trial authors). </p> <p><a href="./references#CD001145-bbs2-0020" title="VentoG , MatassaPG , ZeccaE , TortoroloL , MartelliM , De CarolisMP , et al. Effect of dexamethasone on tracheobronchial aspirate fluid cytology and pulmonary mechanics in preterm infants. Pharmacology2004;71(3):113-9. [DOI: 10.1159/000077444] [PMID: 15161992]VentoG . Personal communication. email2012. ">Vento 2004</a>: six dexamethasone‐treated infants and five control infants were extubated within seven days. Data show no significant differences between groups regarding respiratory distress syndrome, patent ductus arteriosus, or severe intraventricular haemorrhage (grade 3 or 4), as well as lower absolute cell counts (P ≤ 0.05) and proportions of polymorphonuclear cells (P &lt; 0.001) in tracheal aspirate fluid in the treated group on Day 7. Treated infants also had an increase in dynamic pulmonary compliance, which was significant compared with the control group at seven days (P &lt; 0.05). We noted no significant differences between groups regarding inspired oxygen concentration but found that infants in the dexamethasone group had significantly lower MAP on Day 7 (P &lt; 0.05). </p> <p><a href="./references#CD001145-bbs2-0021" title="VincerMJ , AllenAC . Double blind randomized controlled trial of 6-day pulse of dexamethasone for very low birth weight infants (VLBW &lt; 1500 grams) who are ventilator dependent at 4 weeks of age. Pediatric Research1998;43:201A. [CENTRAL: CN-00295187] VincerMJ . Personal communication. email2002. ">Vincer 1998</a>: two of 11 dexamethasone‐treated infants died before hospital discharge compared with one of nine control infants. The number of days when infants had apnoeic spells (14 versus 2; P = 0.005) was greater in the dexamethasone‐treated group. Fewer infants in the dexamethasone group had failed to be extubated by the third day (27% versus 100%) or the seventh day (27% versus 100%). Data show a trend towards more retinopathy of prematurity in the dexamethasone group (64% versus 22%; P = 0.064) but similarities in all other outcome variables between groups. At follow‐up among survivors, cerebral palsy was diagnosed in four of nine children in the dexamethasone group and in two of eight controls. </p> <p><a href="./references#CD001145-bbs2-0022" title="WaltherF . Personal communication. email2012. WaltherFJ , FindlayRD , DurandM . Adrenal suppression and extubation rate after moderately early low-dose dexamethasone therapy in very preterm infants. Early Human Development2003;74(1):37-45. [DOI: 10.1016/s0378-3782(03)00082-3] [PMID: 14512180]">Walther 2003</a>: MAP on the first day of life was higher in the control group than in the dexamethasone group (9.1 versus 7.5 cm H₂O; P &lt; 0.05). More infants in the dexamethasone group were successfully extubated within 7 to 14 days than in the placebo group (P &lt; 0.05). Hyperglycaemia occurred more frequently in the dexamethasone group (P &lt; 0.05), and infants in the control group more often received open‐label dexamethasone (P &lt; 0.05). Incidences of hypertension, sepsis, necrotising enterocolitis, spontaneous gastrointestinal perforation, gastrointestinal bleeding, intraventricular haemorrhage, or periventricular leukomalacia were not significantly different between groups. Similarly, data show no significant differences in duration of ventilation or oxygen, BPD, nor mortality or survival without BPD between groups. Two infants in the control group were discharged home while on oxygen. </p> <p><a href="./references#CD001145-bbs2-0023" title="YatesH , ChiocchiaV , LinsellL , OrsiN , JuszczakE , JohnsonK , et al. Very low-dose dexamethasone to facilitate extubation of preterm babies at risk of bronchopulmonary dysplasia: the MINIDEX feasibility RCT. NIHR Journals Library. Efficacy and Mechanism Evaluation2019;6. [DOI: 10.3310/eme06080] [ISSN: 2050-4365; 2050-4373 ] [PMID: 31479218]">Yates 2019</a>: two of the 12 infants in the dexamethasone group had received hydrocortisone prior to study entry, compared with none of 10 infants in the placebo group. In infants who remained in the study seven days after trial entry, five of eight dexamethasone‐treated infants were extubated by Day 7, compared with four of six control infants. Two of 12 dexamethasone‐treated infants died before 36 weeks' postmenstrual age compared with one of 10 control infants; 100% of survivors in both groups had BPD at 36 weeks' postmenstrual age or at discharge (if sooner) (dexamethasone 10/10; placebo 9/9). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001145-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001145-sec-0064"></div> <p>In this review, we found reductions in mortality at all ages (to 28 days after birth, to 36 weeks' corrected age, to hospital discharge, and at latest reported age) when systemic corticosteroids were started after seven days of age. Both dexamethasone and hydrocortisone contributed to the reduction in mortality, but evidence for either of them alone in reducing mortality was weaker than when they were combined. Systemic corticosteroids show other clear benefits after seven days of age in reducing rates of BPD at 28 days after birth and at 36 weeks' postmenstrual age, and in reducing the combined outcome of mortality or BPD at both time points; these benefits were attributable to dexamethasone ‐ not to hydrocortisone. Systemic corticosteroids also facilitated extubation at multiple time points. These benefits of corticosteroids came at the cost of higher rates of short‐term complications of hypertension, hyperglycaemia, glycosuria, and hypertrophic cardiomyopathy. An increase in severe retinopathy of prematurity was not accompanied by significant increases in blindness or in the need for corrective lenses at follow‐up. </p> <p>Corticosteroids may have other significant effects. They can cause weight loss or poor weight gain (<a href="./references#CD001145-bbs2-0001" title="AriagnoRL , SweeneyTE , BaldwinRB , InguilloD , MartinD . Controlled trial of dexamethasone in preterm infants at risk for bronchopulmonary dysplasia: lung function, clinical course and outcome at three years. Unpublished manuscript supplied by authors2000. AriagnoRL , SweeneyTJ , BaldwinRB , InguilloD , MartinD . Dexamethasone effects on lung function and risks in 3 week old ventilatory dependent preterm infants. American Reviews of Respiratory Disease1987;135:A125. [CENTRAL: CN-00295119] ">Ariagno 1987</a>; <a href="./references#CD001145-bbs2-0008" title="HarkavyKL , ScanlowJW , ChowdhryPK , GrylackLJ . Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants. A controlled trial. Journal of Pediatrics1989;115(6):979-83. [DOI: 10.1016/s0022-3476(89)80754-1] [PMID: 2685220]HarkavyKL . Personal communication. email2002. ">Harkavy 1989</a>; <a href="./references#CD001145-bbs2-0014" title="OhlssonA , CalvertSA , HoskingM , ShennanAT . Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatrica1992;81(10):751-6. [DOI: 10.1111/j.1651-2227.1992.tb12096.x] [PMID: 1421877]OhlssonA . A Randomized Controlled Trial of Dexamethasone Treatment in Very Low Birthweight Infants With Ventilator Dependent Chronic Lung Disease [Masters of Science Thesis]. Hamilton (ON): McMaster University, 1990. ">Ohlsson 1992</a>). Although catchup growth after corticosteroid therapy has been reported (<a href="./references#CD001145-bbs2-0087" title="GibsonAT , PearseRG , WalesJKH . Growth retardation after dexamethasone administration: assessment by knemometry. Archives of Disease of Childhood1993;69(5 Spec No):505-9. [DOI: 10.1136/adc.69.5_spec_no.505] [PMID: 8285754]">Gibson 1993</a>), worries about reduced brain growth have been noted in animal studies (<a href="./references#CD001145-bbs2-0089" title="GramsbergenA , MulderEJ . The influence of betamethasone and dexamethasone on motor development in young rats. Pediatric Research1998;44(1):105-10. [DOI: 10.1203/00006450-199807000-00017] [PMID: 9667379]">Gramsbergen 1998</a>; <a href="./references#CD001145-bbs2-0118" title="WeichselME . The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Annals of Neurology1977;2(5):364-6. [DOI: 10.1002/ana.410020503] [PMID: 617574]">Weichsel 1977</a>), as well as in human studies (<a href="./references#CD001145-bbs2-0016" title="PapileLA , TysonJE , StollBJ , WrightLL , DonovanEF , BauerCR , et al. A multicenter trial of two dexamethasone regimens in ventilator-dependent premature infants. New England Journal of Medicine1998;338(16):1112-8. [DOI: 10.1056/NEJM199804163381604] [PMID: 9545359]StollBJ , TemprosaM , TysonJE , PapileLA , WrightLL , BauerCR , et al. Dexamethasone therapy increases infection in low birth weight infants. Pediatrics1999;104(5):e63. [DOI: 10.1542/peds.104.5.e63] [PMID: 10545589]">Papile 1998</a>). Animal studies have shown abnormal lung growth (<a href="./references#CD001145-bbs2-0116" title="TschanzSA , DamkeBM , BurriPH . Influence of postnatally administered glucocorticoids on rat lung growth. Biology of the Neonate1995;68(4):229-45. [DOI: 10.1159/000244241] [PMID: 8580214]">Tschanz 1995</a>). </p> <p>For this review, data on long‐term neurosensory follow‐up were available from 17 studies comprising 1348 randomised infants, but these studies were of varying methodological quality. The significant increase in abnormal neurological examination among those randomised is of potential concern; however, this is tempered by data showing that cerebral palsy and major neurosensory disability, both overall and among survivors, were not significantly increased, and that abnormal neurological examination findings were reported in only four of the 17 follow‐up studies, and among only 200 randomised participants. It should also be noted that some of the studies reporting cerebral palsy as an outcome did so when children were aged less than five years, an age when a diagnosis of cerebral palsy is not certain in all cases (<a href="./references#CD001145-bbs2-0114" title="StanleyFJ . Using cerebral palsy data in the evaluation of neonatal intensive care: a warning. Developmental Medicine and Child Neurology1982;24(1):93-4. [DOI: 10.1111/j.1469-8749.1982.tb13594.x] [PMID: 7106413]">Stanley 1982</a>). Moreover, only one study was designed primarily to test effects of postnatal corticosteroids on adverse long‐term neurosensory outcomes; that study was terminated for futility with &lt; 10% of the projected sample size recruited (<a href="./references#CD001145-bbs2-0006" title="DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter international randomized controlled trial. Pediatrics2006;117(1):75-83. [DOI: 10.1542/peds.2004-2843] [PMID: 16396863]DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics2007;119(4):716-21. [DOI: 10.1542/peds.2006-2806] [PMID: 17403842]">Doyle 2006</a>). All studies were underpowered to detect clinically important differences in long‐term neurosensory outcomes. Researchers performing animal studies have expressed concern about possible adverse effects of corticosteroids used at these doses during early postnatal life on the neurodevelopment of very immature infants (<a href="./references#CD001145-bbs2-0118" title="WeichselME . The therapeutic use of glucocorticoid hormones in the perinatal period: potential neurologic hazards. Annals of Neurology1977;2(5):364-6. [DOI: 10.1002/ana.410020503] [PMID: 617574]">Weichsel 1977</a>). Clearly, more information on long‐term outcomes of survivors is needed. </p> <p>Clinicians must weigh the benefits of acute improvement in respiratory function and increased chances of extubation, along with improved survival, against potential detrimental effects, both metabolic and neurological. Dexamethasone may be a harmful drug for the immature brain, and clinicians must consider limiting its use to situations in which it is essential to achieve weaning from the ventilator. Lower doses and shorter courses should be considered for these infants; the DART study (an RCT of low‐dose, short‐course dexamethasone in ventilator‐dependent infants), which provided a total dose of only 0.89 mg/kg over 10 days, reported short‐term benefits of extubation and reduced respiratory support (<a href="./references#CD001145-bbs2-0006" title="DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter international randomized controlled trial. Pediatrics2006;117(1):75-83. [DOI: 10.1542/peds.2004-2843] [PMID: 16396863]DoyleLW , DavisPG , MorleyCJ , McPheeA , CarlinJB , DART Study Investigators. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics2007;119(4):716-21. [DOI: 10.1542/peds.2006-2806] [PMID: 17403842]">Doyle 2006</a>). Additional studies of low‐dose systemic corticosteroids for infants at high risk of developing BPD beyond the first week of life are warranted. </p> <section id="CD001145-sec-0065"> <h3 class="title" id="CD001145-sec-0065">Summary of main results</h3> <p>In this review, we found evidence for reductions in mortality, BPD, and the combined outcome of mortality or BPD, without evidence for an effect on cerebral palsy, or the combined outcome of mortality or cerebral palsy. Whether systemic corticosteroids given starting from seven days of age improve survival free of long‐term neurodevelopmental disability among infants with evolving BPD remains to be confirmed. </p> </section> <section id="CD001145-sec-0066"> <h3 class="title" id="CD001145-sec-0066">Overall completeness and applicability of evidence</h3> <p>Data on in‐hospital outcomes were relatively complete, but data on longer‐term outcomes were incomplete. Results are applicable to ventilator‐dependent infants at high risk of developing BPD. </p> </section> <section id="CD001145-sec-0067"> <h3 class="title" id="CD001145-sec-0067">Quality of the evidence</h3> <p>Review authors assessed the certainty of evidence for five major outcomes: mortality at latest reported age, BPD at 36 weeks, mortality or BPD at 36 weeks, cerebral palsy at latest reported age, and mortality or cerebral palsy at latest reported age (<a href="./full#CD001145-tbl-0001">summary of findings Table 1</a>). We assessed the certainty of evidence for most outcomes as high, except for BPD at 36 weeks, which we downgraded to moderate quality because we noted risk of publication bias in these studies, and for the combined outcome of mortality or BPD at 36 weeks because of moderate heterogeneity, particularly among those treated with dexamethasone. Excluding two studies at higher risk of bias from a sensitivity analysis altered no conclusions. </p> </section> <section id="CD001145-sec-0068"> <h3 class="title" id="CD001145-sec-0068">Potential biases in the review process</h3> <p>Although Embase records are indexed in CENTRAL, we acknowledge that the omission of a search of Embase in 2020 may have reduced the sensitivity of our search. </p> </section> <section id="CD001145-sec-0069"> <h3 class="title" id="CD001145-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p>Evidence showing benefit from systemic corticosteroids started from the age of seven days of age for reducing the rate of mortality among infants with evolving BPD is stronger than in earlier versions of this review (<a href="./references#CD001145-bbs2-0120" title="DoyleLW , CheongJL , EhrenkranzRA , HallidayHL . Late (&gt; 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database of Systematic Reviews2017, Issue 10. Art. No: CD001145. [DOI: 10.1002/14651858.CD001145.pub4]">Doyle 2017b</a>). Other main conclusions concerning BPD, extubation, and short‐term complications are consistent with earlier reviews. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001145-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram: review update." data-id="CD001145-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram: review update.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-02" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD001145-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001145-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Mortality, outcome: 1.4 Mortality at latest reported age." data-id="CD001145-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Mortality, outcome: 1.4 Mortality at latest reported age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 2 Bronchopulmonary dysplasia (BPD), outcome: 2.2 BPD at 36 weeks' postmenstrual age." data-id="CD001145-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 2 Bronchopulmonary dysplasia (BPD), outcome: 2.2 BPD at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 3 Mortality or BPD, outcome: 3.2 Mortality or BPD at 36 weeks' postmenstrual age." data-id="CD001145-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 3 Mortality or BPD, outcome: 3.2 Mortality or BPD at 36 weeks' postmenstrual age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-07" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.10 Cerebral palsy at latest reported age." data-id="CD001145-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.10 Cerebral palsy at latest reported age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-FIG-08" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.14 Mortality or cerebral palsy at latest reported age." data-id="CD001145-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-FIG-08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Funnel plot of comparison: 6 Long‐term follow‐up, outcome: 6.14 Mortality or cerebral palsy at latest reported age. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-FIG-08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mortality at different ages, Outcome 1: Neonatal mortality before 28 days after birth" data-id="CD001145-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Mortality at different ages, Outcome 1: Neonatal mortality before 28 days after birth </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mortality at different ages, Outcome 2: Mortality at 36 weeks' postmenstrual age" data-id="CD001145-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Mortality at different ages, Outcome 2: Mortality at 36 weeks' postmenstrual age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mortality at different ages, Outcome 3: Mortality to hospital discharge" data-id="CD001145-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Mortality at different ages, Outcome 3: Mortality to hospital discharge</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mortality at different ages, Outcome 4: Mortality at latest reported age" data-id="CD001145-fig-0012" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Mortality at different ages, Outcome 4: Mortality at latest reported age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 1: BPD at 28 days after birth" data-id="CD001145-fig-0013" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 1: BPD at 28 days after birth</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 2: BPD at 36 weeks' postmenstrual age" data-id="CD001145-fig-0014" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 2: BPD at 36 weeks' postmenstrual age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 3: BPD at 36 weeks in survivors" data-id="CD001145-fig-0015" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 3: BPD at 36 weeks in survivors</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 4: Late rescue with corticosteroids" data-id="CD001145-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 4: Late rescue with corticosteroids</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 5: Home on oxygen" data-id="CD001145-fig-0017" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 5: Home on oxygen</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 6: Survivors discharged home on oxygen" data-id="CD001145-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Bronchopulmonary dysplasia (BPD), Outcome 6: Survivors discharged home on oxygen </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mortality or BPD, Outcome 1: Mortality or BPD at 28 days after birth" data-id="CD001145-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Mortality or BPD, Outcome 1: Mortality or BPD at 28 days after birth</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mortality or BPD, Outcome 2: Mortality or BPD at 36 weeks' postmenstrual age" data-id="CD001145-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Mortality or BPD, Outcome 2: Mortality or BPD at 36 weeks' postmenstrual age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Failure to extubate, Outcome 1: Failure to extubate by 3rd day after treatment" data-id="CD001145-fig-0021" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Failure to extubate, Outcome 1: Failure to extubate by 3rd day after treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Failure to extubate, Outcome 2: Failure to extubate by 7th day after treatment" data-id="CD001145-fig-0022" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Failure to extubate, Outcome 2: Failure to extubate by 7th day after treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Failure to extubate, Outcome 3: Failure to extubate by 14th day after treatment" data-id="CD001145-fig-0023" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Failure to extubate, Outcome 3: Failure to extubate by 14th day after treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Failure to extubate, Outcome 4: Failure to extubate by 28th day after treatment" data-id="CD001145-fig-0024" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Failure to extubate, Outcome 4: Failure to extubate by 28th day after treatment </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 1: Infection" data-id="CD001145-fig-0025" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 1: Infection</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 2: Hyperglycaemia" data-id="CD001145-fig-0026" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 2: Hyperglycaemia</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 3: Glycosuria" data-id="CD001145-fig-0027" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 3: Glycosuria</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 4: Hypertension" data-id="CD001145-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 4: Hypertension</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 5: New cranial echodensities" data-id="CD001145-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 5: New cranial echodensities </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 6: Necrotising enterocolitis (NEC)" data-id="CD001145-fig-0030" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 6: Necrotising enterocolitis (NEC) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 7: Gastrointestinal bleeding" data-id="CD001145-fig-0031" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 7: Gastrointestinal bleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 8: Gastrointestinal perforation" data-id="CD001145-fig-0032" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 8: Gastrointestinal perforation </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 9: Severe retinopathy of prematurity (ROP)" data-id="CD001145-fig-0033" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 9: Severe retinopathy of prematurity (ROP) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 10: Severe ROP in survivors" data-id="CD001145-fig-0034" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 10: Severe ROP in survivors </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 11: Hypertrophic cardiomyopathy" data-id="CD001145-fig-0035" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 11: Hypertrophic cardiomyopathy </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 12: Pneumothorax" data-id="CD001145-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 12: Pneumothorax</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 13: Severe intraventricular haemorrhage (IVH)" data-id="CD001145-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 13: Severe intraventricular haemorrhage (IVH) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-005.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Complications during primary hospitalisation, Outcome 14: Cystic periventricular leukomalacia" data-id="CD001145-fig-0038" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-005.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5: Complications during primary hospitalisation, Outcome 14: Cystic periventricular leukomalacia </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-005.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 1: Bayley Mental Developmental Index (MDI) &lt; ‐2 SD" data-id="CD001145-fig-0039" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 1: Bayley Mental Developmental Index (MDI) &lt; ‐2 SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 2: Bayley MDI &lt; ‐2 SD in survivors tested" data-id="CD001145-fig-0040" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 2: Bayley MDI &lt; ‐2 SD in survivors tested</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 3: Bayley Psychomotor Developmental Index (PDI) &lt; ‐2 SD" data-id="CD001145-fig-0041" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 3: Bayley Psychomotor Developmental Index (PDI) &lt; ‐2 SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 4: Bayley PDI &lt; ‐2 SD in survivors tested" data-id="CD001145-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 4: Bayley PDI &lt; ‐2 SD in survivors tested</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 5: Blindness" data-id="CD001145-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 5: Blindness</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 6: Blindness in survivors assessed" data-id="CD001145-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 6: Blindness in survivors assessed</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 7: Deafness" data-id="CD001145-fig-0045" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 7: Deafness</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 8: Deafness in survivors assessed" data-id="CD001145-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 8: Deafness in survivors assessed</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 9: Cerebral palsy at 1 to 3 years of age" data-id="CD001145-fig-0047" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 9: Cerebral palsy at 1 to 3 years of age</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 10: Cerebral palsy at latest reported age" data-id="CD001145-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.10</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 10: Cerebral palsy at latest reported age</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 11: Mortality before follow‐up in trials assessing cerebral palsy at 1‐3 years of age" data-id="CD001145-fig-0049" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.11</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 11: Mortality before follow‐up in trials assessing cerebral palsy at 1‐3 years of age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 12: Mortality before follow‐up in trials assessing cerebral palsy at latest reported age" data-id="CD001145-fig-0050" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.12</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 12: Mortality before follow‐up in trials assessing cerebral palsy at latest reported age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 13: Mortality or cerebral palsy at 1 to 3 years" data-id="CD001145-fig-0051" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.13</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 13: Mortality or cerebral palsy at 1 to 3 years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 14: Mortality or cerebral palsy at latest reported age" data-id="CD001145-fig-0052" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.14</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 14: Mortality or cerebral palsy at latest reported age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 15: Cerebral palsy in survivors assessed at 1‐3 years of age" data-id="CD001145-fig-0053" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.15</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 15: Cerebral palsy in survivors assessed at 1‐3 years of age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 16: Cerebral palsy in survivors assessed at latest age" data-id="CD001145-fig-0054" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.16</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 16: Cerebral palsy in survivors assessed at latest age </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 17: Major neurosensory disability (variable criteria ‐ see individual studies)" data-id="CD001145-fig-0055" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.17</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 17: Major neurosensory disability (variable criteria ‐ see individual studies) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 18: Mortality before follow‐up in trials assessing major neurosensory disability (variable criteria)" data-id="CD001145-fig-0056" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.18</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 18: Mortality before follow‐up in trials assessing major neurosensory disability (variable criteria) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 19: Mortality or major neurosensory disability (variable criteria)" data-id="CD001145-fig-0057" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.19</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 19: Mortality or major neurosensory disability (variable criteria) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 20: Major neurosensory disability (variable criteria) in survivors assessed" data-id="CD001145-fig-0058" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.20</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 20: Major neurosensory disability (variable criteria) in survivors assessed </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 21: Abnormal neurological exam (variable criteria ‐ see individual studies)" data-id="CD001145-fig-0059" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.21</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 21: Abnormal neurological exam (variable criteria ‐ see individual studies) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 22: Mortality before follow‐up in trials assessing abnormal neurological exam (variable criteria)" data-id="CD001145-fig-0060" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.22</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 22: Mortality before follow‐up in trials assessing abnormal neurological exam (variable criteria) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 23: Mortality or abnormal neurological exam (variable criteria)" data-id="CD001145-fig-0061" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.23</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 23: Mortality or abnormal neurological exam (variable criteria) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 24: Abnormal neurological exam (variable criteria) in survivors assessed" data-id="CD001145-fig-0062" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.24</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 24: Abnormal neurological exam (variable criteria) in survivors assessed </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 25: Re‐hospitalisation" data-id="CD001145-fig-0063" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.25</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 25: Re‐hospitalisation</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-006.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Long‐term follow‐up, Outcome 26: Re‐hospitalisation in survivors seen at follow‐up" data-id="CD001145-fig-0064" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-006.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.26</div> <div class="figure-caption"> <p>Comparison 6: Long‐term follow‐up, Outcome 26: Re‐hospitalisation in survivors seen at follow‐up </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-006.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Later childhood outcomes, Outcome 1: Recurrent wheezing in survivors examined at 5 years" data-id="CD001145-fig-0065" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Later childhood outcomes, Outcome 1: Recurrent wheezing in survivors examined at 5 years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Later childhood outcomes, Outcome 2: Use of corrective lenses in survivors examined at 5 years" data-id="CD001145-fig-0066" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Later childhood outcomes, Outcome 2: Use of corrective lenses in survivors examined at 5 years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Later childhood outcomes, Outcome 3: Use of physical therapy in survivors examined at 5 years" data-id="CD001145-fig-0067" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Later childhood outcomes, Outcome 3: Use of physical therapy in survivors examined at 5 years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Later childhood outcomes, Outcome 4: Use of speech therapy in survivors examined at 5 years" data-id="CD001145-fig-0068" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Later childhood outcomes, Outcome 4: Use of speech therapy in survivors examined at 5 years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-007.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Later childhood outcomes, Outcome 5: Intellectual impairment in survivors tested at 5 or more years" data-id="CD001145-fig-0069" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-007.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7: Later childhood outcomes, Outcome 5: Intellectual impairment in survivors tested at 5 or more years </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-007.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Later childhood outcomes, Outcome 6: IQ" data-id="CD001145-fig-0070" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-007.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7: Later childhood outcomes, Outcome 6: IQ</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-007.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 1: Asthma in survivors assessed" data-id="CD001145-fig-0071" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 1: Asthma in survivors assessed </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 2: Forced expired volume in 1 second &lt; ‐2 SD" data-id="CD001145-fig-0072" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 2: Forced expired volume in 1 second &lt; ‐2 SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 3: Forced expired volume in 1 second ‐ z‐score" data-id="CD001145-fig-0073" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 3: Forced expired volume in 1 second ‐ z‐score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 4: Forced expired volume in 1 second ‐ % predicted" data-id="CD001145-fig-0074" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 4: Forced expired volume in 1 second ‐ % predicted </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 5: Forced expired volume in 1 second ‐ standardised mean difference" data-id="CD001145-fig-0075" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 5: Forced expired volume in 1 second ‐ standardised mean difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 6: Forced vital capacity ‐ z‐score" data-id="CD001145-fig-0076" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 6: Forced vital capacity ‐ z‐score </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 7: Forced vital capacity ‐ % predicted" data-id="CD001145-fig-0077" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 7: Forced vital capacity ‐ % predicted </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 8: Forced vital capacity ‐ standardised mean difference" data-id="CD001145-fig-0078" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 8: Forced vital capacity ‐ standardised mean difference </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 9: FEV₁/FVC %" data-id="CD001145-fig-0079" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 9: FEV₁/FVC % </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 10: FEV₁/FVC &lt; ‐2 SD" data-id="CD001145-fig-0080" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 10: FEV₁/FVC &lt; ‐2 SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 11: FEF25% -75% ‐ % predicted" data-id="CD001145-fig-0081" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.11</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 11: FEF<sub>25% -75%</sub> ‐ % predicted </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 12: Positive bronchodilator response" data-id="CD001145-fig-0082" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.12</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 12: Positive bronchodilator response </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 13: Forced vital capacity &lt; ‐2 SD" data-id="CD001145-fig-0083" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.13</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 13: Forced vital capacity &lt; ‐2 SD </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-008.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 14: Exercise‐induced bronchoconstriction" data-id="CD001145-fig-0084" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-008.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.14</div> <div class="figure-caption"> <p>Comparison 8: Respiratory outcomes in childhood ‐ after 5 years, Outcome 14: Exercise‐induced bronchoconstriction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-008.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Growth in childhood, Outcome 1: Height ‐ z‐score" data-id="CD001145-fig-0085" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Growth in childhood, Outcome 1: Height ‐ z‐score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Growth in childhood, Outcome 2: Height &lt; ‐2 SD" data-id="CD001145-fig-0086" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Growth in childhood, Outcome 2: Height &lt; ‐2 SD</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Growth in childhood, Outcome 3: Weight ‐ z‐score" data-id="CD001145-fig-0087" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Growth in childhood, Outcome 3: Weight ‐ z‐score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Growth in childhood, Outcome 4: Weight &lt; ‐2 SD" data-id="CD001145-fig-0088" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Growth in childhood, Outcome 4: Weight &lt; ‐2 SD</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Growth in childhood, Outcome 5: Body mass index (BMI) ‐ z‐score" data-id="CD001145-fig-0089" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Growth in childhood, Outcome 5: Body mass index (BMI) ‐ z‐score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-009.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Growth in childhood, Outcome 6: BMI &lt; ‐2 SD" data-id="CD001145-fig-0090" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-009.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9: Growth in childhood, Outcome 6: BMI &lt; ‐2 SD</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-009.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Blood pressure in childhood, Outcome 1: Systolic blood pressure &gt; 95th centile" data-id="CD001145-fig-0091" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Blood pressure in childhood, Outcome 1: Systolic blood pressure &gt; 95th centile </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-010.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Blood pressure in childhood, Outcome 2: Systolic blood pressure z‐score" data-id="CD001145-fig-0092" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-010.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10: Blood pressure in childhood, Outcome 2: Systolic blood pressure z‐score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-010.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Blood pressure in childhood, Outcome 3: Diastolic blood pressure &gt; 95th centile" data-id="CD001145-fig-0093" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-010.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10: Blood pressure in childhood, Outcome 3: Diastolic blood pressure &gt; 95th centile </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001145-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/urn:x-wiley:14651858:media:CD001145:CD001145-CMP-010.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Blood pressure in childhood, Outcome 4: Diastolic blood pressure z‐score" data-id="CD001145-fig-0094" src="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_t/tCD001145-CMP-010.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10: Blood pressure in childhood, Outcome 4: Diastolic blood pressure z‐score</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/media/CDSR/CD001145/image_n/nCD001145-CMP-010.04.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001145-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Systemic corticosteroids (dexamethasone or hydrocortisone) compared with control (placebo or nothing) for chronic lung disease in preterm infants</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Systemic corticosteroids (dexamethasone or hydrocortisone) compared with control (placebo or nothing) for chronic lung disease in preterm infants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> preterm infants with chronic lung disease<br/><b>Setting:</b> multiple neonatal intensive care units from high‐income countries<br/><b>Intervention:</b> systemic corticosteroids (dexamethasone or hydrocortisone)<br/><b>Comparison:</b> control (placebo or nothing) </p> </td> </tr> <tr class="separated"> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="left" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No. of participants<br/>(studies)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="left" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="table-header separated"> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with control (placebo or nothing)</b> </p> </th> <th align="left" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with systemic corticosteroids (dexamethasone or hydrocortisone)</b> </p> </th> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Mortality at latest reported age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.81<br/>(0.66 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1428<br/>(21 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>228 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>185 per 1000<br/>(151 to 226) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.85<br/>(0.66 to 1.11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>993<br/>(19 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>193 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>164 per 1000<br/>(128 to 215) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.74<br/>(0.54 to 1.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>305 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>226 per 1000<br/>(165 to 311) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>BPD at 36 weeks' PMA</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.89<br/>(0.80 to 0.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>988<br/>(14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>a</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Strong evidence for subgroup differences (interaction P &lt; 0.001)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>594 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>529 per 1000<br/>(475 to 588) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.76<br/>(0.66 to 0.87) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>553<br/>(12 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊝<br/>MODERATE<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>659 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>501 per 1000<br/>(435 to 573) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.10<br/>(0.92 to 1.31) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>516 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>567 per 1000<br/>(474 to 676) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Mortality or BPD at 36 weeks' PMA</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.85<br/>(0.79 to 0.92) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>988<br/>(14 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Strong evidence for subgroup differences (interaction P &lt; 0.001)</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>771 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>656 per 1000<br/>(609  to 710) </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.75<br/>(0.67 to 0.84) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>553<br/>(12 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊝<br/>MODERATE<sup>b</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>787 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>590 per 1000<br/>(527to 661) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.98<br/>(0.88 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>753 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>738 per 1000<br/>(663 to 832) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Cerebral palsy ‐ at latest reported age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/>(0.84 to 1.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1290<br/>(17 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Critical outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>109 per 1000<br/>(78 to 150) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.17<br/>(0.84 to 1.61 </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1290<br/>(17 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>121 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>135 per 1000 (95 to 193)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 1.40</p> <p>(0.60 to 3.26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435 (2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>40 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>57 per 1000</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="6" valign="top"> <p>Mortality or cerebral palsy ‐ at latest reported age</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population (studies treating with dexamethasone or hydrocortisone)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.90<br/>(0.76 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>1290<br/>(17 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Critical outcome.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>324 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>291 per 1000<br/>(246 to 343) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with dexamethasone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.95 (0.77 to 1.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>855 (15 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>312 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>296 per 1000 (240 to 362)</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>Study population (subgroup of studies treating with hydrocortisone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>RR 0.82 (0.62 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>435 (2 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>⊕⊕⊕⊕<br/>HIGH </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>Critical outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>345 per 1000</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>283 per 1000</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><br/><b>BPD:</b> bronchopulmonary dysplasia; <b>CI:</b> confidence interval; <b>PMA:</b> postmenstrual age; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence.</b> </p> <p><b>High certainty:</b> further research is very unlikely to change our confidence in the estimate of effect. </p> <p><b>Moderate certainty:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. </p> <p><b>Low certainty:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low certainty:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded one level because publication bias was suspected. </p> <p><sup>b</sup>Downgraded one level for moderate heterogeneity. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Systemic corticosteroids (dexamethasone or hydrocortisone) compared with control (placebo or nothing) for chronic lung disease in preterm infants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/full#CD001145-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mortality at different ages</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Neonatal mortality before 28 days after birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>970</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.39, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>599</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.24, 0.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.43, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Mortality at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1029</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.52, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>594</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.43, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.49, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Mortality to hospital discharge <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.63, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>971</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.62, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.53, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Mortality at latest reported age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1428</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.66, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.66, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.54, 1.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Mortality at different ages</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Bronchopulmonary dysplasia (BPD)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 BPD at 28 days after birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.84, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>623</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.81, 0.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.83, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 BPD at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.80, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>553</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.66, 0.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.92, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 BPD at 36 weeks in survivors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>624</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.82, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.69, 0.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.88, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Late rescue with corticosteroids <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1489</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.41, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1054</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.37, 0.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.40, 0.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Home on oxygen <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>611</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.54, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Survivors discharged home on oxygen <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.51, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Bronchopulmonary dysplasia (BPD)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Mortality or BPD</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Mortality or BPD at 28 days after birth <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>934</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.83, 0.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>563</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.79, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.84, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Mortality or BPD at 36 weeks' postmenstrual age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>988</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.79, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>553</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.67, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.88, 1.09]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Mortality or BPD</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Failure to extubate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Failure to extubate by 3rd day after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.78, 0.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.69, 0.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>356</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.84, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Failure to extubate by 7th day after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.62, 0.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>783</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.60, 0.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>347</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.60, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Failure to extubate by 14th day after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.53, 0.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.45, 0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>334</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.51, 0.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 Failure to extubate by 28th day after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.37, 0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Failure to extubate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Complications during primary hospitalisation</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.96, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.73, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Hyperglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1684</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [1.34, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.53 [1.26, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.85 [1.23, 2.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Glycosuria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.03 [2.43, 26.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Hypertension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1628</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.67 [1.19, 2.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.45 [1.48, 4.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.70, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.5 New cranial echodensities <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [0.41, 118.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.6 Necrotising enterocolitis (NEC) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.62, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>974</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.54, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.51, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.7 Gastrointestinal bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1385</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.97, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.99, 1.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.40, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.8 Gastrointestinal perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>552</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.26, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.27, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.9 Severe retinopathy of prematurity (ROP) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>929</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [1.03, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [1.07, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.76, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.10 Severe ROP in survivors <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>697</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.94, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.31 [0.99, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.69, 1.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.11 Hypertrophic cardiomyopathy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.76 [1.33, 5.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.12 Pneumothorax <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.13 Severe intraventricular haemorrhage (IVH) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>639</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.26, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.13.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>268</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.23, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.13.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.12, 4.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.14 Cystic periventricular leukomalacia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.30, 1.84]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.14.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.01, 6.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.14.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.31, 2.15]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Complications during primary hospitalisation</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Long‐term follow‐up</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Bayley Mental Developmental Index (MDI) &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>333</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.47, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Bayley MDI &lt; ‐2 SD in survivors tested <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.45, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Bayley Psychomotor Developmental Index (PDI) &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.34, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Bayley PDI &lt; ‐2 SD in survivors tested <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.30, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.5 Blindness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>784</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.35, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.35, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.6 Blindness in survivors assessed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>539</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.35, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.35, 1.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.7 Deafness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>936</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.26, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.22, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.13, 2.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.8 Deafness in survivors assessed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.29, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.1 Dexamethasonep</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>325</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.27, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.11, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.9 Cerebral palsy at 1 to 3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.11 [0.81, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>876</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.76, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.60, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.10 Cerebral palsy at latest reported age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.84, 1.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.10.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>855</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.79, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.10.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.60, 3.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.11 Mortality before follow‐up in trials assessing cerebral palsy at 1‐3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1746</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.66, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.11.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.65, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.11.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.54, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.12 Mortality before follow‐up in trials assessing cerebral palsy at latest reported age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.56, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.12.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>855</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.55, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.12.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.43, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.13 Mortality or cerebral palsy at 1 to 3 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.76, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.13.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>876</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.76, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.13.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.62, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.14 Mortality or cerebral palsy at latest reported age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.76, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.14.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>855</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.77, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.14.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.62, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.15 Cerebral palsy in survivors assessed at 1‐3 years of age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.79, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.15.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>631</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.75, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.15.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.27 [0.55, 2.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.16 Cerebral palsy in survivors assessed at latest age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>883</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.80, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.16.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>591</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.75, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.16.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [0.53, 3.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.17 Major neurosensory disability (variable criteria ‐ see individual studies) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.88, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.17.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>655</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.85, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.17.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.78, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.18 Mortality before follow‐up in trials assessing major neurosensory disability (variable criteria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.64, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.18.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>655</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.63, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.18.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.54, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.19 Mortality or major neurosensory disability (variable criteria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1090</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.85, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.19.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>655</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.86, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.19.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>435</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.75, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.20 Major neurosensory disability (variable criteria) in survivors assessed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>778</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.83, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.20.1 Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>480</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.81, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.20.2 Hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.73, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.21 Abnormal neurological exam (variable criteria ‐ see individual studies) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.81 [1.05, 3.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.22 Mortality before follow‐up in trials assessing abnormal neurological exam (variable criteria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.33, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.23 Mortality or abnormal neurological exam (variable criteria) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.71, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.24 Abnormal neurological exam (variable criteria) in survivors assessed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.62 [0.96, 2.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.25 Re‐hospitalisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.79, 1.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.26 Re‐hospitalisation in survivors seen at follow‐up <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.72, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Long‐term follow‐up</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Later childhood outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Recurrent wheezing in survivors examined at 5 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.82, 2.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Use of corrective lenses in survivors examined at 5 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.61 [0.82, 3.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 Use of physical therapy in survivors examined at 5 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.71, 3.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Use of speech therapy in survivors examined at 5 years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.21, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.5 Intellectual impairment in survivors tested at 5 or more years <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.71, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.6 IQ <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.35, 0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Later childhood outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Respiratory outcomes in childhood ‐ after 5 years</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Asthma in survivors assessed <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.44, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Forced expired volume in 1 second &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>187</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.36, 0.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 Forced expired volume in 1 second ‐ z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.28 [‐0.14, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Forced expired volume in 1 second ‐ % predicted <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [‐1.26, 13.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.5 Forced expired volume in 1 second ‐ standardised mean difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.02, 0.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.6 Forced vital capacity ‐ z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.31, 0.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.7 Forced vital capacity ‐ % predicted <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.77 [1.79, 13.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.8 Forced vital capacity ‐ standardised mean difference <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>218</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [‐0.02, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.9 FEV₁/FVC % <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [‐3.70, 5.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.10 FEV₁/FVC &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.44, 1.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.11 FEF<sub>25% -75%</sub> ‐ % predicted <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [‐5.40, 19.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.12 Positive bronchodilator response <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.42, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.13 Forced vital capacity &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.24, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.14 Exercise‐induced bronchoconstriction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.13, 5.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Respiratory outcomes in childhood ‐ after 5 years</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Growth in childhood</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Height ‐ z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [‐0.18, 0.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 Height &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>229</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.36, 1.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 Weight ‐ z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.35, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 Weight &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.17, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 Body mass index (BMI) ‐ z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.34, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.6 BMI &lt; ‐2 SD <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.13, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Growth in childhood</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001145-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Blood pressure in childhood</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Systolic blood pressure &gt; 95th centile <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.49, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.2 Systolic blood pressure z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [‐0.43, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.3 Diastolic blood pressure &gt; 95th centile <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>206</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.23, 4.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.4 Diastolic blood pressure z‐score <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.32, 0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Blood pressure in childhood</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001145.pub5/references#CD001145-tbl-0011">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001145.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001145-note-0006">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001145-note-0014">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001145-note-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001145-note-0013">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD001145-note-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001145-note-0012">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD001145-note-0008">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD001145-note-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001145-note-0005">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001145-note-0007">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001145\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001145\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001145\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001145\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001145\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=dLyXbLct&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001145.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001145.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001145.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001145.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001145.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718742006"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001145.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718742010"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001145.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd7c058b3f47a',t:'MTc0MDcxODc0Mi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 